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The human gastrointestinal tract is colonized by a diverse community of symbiotic 
microorganisms, mainly bacteria, that are known to play essential roles in maintaining the health 
of their human host. Disruption of this bacterial community has been associated with numerous 
diseases, including Colorectal Cancer (CRC). CRC is one of the leading causes of cancer-related 
deaths worldwide. As such, focus has been placed on the modulation of the bacterial community 
within the cancer-associated gut microbiome as the next step in possible CRC treatment and 
prevention strategies. To use the bacterial community for these purposes, a better understanding 
of the associations that exist between bacteria within the healthy human gut microbiome and how 
these associations have changed within the CRC-associated gut microbiome is direly needed. In 
this dissertation, we first utilized whole-genome shotgun sequence data from four previously 
published healthy human cohorts to explore the composition and community structure of the 
healthy gut microbiome across populations. We show that despite species carriage differences, 
bacterial communities across healthy human populations are similar in both their structure and 
functional capacities. In addition, we found that positive associations occur between 
taxonomically and functionally related species in the gut microbiome. In follow-up work, we 
employed a similar approach to study the bacterial community composition and structure in late-
stage CRC patient gut microbiomes. We found key differences between CRC and healthy gut 
bacterial communities, suggesting an overgrowth of potentially pathogenic species classified as 
oral microbes. Additionally, a striking difference in the bacterial community structure was found 




tumor formation in the CRC-associated gut microbiome. Overall, our findings shed new light on 
how the bacterial community is structured within the healthy gut microbiome and how this 
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CHAPTER 1: INTRODUCTION 
The Human Gut Microbiome 
Within the intestinal tract of the human body exists a microbial ecosystem that is 
significant enough to human health to be described as a previously unknown ‘organ’ (Baquero & 
Nombela, 2012). This ‘organ’ is commonly referred to as the human gut microbiome and is a 
microbial ecosystem that has coevolved with humans and their ancestors over millions of years 
(Moeller et al., 2016). The human gut microbiome is a remarkably complex microbial ecosystem. 
Its community membership and function are influenced by the direct and indirect interactions 
between all domains of life (Eukarya, Archaea, Bacteria) and viruses. However, out of all 
community members, the bacterial component of the gut microbiome constitutes the largest 
proportion of the gut microbiota where, remarkably, the total number of bacterial cells within the 
gut microbiome is believed to be comparable to the total number of cells of the human body 
(Sender et al., 2016). This bacterial community is not only vastly abundant but also extensive in 
its taxonomic diversity. More than one thousand bacterial species have been found to regularly 
exist within the gut microbiome across human populations, although the taxonomic profile of the 
gut microbiota specific to an individual host is only comprised of around a few hundred (150-
400) species (Lloyd-Price et al., 2016). This variation in bacterial species found across hosts is 
most likely due to the numerous lifestyle factors which have been shown to influence the 
bacterial community composition, such as birth mode, formula or breastfed, antibiotic usage, 
age, sex, geographic location, and genetics, to name a few (Bokulich et al., 2016; Goodrich et al., 




host bacterial carriage rates makes unraveling which species are liable for driving certain 
community functions challenging to discern. Despite community taxonomic disparities, there is a 
general agreement in the literature that the bacteria community functional capacities are highly 
conserved across host gut microbiomes (Human Microbiome Project Consortium, 2012; Visconti 
et al., 2019). This conserved functional capacity is estimated to be an astoundingly rich genomic 
collection consisting of ~150 times more genes than that contained within the human genome 
(MetaHIT Consortium et al., 2010). Accordingly, this makes the gut microbiota a tremendous 
reservoir of foreign genes that can potentially be leveraged to benefit the human host (e.g., 
degradation of complex polysaccharides) (MetaHIT Consortium et al., 2010).  
The relationship between the human host and its symbiotic gut bacteria (i.e., commensal 
bacteria) is believed to be a mutualistic one (i.e., both parties positively benefit). In this co-
beneficial arrangement, the human host provides its commensal gut bacteria a plethora of free 
nutrients, as well as a warm-anoxic (i.e., favorable) environment to colonize. In return, the 
bacterial community provides a breadth of beneficial services critical for maintaining their host’s 
health. One of these valuable services is the supplementation of the host’s metabolism. Bacteria 
in the large intestine have been shown to perform a crucial role in aiding their human host's 
digestion by salvaging essential nutrients through fermenting the indigestible polysaccharides 
and proteins, which make up 10-30% of their host’s total ingested energy (Bergman, 1990). In 
fact, upwards of ten percent of the host’s total energy requirements are provided from the by-
products produced from gut bacterial metabolism (Bergman, 1990). This bacterial service has 




recognized as a possible contributing factor to the formation of metabolic diseases like obesity 
(Devaraj et al., 2013; Musso et al., 2010; Turnbaugh et al., 2006). Interestingly, a study 
performed by Turnbaugh et al. showed that when the gut microbiome of an obese mouse was 
transferred to a lean mouse devoid of bacteria (i.e., a germ-free mouse), it caused a significant 
increase in the total body fat of the lean mouse (Turnbaugh et al., 2006). Moreover, a study by 
Visconti et al. implicated the gut microbiota in the production of 71% of fecal metabolites, as 
well as upwards of 15% of the metabolites found in the host blood, suggesting bacterial 
metabolic by-products are not only important locally but also absorbed and used systemically 
(Visconti et al., 2019). The primary by-products produced from bacterial metabolism are short-
chain fatty acids (SCFAs), bile acids, branched-chain fatty acids (BCFAs), vitamins (e.g., 
vitamin K), ammonia, amines, phenols, indols, sulfur compounds, glycerol, choline, as well as 
carbon dioxide and hydrogen (den Besten et al., 2013; Nicholson et al., 2012). These bacterial-
produced metabolites have been experimentally shown to have essential functions outside simply 
supplementing the host’s metabolism, one of which is modulating the host's intestinal immune 
system (Spiljar et al., 2017). In fact, the development and regulation of the host’s intestinal 
immune system is another essential beneficial service provided by the commensal gut bacteria 
(Honda & Littman, 2016; Y. K. Lee & Mazmanian, 2010; Thaiss et al., 2016).  
The human intestinal tract is the largest mucosal surface of the human body and contains 
the most significant proportion of immune cells (Mowat & Agace, 2014). These immune cells 
are constantly being bombarded with immunostimulatory agents derived from food antigens and 




initiating or inhibiting immune responses to defend against potentially harmful organisms (i.e., 
pathogens) while simultaneously attempting to maintain the relationship with commensal 
bacterial species (i.e., tolerance and homeostasis) (Shibolet & Podolsky, 2007). This is a delicate 
balancing act that must be regulated, as a prolonged activated response by the immune system 
can result in intestinal inflammation and tissue damage. Still, failure to defend and respond to 
invaders can lead to infection, disease, and possibly death. This immune response is modulated 
by the combined functions of the human host and its commensal bacteria, although the exact 
mechanism by either party depends on the specific region of the intestinal tract (i.e., the small or 
large intestine), as they have distinct physiological and anatomical characteristics.  
The small intestine is longer (6-7 meters) than the large intestine (around 1.5 meters) and 
composed of the duodenum, the jejunum, and the ileum, whereas the large intestine encompasses 
the caecum, ascending (proximal) colon, transverse colon, descending (distal colon), and 
rectum/anus. These two intestinal sections are similar in that they are formed by a tube internally 
lined with a single layer of columnar epithelium (Mowat & Agace, 2014). The intestinal 
epithelial cells (IECs) within this layer are continuously shed over a 4–5-day period whereby 
they are then replenished by the multipotent stem cells (i.e., intestinal epithelial stem cells 
(IESCs)) that originate from invaginations in the epithelium, called the crypts of Lieberkühn 
(here on referred to as crypts). Most IESCs will differentiate into absorptive enterocytes whose 
primary function is geared toward metabolic and digestive purposes. IESCs who do not become 
enterocytes will differentiate into secretory IECs (i.e., goblet cells, paneth cells, enteroendocrine 




the intestinal epithelium depends on which region of the intestine the epithelium is within. The 
small intestine is considered a metabolically active organ whose main specialization is to absorb 
nutrients from ingested foodstuffs (e.g., dietary fibers). This absorptive function is aided by the 
formation of epithelial projections, known as villi, which extend into the intestinal lumen, 
increasing the surface area of the epithelium. Since epithelial villi are formed to aid in nutrient 
absorption, they are not found within the large intestine. The main role of the large intestine is to 
reabsorb water and expel any of the remaining undigested foodstuffs. Additionally, the large 
intestine contains most of the gut microbiota. As such, we will focus more on how the host and 
microbiota work together to regulate the intestinal immune response within the large intestine.  
The primary strategy employed by the host to regulate its intestinal immune response is 
to erect physical and biochemical barriers to minimize contact between the cells of the 






Figure 1: The intestinal epithelium and mucus layer within the large intestine. 
Source: Mark Loftus 
 
 
One of the most important of these barriers is the intestinal mucus layer (i.e., glycocalyx) which 
provides physical protection by directly separating the bacterial community from the host cells 
(Hansson, 2012; H. Li et al., 2015). Within the small intestine, the glycocalyx is only one layer, 
but within the large intestine, it is two, most likely due to the greater abundance of bacteria 
existing within the large intestine. The glycocalyx of the large intestine is composed of a ‘loose’ 
outer layer and a denser inner layer attached directly to the epithelium. Mucus is primarily 




forming mucin produced and secreted by goblet cells within the epithelium (Hansson, 2012; 
Lidell et al., 2003). MUC2 has a large O-glycosylated domain and N – and C-terminal domains 
that are cysteine rich, which homo-oligomerizes into a lattice-like structure that covers the 
epithelium forming the layers (Godl et al., 2002; Herrmann et al., 1999; Lidell et al., 2003). 
Despite the outer and inner mucus layers containing similar protein compositions, the outer 
mucus layer is where most commensal bacteria have been shown to colonize, whereas the denser 
inner mucus layer is essentially devoid of bacteria (Johansson et al., 2010). The commensal 
bacteria utilize MUC2 O-glycans in the outer layer to aid their colonization (by attaching with 
their adhesins) and as an energy source (Backhed, 2005). Accordingly, large portions of 
commensal gut bacteria’s genomic content have been shown to target glycan degradation (van 
Passel et al., 2011). This has been postulated to be one mechanism that the human host has 
evolved for regulating the microbial balance of commensal bacterial species (Derrien et al., 
2010; Juge, 2012). The continuous secretion and physical protection provided by the mucus layer 
is vital for regulating the immune response, as the experimental loss of the mucus layer in the 
Muc2-/- mouse colon was shown to lead to bacterial encroachment and penetration of intestinal 
crypts triggering a robust pro-inflammatory response (Heazlewood et al., 2008). Furthermore, 
studies have shown a reduction of the colonic mucin layer within subjects that have 
Inflammatory Bowel Diseases (IBD) (e.g., Ulcerative Colitis) (Podolsky & Isselbacher, 1983). 
Despite being a host-derived product, the mucus layer has been found to require the gut 
microbiota to become fully functional. For example, the mucus layer is thinner and less compact 
in mice depleted of their microbiota due to reduced bacterial-mediated host mucus fucosylation 




Host IECs and immune cells also secrete a biochemical barrier to reinforce the physical 
protection provided afforded by the mucus layer. This biochemical defense comprises numerous 
anti-microbial peptides (AMPs) and immunoglobulins that bind and inhibit bacterial 
trespassing/motility to control but not destroy the native commensal bacteria (Bevins & Salzman, 
2011; Gallo & Hooper, 2012; Schroeder, 2019). For example, enterocytes secrete the AMP C-
type lectin regenerating islet-derived protein III gamma (REGIIIγ) in both the small intestine and 
colon (Mukherjee et al., 2009). Moreover, intestinal dendritic cells (DCs) induce the production 
of Secreted Immunoglobulin A (SIgA) by IgA+ B cells within the colon (Mowat & Agace, 2014). 
SIgA is translocated across the epithelium to target and bind commensal organisms or bacterial-
derived polysaccharides (e.g., lipopolysaccharide) to aid in their rapid detection and subsequent 
removal (Fernandez et al., 2003). It has been shown that without these biochemical defense’s 
bacteria (commensal and pathogenic) can more easily penetrate the mucus layer, reach the 
epithelium, and disrupt the immune response balance (Mowat & Agace, 2014). Lastly, the 
epithelium itself will act as a final barrier if all other physical and biochemical defenses fail to 
stop bacterial migration to the underlying tissues (i.e., lamina propria). When an IEC comes in 
direct contact with a bacterium, or bacterial-derived ligand, they can recruit, activate, and 
condition cells of the intestinal immune system to respond appropriately. IECs are capable of this 
through their cellular expression of pattern-recognition receptors (PRRs), granting them the 
ability to distinguish friend from foe through recognition of microbial-associated molecular 




The proper development of intestinal immune responses to the commensal microbiota 
and the architecture of the intestinal immune system is believed to be influenced by the 
commensal microbiota beginning as early as the host’s birth. The passage through the birth canal 
is the first exposure of the human host, and host immune system, to bacteria. The overall 
importance of this initial bacterial colonization is as yet not completely understood, although the 
mode of birth (i.e., vaginal or cesarean section) has been shown to alter the bacterial community 
that develops within the host gut (Bokulich et al., 2016). Following this first exposure, infant 
intestinal tracts are then directly introduced to commensal bacteria through breastfeeding. Breast 
milk is selectively seeded with live commensal microbes, directly taken from the mother’s 
intestinal tract by DCs, as well as other essential metabolites, immune cells, cytokines, and 
antibodies (e.g., IgA) (Jost et al., 2014; Martín et al., 2003; Pannaraj et al., 2017). Additionally, 
the oligosaccharides in breast milk promote the selective growth of specific commensal bacteria 
within the infant gut microbiome, such as Bifidobacterium and Bacteroides species (Marcobal et 
al., 2010; Marcobal & Sonnenburg, 2012). This imprinting of the neonates’ bare intestines lays 
the foundation for establishing how the host’s immune system tolerates commensal species in the 
long term. In fact, it has been experimentally shown that mice depleted of their gut microbiota 
exhibit impaired immune responses (Iida et al., 2013). Another study performed by John Cebra 
experimentally showed that GF mice display an impaired development of gut-associated 
lymphoid tissues (Cebra, 1999). Additional studies using GF animals have provided evidence 
showing a reduction in immune cell populations (e.g., CD4+ T cells, Th17 cells, Treg cells, and 
Plasma Cells) as well as in size and number of gut-associated lymphoid tissues (i.e., Peyer’s 




2007; Talham et al., 1999). This suggests that the presence of the gut microbiota is essential for 
the proper development and function of the gut mucosal immune system. 
The last beneficial service that gut bacteria provide their human host is their ability to 
prevent the colonization of the host gut by potentially pathogenic organisms. The commensal gut 
bacteria utilize various mechanisms to resist the colonization of their territory (i.e., niche). These 
mechanisms either block pathogen growth, targeting the pathogen for elimination, or prime the 
host’s immune system for defense against the pathogen (Kamada et al., 2013). Commensal 
bacterial species can block pathogen growth due to an invaluable adaptational advantage they 
have over foreign pathogenic bacteria. For example, commensal species that are functionally 
suited for consuming the available nutrients in the gut ecosystem will outcompete species foreign 
to the gut, limiting the nutrients accessible for their growth. Additionally, some of the metabolic 
by-products of commensal species have been shown to inhibit pathogen colonization directly. 
For example, many of the metabolic by-products resulting from bacterial fermentation are acidic 
(e.g., SCFAs) and can lower the local environmental pH in the gut making colonization 
unfavorable to invaders (Cherrington et al., 1991; Shin et al., 2002). Furthermore, gut pathogens 
have difficulty locating available spaces to colonize (e.g., epithelial or mucus-derived sites) as 
the dense commensal bacterial lawn presently occupies most. If these mechanisms fail to curb 
pathogen colonization, then commensal bacteria will directly target the pathogen for elimination. 
As an example, some commensal bacteria have been shown to produce proteinaceous toxins 
(e.g., bacteriocins) to directly target and kill gut pathogens such as enterohaemorrhagic 




provided by the gut commensal bacteria is extremely important for human host health as 
intestinal colonization by pathogenic organisms can lead to infection, tissue damage, and the 
possible dissemination of pathogenic, as well as commensal, bacterial species into the blood 
stream resulting in sepsis, systemic infections, and potentially host death.  
The study of the human-associated microbiome has shown that the human body does not 
correctly function solely through the actions of its cells but as a composite of characteristics that 
exist due to the mutualistic relationship that has co-evolved between human hosts and their 
symbiotic bacteria. These reasons are why the human microbiome has been an important focus of 
researchers across multiple fields in biomedicine. However, when the gut microbiome is 
discussed in present-day articles it usually comes across as a recent field of study that was only 
enabled by the advent of next generation sequencing technologies when in fact it has been a field 
undergoing a tremendous metamorphosis that dates its genesis back over 300 years. 
A Brief History of the Human Gut Microbiome Field 
Human microbiome research is arguably becoming one of the most critical fields in 
biomedical study, given its proven and suspected roles in affecting human health and its potential 
for a breadth of medical applications. The study of the human microbiome is typically regarded 
as a new field of research beginning with the advent of present-day sequencing technologies. 
Indeed, it is inarguable that the creation of these technologies has provided researchers a culture-
independent way to analyze the complexity of microbial ecosystems on a scale that was once 
thought impossible. However, this field is hundreds of years older, and its genesis can be dated 




Antonie van Leeuwenhoek was an “unschooled” chamberlain to the sheriffs of Delft with 
a curious hobby of studying tiny objects using microscopes equipped with high-quality lenses 
that he produced at home. Antonie’s interest in all things small would result in him being the first 
individual to describe and illustrate microorganisms (i.e., protozoans), which he deemed 
“animalcules” (N. Lane, 2015). These observations can be traced to dated letters he wrote to the 
Royal Society of London in the late 17th century (Leeuwenhoek, 1677). Antonie observed these 
“animalcules” within various samples (mostly rainwater) he had collected, although eventually, 
he would also examine samples taken from his (and others) mouth and stool. Furthermore, it is 
believed that Antonie is one of the earliest researchers to have compared differences in the 
microbiota associated with healthy and diseased individuals. From his pioneering work, Antonie 
van Leeuwenhoek is not only attributed with being the founding father of microbiology, but he is 
also the first human gut microbiome researcher, although he would have modestly described 
himself as merely an “observer” (Bellis, 2019).  
Following Antonie van Leeuwenhoek came a plethora of scientific giants (e.g., Leidy, 
Metchnikoff, Koch, etc.) who have inarguably been catalysts for pushing forward the field of 
microbiology. However, this is a brief recount of essential milestones in the history of the human 
gut microbiome field, as such, their total contributions are outside the scope of this dissertation. 
However, we will discuss two of these scientific giants, Louis Pasteur and Theodor Escherich.  
Louis Pasteur was a 19th-century French microbiologist/biochemist who is now justly 
renowned for his scientific accomplishments pertaining to microbial fermentation, vaccine 




notable findings, the two most important for the human gut microbiome field were his discovery 
of anaerobic (i.e., requiring an absence of oxygen) bacterial life and his invention of anaerobic 
culturing methods (Sebald & Hauser, 1995). These discoveries were paramount for advancing 
the gut microbiome field because most bacteria within the colon are obligate anaerobes. Over 
time these anaerobic culturing techniques would, of course, be improved upon by more efficient 
methods (e.g., Robert Hungate’s Roll-Tube (Chung & Bryant, 1997)), but their invention marked 
a new paradigm in research for the gut microbiome field. 
Theodor Escherich was a German-Austrian pediatrician who performed many scientific 
studies in the late 19th century focused on the impact of the intestinal bacteria on human 
physiology and disease (Shulman et al., 2007). He is most famous for his work describing the 
intestinal bacteria of neonates and infants and the importance of the common intestinal organism 
we now call Escherichia coli (Haubrich, 2002). Escherich was one of the first researchers to 
recognize and establish some essential central hypotheses about the gut microbiota: (1) intestinal 
microorganisms interact with one another, (2) the gut microbiota influence physiological 
properties of their host, and (3) organisms in the gut can cause disease (Savage, 2001). His 
hypotheses are now considered foundational cornerstones for research in the human gut 
microbiome for well over a century. Escherich was undoubtedly a brilliant scientist, but he was 
limited by the technology available to him. This sentiment can be felt in an infamous (albeit 
translated) statement of his, “…it would appear to be a pointless and doubtful exercise to 
examine and disentangle the apparently randomly appearing bacteria in normal feces and the 




It would be over 40 years after Escherich’s death until the next major milestone in the gut 
microbiome field. This milestone is marked by the first in vivo gut microbiome experiments 
involving germ-free (GF) mice. GF mice are mice born and raised in sterile conditions so that 
they are not introduced to microorganisms. These conditions result in GF mice having no 
microbiome (including gut microbiome). These mice are routinely used today to study how the 
absence of the bacterial community affects host development and physiology (Laqueur et al., 
1967; Szentkuti et al., 1990). GF mice are known as gnotobiotic mice when they are deliberately 
seeded (i.e., colonized) with a specific bacterium, or bacterial community, to study how certain 
‘designer’ communities (e.g., probiotic species) affect the host. Scientific breakthroughs 
provided from the findings of using GF mice eventually led to the first successful fecal 
microbiota transplantation (FMT) performed by Ben Eiseman. FMT entails transferring the 
‘good’ microbiota from a healthy individual to the gut of a diseased patient in hopes of 
normalizing the microbial community. Eiseman successfully treated a case of 
pseudomembranous enterocolitis, a condition believed to be caused by Clostridium difficile, 
using fecal enemas in 1958 (EISEMAN et al., 1958). Eiseman’s use of FMT was another 
milestone in gut microbiome research as it unequivocally showed that the gut microbiota could 
be used as a treatment for combating disease. Interestingly, FMT is an effective therapy and is 
now considered standard care for treating recurrent Clostridium difficile infections (Abdali et al., 
2020). Despite advancements in bacterial culturing and animal models, researchers were acutely 
aware that they were greatly limited in their knowledge of the true extent of bacterial diversity 
within the human gut microbiome. This limitation was famously described in 1985 by James 




Konopka, 1985). The great plate count anomaly refers to the substantial contrast, usually in the 
order of magnitudes, between the number of bacterial cells that form colonies on agar media and 
the number of countable cells under the microscope. Staley and Konopka contributed species 
nutritional differences and the limitations of conventional laboratory equipment/procedures, at 
the time, as the reason these microbes were yet unable to be cultured. This inability to study the 
‘unculturable’ microbes from the human gut microbiome has plagued gut microbiome 
researchers since the advent of the field. However, this limitation would eventually be relieved 
by the advent of culture-independent techniques (e.g., sequencing). 
The ability to explore bacterial diversity without the need to culture is arguably the most 
significant breakthrough for human gut microbiome research. Today, sequencing technology 
allows microbiologists to determine the sequence of nucleic acid residues (e.g., DNA or RNA) 
originating from microorganisms that exist within environmental samples (i.e., the gut 
microbiome) without the need to culture them. These sequences are termed reads and, depending 
on the sequencing platform utilized (i.e., Illumina), usually comprise hundreds or thousands 
(now recently hundreds of thousands or more) of base pairs long. However, the capability to 
mass sequence the nucleic acid residues (along with proteins, metabolites, etc.) of entire 
microbial communities (e.g., metagenomics) results from decades of technological refinement. In 
fact, the first biological molecule that was sequenced was not a nucleic acid but two chains of an 
insulin protein (Sanger & Thompson, 1953). It would be another twelve years until the first 
nucleic acid (specifically RNA) sequencing techniques were created. Their creation is attributed 




analytical chemistry and selective ribonuclease treatments, Robert Holley and his colleagues 
were able to produce the first whole nucleic acid sequence of alanine transfer RNA isolated from 
Saccharomyces cerevisiae (Holley et al., 1965). In comparison, Frederic Sanger and his 
colleagues developed a technique based on detecting radiolabeled partial-digestion fragments 
after two-dimensional fractionation (Sanger et al., 1965). Regardless of who should be crowned 
first (although that honor is often given to Sanger), the work of both researchers, and their 
colleagues, played an essential role in the birth of the culture-independent era. Naturally, after 
these early applications in RNA sequencing came many breakthroughs in DNA sequencing due, 
in part, to the work of Wu, Sanger, Fiers, Gilbert, and Maxam. (Brownlee et al., 1968; Fiers et 
al., 1976; Gilbert & Maxam, 1973; Maxam & Gilbert, 1977; Sanger et al., 1977; Wu & Kaiser, 
1968). These pioneering sequencing techniques were time-consuming and low throughput as 
they were mainly chemical in approach and considered the first generation of sequencing. It 
would not be until the second generation of sequencing technologies were created, termed Next-
Generation Sequencing (NGS), that gut microbiome researchers began to benefit immensely 
from utilizing sequencing.  
The NGS era began around the early 2000s with the introduction of Massively Parallel 
Signature Sequencing (MPSS) and Pyrosequencing (Barba et al., 2014). These NGS platforms 
would be an accelerant for human gut microbiome research. They reduced sequencing costs and 
produced a greater abundance of data making sequencing more accessible to a greater number of 
researchers (Barba et al., 2014). Additionally, NGS enhanced two paradigm-changing 




amplicon sequencing (e.g., 16S rRNA sequencing), was built off the work of Carl Woese by 
Norman Pace. Carl Woese’s research involving phylogenetic taxonomy and the 16S ribosomal 
RNA gene sequence not only revolutionized microbiology but the entire field of biology. The 
small subunit ribosomal RNA (e.g., 16S rRNA) gene is present in most bacteria, and its sequence 
is highly conserved within taxa providing greater accuracy for measuring evolutionary time and 
taxonomic classification (Janda & Abbott, 2007). As such, in 1977, Woese, along with the aid of 
his postdoc George Fox, used the ribosomal RNA gene as a comparative evolutionary marker, 
and in doing so led to the discovery and classification of the three domains of life (Bacteria, 
Eukarya, and Archaea) (Woese & Fox, 1977). Subsequently, Woese’s work would play a pivotal 
role in Norman Pace’s (and colleagues) application of selectively targeting, amplifying, and 
sequencing the 16S rRNA gene sequences from environmental samples (D. J. Lane et al., 1985). 
This would be the breakthrough needed to start studying bacterial diversity in environmental 
samples without culturing. However, the taxonomic classification accuracy of 16S rRNA 
sequencing suffers from multiple factors: (i) sample type, (ii) reference database used, (iii) 
segment region targeted, (iv) PCR artifacts, (v) identity similarity cut-off used, (vi) non-unique 
16S rRNA sequences between certain species, (vii) multiple copies within genomes, and (viii) 
intragenomic copy variants (Edgar, 2017, 2018). These pitfalls have been shown to result in 
inaccurate classifications of bacteria at the species level and skew estimates of bacterial diversity 
within samples (Edgar, 2017, 2018). Despite these known issues, 16S rRNA sequencing is 
currently the most widely used modern-day sequencing technique for studying bacterial diversity 




The second paradigm-changing technique was “shotgun” sequencing which was 
proposed by Staden, developed by Messing, and employed by Sanger (Messing et al., 1981; 
Sanger et al., 1982; Staden, 1979). It entailed cloning random fragments of a long DNA molecule 
into bacterial vectors, which afterward the fragments are sequenced, and reads are strung 
together using their overlaps. However, shotgun sequencing is considered revolutionary as it 
allowed genomes larger than ever before to be sequenced and would eventually become the 
precursor for Whole-Genome Shotgun (WGS) sequencing. WGS sequencing works by utilizing 
random pieces of DNA within a sample as a primer for the amplification of an organism’s entire 
genome. Interestingly, WGS would be used to sequence the first genome of a living organism (a 
bacterium), Haemophilus influenzae, by The Institute of Genomic Research (TIGR) in 1995 
(Fleischmann et al., 1995). The advent of WGS and its application on samples taken from 
microbial ecosystems brought about the ability to explore the bacterial diversity and the 
functional capability (i.e., genes of bacteria) within environmental samples, now referred to as 
metagenomics. WGS would have a monumental impact on research in the human gut 
microbiome field and eventually be utilized within one of the most iconic human microbiome 
research studies, the Human Microbiome Project (HMP). The HMP was launched in 2007 with 
the specific goal to study and characterize the microbiota associated with the human body to 
understand further how the microbiome impacts human health and disease (Turnbaugh et al., 
2007). WGS sequencing was performed on samples from 300 healthy individuals to characterize 
the microbial community in the nasal passages, oral cavity, skin, urogenital tract, and 
gastrointestinal tract. Interestingly, this same WGS data is utilized, in part, within my dissertation 




microbiome field as it is what brought the microbiome to mainstream audiences (including 
myself). As such, it is no wonder that the study of human-associated microbiota, like that of the 
gut microbiome, is so commonly regarded to be a ‘new’ field brought about by the creation of 
sequencing technologies. The human gut microbiome has now become widely acknowledged, by 
both scientist and the public, to be important for human health. As of today, thousands of studies 
have been and are being performed whose findings cement Escherich’s hypotheses that an 
association exists between human disease and disturbance in the bacterial community within the 
gut microbiome.  
The Gut Microbiome and Colorectal Cancer 
In the past decade, studies focused on the gut bacterial community and its role in human 
health have produced one of the most widely debated ideas in the microbiome field, “dysbiosis.” 
Currently, there is no one definition of “dysbiosis” readily agreed upon in the microbiome 
community (Brüssow, 2020). However, broadly it can be described as any alteration in the 
bacterial inhabitants within the gut microbiome that results in a sub-optimal bacterial community 
for the human host. This sub-optimal community can either be the direct result of disease, initiate 
disease, exacerbate illness, or all the above. As such, within the literature, “dysbiosis” has been 
used more as an ambiguous umbrella term to describe the various gut bacterial community 
alterations associated with numerous host pathologies (not limited to intestinal pathologies), one 
of which is colorectal cancer (CRC).  
The study of colorectal cancer is of great importance as it is one of the most diagnosed 




2020). Cancer is a disease characterized by the cells of the human body failing to regulate their 
growth cycle, eventually leading to uncontrolled cellular proliferation and spreading into 
surrounding tissues/organs. Cancers that are detected within the colon and rectum are regularly 
grouped hence the term colorectal cancer. CRC comprises multiple stages and primarily begins 
with the mutation of DNA (i.e., driver mutations) within a cell of the intestinal epithelium 
leading to cell cycle dysregulation and formation of a cellular mass in the inner lining of the 
colon or rectum, referred to as a polyp. Polyps are classified as either adenomatous (i.e., 
adenoma) or serrated, based on their growth pattern, though adenomas are the most common. 
There are often no symptoms at this early stage of cancer growth, making routine screening in 
individuals crucial for its early detection. In fact, in a screening study performed by Corley et al., 
polyp formation was detected in half of the individuals undergoing colonoscopy 50 years of age 
or older, thereby showing polyp formation is prevalent, especially among older men (Corley et 
al., 2013). Despite the high prevalence of polyp formation, it is estimated that less than 10% of 
polyps will progress to the invasive cancer stages (Levine & Ahnen, 2006; Risio, 2010). The 
transformation of polyp into a cancerous tumor can take many years, upwards of 20, and is more 
likely to happen the larger the polyp is allowed to grow (Stryker et al., 1987; Winawer & Zauber, 
2002). Tumors that do form within the colon and rectum have been found to vary in their 
molecular, biological, and clinical features (Street, 2020). However, if given enough time and left 
untreated, all cancerous tumors will eventually infiltrate the nearby blood and lymph vessels. If 
this occurs, cancerous cells will spread to distant tissues of the body (i.e., metastasis) and most 




(stages 0-4; four being the worst) that are classified based on both the extent of epithelial 











Figure 2: Simplified overview of tumor growth throughout colorectal cancer stages. Tumors can 
form throughout the large intestine (colon or rectum), which can be seen in the blue panel 
colored pink. (a) A cell within the intestinal epithelium that has mutated due to DNA damage 
(red cell). (b) An early stage of CRC where unrestricted cellular division has resulted in the 
formation of a polyp/early tumor which is extending into the lumen (yellow) of the large 
intestine. (c) A later stage of CRC where the tumor has grown and begun to infiltrate into the 
lamina propria (light pink) of the large intestine. New blood vessels have begun forming (i.e., 
angiogenesis) to supply the tumor with oxygen and nutrients. By this point immune cells (pink 
cells) have also been drawn to the tumor. These cells will eventually be inhibited and 
reprogrammed by cancer cells to aid their cancerous growth. (d) The tumor has continued to 
grow, and cancerous cells have infiltrated the blood vessels and begun to spread to distant tissues 
of the body (i.e., metastasis).  





CRC during stage 0 is referred to as in situ cancer as cancerous cells are still located within the 
mucosa/inner lining of the colon or rectum. Stage I CRC is where the cancerous tumor has 
grown beyond the colon's inner lining but has not spread outside the colon wall or to the nearby 
lymph nodes. In stage II CRC, the cancerous tumor has grown through the colon wall but has yet 
to spread to the nearby lymph nodes. In stage III CRC, cancerous cells have spread to the nearby 
lymph nodes but have yet to metastasize to other body tissues. Lastly, stage IV CRC is where 
cancer has metastasized to distant tissues and organs (most often the liver). The stage at which 
CRC is diagnosed is considered the most important predictor for patient survival, but 
unfortunately, only around 38% of CRC patients are diagnosed during the early localized stages 
(Street, 2020). My dissertation research, in part, focuses on the gut microbiome within subjects 
that have been diagnosed with late-stage (i.e., stage III and IV) CRC.  
As of now, the exact etiological mechanism of colorectal cancer formation is not known, 
but the majority (~90%) of CRC cases are attributed to genetic and environmental risk factors 
(Street, 2020). These risk factors can be further classified as either being nonmodifiable or 
modifiable. Nonmodifiable risk factors are outside an individual's control, such as heredity 
(family history) and medical history (e.g., chronic inflammatory bowel disease, diabetes, etc.). 
Family history is considered one of the most critical risk factors of CRC formation as 30% of 
CRC patients have been shown to have a history of the disease within their family (Lowery et al., 
2016; Patel & Ahnen, 2012). In contrast to the relatively few nonmodifiable risk factors, there 
are numerous modifiable risk factors such as smoking, alcohol consumption, physical inactivity, 




diets) (Feng et al., 2015; Nakatsu et al., 2015; J. Yu et al., 2017). Interestingly, these modifiable 
risk factors have also been shown to produce changes in the bacterial composition within the 
human gut microbiome (Watson & Collins, 2011). This has been a point of interest to gut 
microbiome researchers who firmly believe there is a connection between alterations in the gut 
microbiota and colorectal cancer formation/progression.  
The first experimental connections between CRC susceptibility and the gut microbiota 
can be dated back to an early study performed by Laquer et al., which showed that germfree rats 
given glucoside cycasin (a hepatotoxin and carcinogen) fail to produce the same carcinogenic 
effects as those seen in conventional rats (Laqueur et al., 1967). These carcinogenic effects were 
shown to be due to the action of beta-glucosidase, of bacterial origin, which mediates the 
liberation of aglycone (the proximate carcinogen) from the glucoside cycasin. Naturally, as 
technology (i.e., sequencing technology) has progressed, so has our ability to study the 
relationship between gut microbiota and colorectal cancer. As a result, there are now numerous 
studies suggesting that the gut microbiota may contribute not only to the development but also 
the progression and treatment efficacy of CRC (Feng et al., 2015; Kostic et al., 2013; Nakatsu et 
al., 2015; T. Yu et al., 2017). Sequencing based studies comparing the healthy human gut 
microbiome and the CRC-associated gut microbiome routinely show a global shift in the 
bacterial composition within the microbiota, suggesting a change in the ecological 
microenvironment that exists within CRC patients (Ahn et al., 2013; Feng et al., 2015; Sobhani 
et al., 2011; T. Wang et al., 2012; J. Yu et al., 2017; Zackular et al., 2014; Zeller et al., 2014). 




sequencing data, CRC stage, etc.), there are a few select bacteria that are regularly found to have 
an association with CRC, such as Fusobacterium nucleatum, Bacteroides fragilis, and 
Escherichia coli (Bonnet et al., 2014; W. T. Cheng et al., 2020; Kostic et al., 2013; Swidsinski et 
al., 1998; Ulger Toprak et al., 2006). However, there is no consensus across all studies of any 
individual bacterium being associated with CRC. This lack of agreement could be because 
colorectal cancer progresses in stages, and as such, changes in the bacterial community, or a 
single species, are stage-specific. This sentiment is reflected by one of the leading models 
describing the bacterial involvement in CRC development, the “driver-passenger model,” which 
proposes that different bacterial species will associate with the tumor as it develops through its 
growth stages (Tjalsma et al., 2012). Nevertheless, it is generally agreed upon by cancer gut 
microbiome researchers that there are at least four possible mechanisms thereby which bacteria 
within the gut microbiota could directly, or indirectly, influence cancer initiation and progression 
which are: (i) Genotoxicity, (ii) Bacterial Metabolism (iii) Inflammation, and (iv) Immune 
System Modulation (Scott et al., 2019).  
Genotoxicity refers to the bacterial involvement in producing structural damage to the 
DNA within the human host’s cells. If damage to the DNA occurs in specific regions (i.e., proto-
oncogenes or tumor-suppressor genes) and is not repaired, it can result in the formation of a 
cancerous cell phenotype. For example, Escherichia coli, a common species found in the gut 
microbiome, is known to contain within its genome the capability to produce a genotoxin called 
cytolethal distending toxin (CDT). CDT has DNAse capabilities which can induce double-




2004). Bacterial toxins are not the only way bacteria can cause DNA damage, as certain by-
products produced from the metabolic activity of the normal commensal gut bacteria have been 
experimentally shown to produce genotoxic effects. For example, hydrogen sulfide (HS) is 
released by the sulfate-reducing Bilophila wadsworthia, a bacterium also regularly found in the 
human gut microbiome, while converting taurine to acetate and ammonia. HS has been shown to 
directly produce genotoxic effects in Chinese Hamster Ovary and HT29-CI cells (Attene-Ramos 
et al., 2006). This study suggests that human hosts containing a genetic background predisposing 
them to compromises in cellular DNA repair mechanisms could be at risk of genomic instability 
and cancer formation when exposed to bacterial-produced HS (Attene-Ramos et al., 2006). 
Unsurprisingly, many of the genetic markers used today to screen individuals on their 
predisposition to CRC are linked to DNA repair mechanism genes (e.g., MSH2) (Peluso et al., 
2017).  
Inflammation is a vital defense mechanism that the body uses for protection and healing 
after an infection or injury (Hakansson & Molin, 2011). The cellular release of pro-inflammatory 
mediators drives inflammation (e.g., Interleukin-6), resulting in increased blood flow, swelling of 
tissues (due to an outflow of proteins and fluids from the blood), and immune cell recruitment to 
the target site (i.e., injury). This process supplies the wounded tissue with nutrients and other 
components necessary (e.g., growth factors) to aid cellular proliferation for tissue regeneration. 
Inflammation can be short-term (i.e., acute inflammation) or long-term (i.e., chronic 
inflammation), depending on if the inflammation source can be eliminated. Interestingly, chronic 




feature accompanying most cancers (Coussens & Werb, 2002). Interestingly, tumors are regularly 
regarded as a wound that the body cannot heal (Dvorak, 1986). Bacteria within the gut 
microbiome can induce a pro-inflammatory response in the gut, which could either initiate or aid 
the progression of tumor development. For example, if host gut barriers fail to inhibit bacterial 
translocation, the intestinal tissue would be exposed to immunogenic bacterial compounds (i.e., 
virulence factors or antigens), leading to a strong pro-inflammatory immune response. During 
this pro-inflammatory response, reactive nitrogen species (RNS) and reactive oxygen species 
(ROS) would be produced by the innate immune system, and the overproduction of these 
molecules is known to generate oxidative damage (i.e., genotoxic mutations) to host cell DNA 
(Weidinger & Kozlov, 2015). This results in creating a positive feedback loop where chronic 
inflammation leads to an abundance of DNA damage and cell senescence, giving rise to more 
inflammation continuing the cycle (Rodier et al., 2009). Eventually, this DNA damage could lead 
to a mutation initiating cancer development. If a tumor is currently formed, a bacterial infection 
will aid cancer progression by exacerbating inflammation stimulating further production of 
cytokines/growth factors driving cell survival, proliferation, and angiogenesis. Angiogenesis is 
the growth of new blood vessels and is particularly important as it supplies direly needed oxygen 
and nutrients to cancer cells within the tumor, aiding its development (Francescone et al., 2014; 
Karin, 2006). Furthermore, the bacterial-induced inflammation acts as a recruitment signal 
bringing additional innate (e.g., neutrophils, dendritic cells, natural killer cells, macrophages, 
mast cells, and myeloid-derived suppressor cells) and adaptive (e.g., B and T lymphocytes) 




The modulation of the gut immune response is the last mechanism by which bacteria can 
promote CRC progression. Typically, when these immune cells are recruited to sites of 
inflammation, their role is to sustain inflammation, eliminate any infectious agents or dead 
cellular debris, and then resolve the inflammation (Hakansson & Molin, 2011). However, when 
immune cells (e.g., Macrophages) are recruited to the TME, cancer cell activity will polarize 
these cells, converting them from a tumor-suppressive (e.g., M1 Macrophage) to tumor-
promoting (e.g., M2 Macrophage) cell type, thereby subverting normal immune functions to aid 
in tumor development (Gonzalez et al., 2018; J. Wang et al., 2019; Zamarron & Chen, 2011; X. 
Zheng et al., 2017). Tumor cells can be aided in this endeavor by certain bacteria. For example, 
Fusobacterium nucleatum, a bacterial species classified as an oral anaerobic bacterium but is 
commonly found enriched in fecal, and tumor mucosal samples from CRC-associated gut 
microbiomes, was shown to potentiate tumor multiplicity by assisting in the recruitment of 
tumor-infiltrating myeloid cells (macrophages, dendritic cells (DCs), granulocytes) through 
activation of the nuclear factor-kB (NF-kB) pro-inflammatory pathway (Kostic et al., 2013). 
Interestingly, F. nucleatum also possesses the capability to impair the host’s anti-tumor immune 
functions (Kostic et al., 2013). This immune impairment has been experimentally shown in a 
study performed by Chamutal Gur and colleagues, which showed that the Fap2 protein of F. 
nucleatum could bind to T cell immunoglobulin and ITIM domain (TIGIT), an inhibitory 
receptor on natural killer (NK) cells leading to the direct inhibition of their tumor-killing 
cytotoxic activity and increasing cancer cell immune evasion (Gur et al., 2015). The bacterial 




development. Still, it is also imperative to recognize that it holds invaluable capabilities that can 
be harnessed towards combating cancer. 
Current Cancer Treatments and the Gut Microbiome 
Current colorectal cancer treatment regimens involve a patient-tailored combination of 
surgery, radiation, and systemic (e.g., chemotherapy, immunotherapy, etc.) therapies whose 
mixture is primarily based on the cancer cell’s molecular genotype and stage at diagnosis. If the 
tumor is detected early enough (e.g., stage I), then typically, only a minor surgery (e.g., local 
excision) to remove the cancerous tumor and a section of the surrounding healthy tissue is all 
that is required. This surgery usually results in minimal side effects, and the patient would only 
be required to have routine maintenance screenings to be watchful for tumor recurrence. Doctors 
may elect to utilize a combination of surgery, radiation therapy (e.g., external-beam, stereotactic, 
intraoperative, brachytherapy) and systemic therapies if the cancer is further along. The term 
radiation therapy describes the directed use of high-energy x-rays to target and destroy cancer 
cells. This form of treatment is usually performed in combination with surgery, either before or 
after, and typically consists of multiple treatments spaced out over some time (e.g., days to 
weeks). Radiation therapy produces side effects such as upset stomach, loose bowel movements, 
fatigue, and sometimes bleeding, but these are short-lived. Patients diagnosed with late-stage 
CRC, such as those studied within the research of this dissertation, are additionally prescribed 
systemic therapies. Systemic therapy is a blanket term that covers chemotherapeutic drugs (e.g., 
Capecitabine, Fluorouracil, Irinotecan, etc.), targeted therapies (e.g., Bevacizumab, Regorafenib, 




Chemotherapeutics are given intravenously or in capsule form and work by inhibiting the growth 
and division of cancer cells. Nausea, diarrhea, tiredness, and hair loss are some of the typical side 
effects of chemotherapy. These side effects can be difficult to handle for many patients but 
usually abate after their treatment is finished. Targeted therapies are more specialized as they 
target specific genes or proteins in the cancer cell or indirectly by altering the TME. For 
example, some targeted therapies are designed to inhibit angiogenesis, thereby effectively 
“starving” the cancerous cells within the tumor of essential nutrients needed for their growth and 
dampen their ability to spread to other parts of the body. These therapies are preferred as they 
limit the damage done to healthy cells and only produce mild side effects like skin rashes. Lastly, 
Immunotherapies are explicitly designed to improve the function of the natural anti-cancer 
defenses of the body’s immune system. For example, the immunotherapy drug Pembrolizumab 
targets the programmed cell death protein 1 (PD-1) receptor of tumor cells which hinders the 
capability of tumor cells to obscure themselves from the immune system leading to their T-cell 
mediated destruction (McDermott & Jimeno, 2015). Immunotherapies have a range of side 
effects, depending on the immunotherapy received, which typically include rashes, fatigue, 
nausea, muscle pains, fever, and vomiting. Overall, these treatments largely employ a tumor-
centric approach for combating cancer, but unfortunately, they too often produce patient 
suffering and death. Recently, a significant amount of attention has shifted toward the 
modulation of the gut microbiota within cancer patients as a novel way to combat cancer and 





Figure 3: Modulation of the bacteria community for therapeutic purposes. Researchers seek to 
understand how best to modulate the bacterial community through selective elimination or 
introduction (perhaps both) of gut bacterial species to aid CRC treatment. Bacteria community 
modulation can dampen cancer progression, improve the efficacy of anti-cancer drugs, lessen 
treatment side effects (e.g., diarrhea), and improve the emotional state of cancer patients.  
Source: Mark Loftus 
 
 
Approval towards the modulation of the gut bacterial community for therapeutic purposes 
has been growing as more evidence emerges suggesting the composition of the bacterial 
community within the gut has a measurable effect on tumor growth dynamics, the 




treatment side effects, as well as the emotional state of cancer patients (W. Y. Cheng et al., 2020; 
O’Keefe et al., 2015; D.-W. Zheng et al., 2019). Modulation broadly refers to introducing, 
eliminating, or cultivating select bacterial species within a cancer patient’s gut microbiome to 
improve their clinical outcome. This procedure first requires that a cancer patient’s gut bacterial 
community profile be created from a fecal sample (i.e., sequencing). Once a patient’s gut 
community profile has been established, doctors can identify bacterial species for elimination 
that could be promoting tumor progression or negatively impacting treatment efficacy, as well as 
pinpoint commensal bacteria that are missing, or reduced in abundance, for gut seeding in hopes 
of bolstering patient prognosis. Essentially there are two preeminent techniques that researchers 
may employ to modulate a patient’s bacterial community. The first method involves the total 
replacement of the patient’s gut bacterial community by using broad-spectrum antibiotics to kill 
all species indiscriminately (i.e., cleansing) followed by fecal microbiota transplantation (FMT). 
FMT refers to the transfer of the entire gut microbiota from a healthy subject to the cancer 
patient. This method is not without risks as it requires the cancer patient to undergo anesthesia to 
deliver the donor stool to their intestine through colonoscopy. It may also inadvertently expose 
the cancer patient’s bare intestines to potential pathogens if the donor stool is not thoroughly 
screened. Nonetheless, FMT is promising for cancer patients undergoing radiation therapy. FMT 
has been shown to reduce radiation-induced gastrointestinal toxicity, increase survival rates, 
improve intestinal epithelial integrity, and elevate peripheral white blood cell counts in irradiated 
mice (Cui et al., 2017). The second community modulation method entails using techniques that 
provide greater precision pertaining to which bacterial species are eliminated from the gut. For 




eliminate Fusobacterium nucleatum from the gut microbiota, which led to improving the 
effectiveness of irinotecan (a chemotherapeutic) against colorectal cancer cells (D.-W. Zheng et 
al., 2019). Bacteriophages (i.e., phages) are viruses that target and prey on specific bacteria, and 
their engineered use with the CRISPR-Cas9 system, or nanotechnologies, provides greater 
control and minimizes damage to commensal species (Bikard et al., 2014; Citorik et al., 2014; 
D.-W. Zheng et al., 2019). Following the targeted elimination of specific bacteria (i.e., harmful 
bacteria) from the gut, the patient may be given a probiotic containing a specifically devised 
payload of live commensal bacteria to boost the abundance of species designated as beneficial. 
Probiotic intervention has been shown to directly alter the bacterial profile taken from cancer 
patient tumor tissues and nearby mucosa (Hibberd et al., 2017). For example, Bacteroides 
species in the gut have been shown to increase the effectiveness of immune checkpoint inhibitors 
(ICIs) (Frankel et al., 2017; Vetizou et al., 2015). Historically, ICIs have been shown to enhance 
T cells' anti-tumor immune responses greatly, but only in a small proportion of patients and only 
for limited durations (Cogdill et al., 2017). As such, the targeted removal of harmful bacteria 
combined with the supplementation of beneficial species known to increase the effectiveness of 
cancer treatments, like ICIs, could be a potential new avenue for inhibiting cancer progression 
while improving clinical responses making specific treatments viable for a more significant 
number of cancer patients.  
A prebiotic may also be given to cancer patients to aid methods in modulating the gut 
microbiota. Prebiotics are capsules filled with dietary fiber. They are ingested to stimulate the 




promoting the microbial production of health-promoting metabolites. One such important 
metabolite being used for combating cancer is the SCFA butyrate (Encarnação et al., 2015). 
Butyrate is formed from bacterial fermentation of dietary fibers and has been experimentally 
shown to have potent anti-inflammatory and anti-tumorigenic effects (Canani, 2011; Dahm et al., 
2010). The mechanism behind these effects has been experimentally shown to be due to butyrate 
acting as a histone deacetylase inhibitor. Butyrate inhibition of histone deacetylases suppresses 
malignant transformation and stimulates apoptosis in cancer cells (Waldecker et al., 2008). 
Unsurprisingly, diets high in fiber and low in fats are associated with a lower risk of CRC 
development, and the loss of butyrogenic bacteria in the gut is associated with higher risks of 
CRC (Dahm et al., 2010; Encarnação et al., 2015; O’Keefe et al., 2015). Nevertheless, butyrate 
production from dietary fiber introduced through prebiotic consumption is just one example of 
how bacterial metabolic activity can be harnessed to aid cancer patient treatment. An additional 
and often overlooked potential application for modulating the gut bacterial community is to 
assist cancer patient palliative care.  
Palliative care is focused on relieving physical symptoms and improving the emotional 
state of patients (i.e., enhancing quality of life) while undergoing their cancer treatment. 
Unfortunately, many of the current forms of cancer treatments can result in debilitating side 
effects/physical symptoms, which alone can produce intense negative psychosocial factors (i.e., 
stress and depression) in patients. Moderation of these psychosocial factors through emotional 
regulation is crucial as it has been shown to positively impact the long-term outcomes of cancer 




pathways between the gut microbiota and the host's central nervous system (CNS), deemed the 
microbiome-gut-brain-axis (Bercik et al., 2010; Carabotti et al., 2015; Cryan & O’Mahony, 2011; 
Forsythe et al., 2010). Unfortunately, this connection between host CNS function and gut 
microbiota composition/function is still unknown. However, evidence suggests it involves the 
neural pathways (vagus and enteric nervous system) that interface with the gastrointestinal tract 
and the metabolic activity of the gut microbiota (Carabotti et al., 2015; Cryan & Dinan, 2012; 
Cryan & O’Mahony, 2011). For example, a study in mice performed by Javier Bravo 
demonstrated region-dependent alterations in GABAB1b mRNA in the brain induced by chronic 
treatment with Lactobacillus rhamnosus (JB-1) (Bravo et al., 2011). This alteration resulted in 
reduced corticosterone production and depression- and anxiety-related behavior in mice, but only 
while the vagus nerve was left intact (Bravo et al., 2011). As of today, various studies have 
shown alterations of the gut microbiome bacterial community composition in subjects with CNS 
disorders such as anxiety, depression, autism, and schizophrenia (Carabotti et al., 2015; Dinan et 
al., 2013; Mayer et al., 2014). It is now becoming generally accepted that the gut microbiota is a 
key determinant in the direct regulation of positive emotions and the mental well-being of their 
human host (S.-H. Lee et al., 2020). 
The gut microbiome bacterial community can also aid patient palliative care by indirectly 
improving the emotional state of cancer patients by lessening the intensity/toxicity of treatment 
side effects. For example, numerous studies have shown that the appropriate use of probiotics 
containing select commensal species (e.g., Lactobacillus rhamnosus GG (LGG)) provided daily 




can be a safe alternative for reducing diarrhea symptoms (Y.-H. Wang et al., 2016). Lessening 
side effects such as diarrhea in cancer patients improves their quality of life and the efficacy of 
their treatment. Furthermore, diarrhea is a sign that the patient’s body cannot tolerate the 
standard dose of medicine necessary to combat their cancer. Consequently, their treatment 
dose/frequency could be reduced, resulting in a suboptimal regimen (Banna et al., 2017). 
Therefore, the purposeful modulation of the gut microbiome composition affords new 
opportunities (both direct and indirect) for physicians seeking to enhance cancer patients' 
emotional well-being and, therefore, patient prognosis.  
Overall, these insights have significant implications about how the gut microbiota must 
be factored into the future design of cancer patient treatment strategies. However, to truly 
modulate bacterial communities for these purposes requires additional knowledge beyond the 
fundamental differences in the bacteria community taxonomic/functional profiles between 
healthy and CRC-afflicted individuals. Researchers need a better understanding of the gut 
bacterial community structure in healthy individuals and how this structure has been altered in 
CRC-associated gut microbiomes.  
Bacterial Community Structure 
The complex ecological relationships existing between bacterial species (i.e., the bacteria 
community structure) is what ultimately dictates the microbial distributions, abundances, and 
functions within microbial ecosystems (e.g., the human gut microbiome) (Hibbing et al., 2010). 
Relationships between bacteria are often formed due to a similarity in niche preference or 




(e.g., competitive). For example, it is well-known that a positive relationship exists between 
methanogens and obligate anaerobes within the gut microbiome, where methanogens (e.g., 
Methanobrevibacter smithii) will utilize the hydrogen molecules that the obligate anaerobes 
produce as waste (Dridi et al., 2011). Studying the bacterial relationships within the human gut 
microbiome is challenging as the gut is relatively inaccessible for direct examination and 
reproducing its exact environmental conditions outside of the body is problematic and incredibly 
complex. For these reasons, researchers elect to use associations (e.g., positive or negative 
associations) as a proxy for the true underlying relationship existing between bacteria. These 
associations are inferred from bacterial counts within multiple gut microbiome biological 
samples (usually fecal samples). A sample-taxa matrix is created from the total count of each 
bacterial taxon within each sample, and then mathematical models are applied to predict the 
associations from co-occurrence or correlation patterns within the matrix, referred to as network 
inference (Faust & Raes, 2012). Network inference methods vary in their simplicity and span of 
use. The easiest and most employed network inference methods researchers use are pairwise 
techniques, like correlations (e.g., Pearson or Spearman), computed from the co-occurrences or 
abundances of bacteria across samples. Pairwise techniques can predict the relationship between 
two species but are incapable of disentangling more complicated interactions. For example, 
interactions where more than one other bacterial species influence a bacterium. Therefore, 
different techniques must be used to capture these more complex ecological interactions 
(Agrawal et al., 1993; Faust & Raes, 2012). However, no matter which network inference 
method a researcher utilizes to infer the microbial associations within their samples, numerous 




The main pitfall of network inference originates from how the bacterial count data is 
produced (i.e., sequencing). Historically, bacterial counts were produced from culture-based 
methods but are now routinely generated from sequencing samples. The problem is that data 
produced from sequencing techniques are compositional (Gloor et al., 2017). Compositional data 
only provide the relative abundance of the constituent taxa within a sample, not their true 
absolute abundance counts (Gloor et al., 2017). Therefore, computing correlations directly from 
bacterial relative abundances provided from sequencing data is incorrect as compositional data is 
constrained by the simplex (i.e., sums to one) and will result in producing erroneous results (i.e., 
compositionality bias) (Aitchison, 1982). For example, if one bacterial species’ relative 
abundance accounts for most of the total sample relative abundance, and that species decreases 
in its relative abundance, then all other species will increase in their relative sample abundance, 









Figure 4: Correlation applied to compositional data produces artefactual associations. (G) and (P) 
represent green and purple bacteria, respectively. The left panel shows an example of 
compositional data (species relative abundances), whereas the right panel displays absolute 
counts. Since compositional data is constrained, when one species’ relative abundance increases, 
the second species’ relative abundance will be forced to decrease, even if there is no actual 
change in the second species true abundance. If a correlation is applied to their relative 
abundances across samples, it will result in a false negative association between those two 
species. From the absolute bacterial counts, we can see no relationship between the increase in 
one species’ abundance and the abundance of the second species. 








This would produce an artefactual correlation stating that the highly abundant bacterial species is 
negatively associated with the other species when this is just a by-product of the data itself and 
not a genuine relationship. The proper way to relieve this compositional data constraint is by 
applying a log-ratio transformation (e.g., Centered Log-Ratio; CLR-transformation) to the 
relative abundance data, which first requires treating the zero values of bacterial abundances 
within the sample-taxa matrices. Sample-taxa matrices produced from sequencing the human gut 
microbiome (i.e., fecal samples) are known to contain a large proportion of zeros. A zero can 
either mean a bacterium is genuinely absent or that the abundance of that species within the 
sample was beneath the detection level of the sequencing technology. No matter the reason for 
these bacterial zero counts, if they are retained, a log-ratio transformation cannot be applied as 
this would result in negative infinities (Aitchison, 1982). Luckily, this can be quickly addressed 
by replacing all the bacterial zero counts with a minimal value before applying the log-ratio 
transformation. A study performed by Rasmussen et al. showed that replacing zeros with a value 
less than the smallest observation does not affect the relative structure of the data (Rasmussen et 
al., 2020). The high prevalence of zeros within microbiome sample-taxa matrices is related to 
another pitfall, data sparsity. Data sparsity refers to there being fewer samples compared to total 
species (i.e., large p small n problem) within a sample-taxa matrix. For example, to infer the 
community structure of p total species, there will be p * (p -1) / 2 associations that need to be 
determined. When there are hundreds of more species than samples, this results in an under-
determined system of equations. Data sparsity can be addressed either by having more samples 
or by assuming the overall network of bacterial associations is sparse (i.e., total bacterial 




researchers is the incorrect prediction of a relationship between two bacteria because of their 
actual relationship to a third bacterium (i.e., conditional independence). For example, an indirect 
negative correlation could arise between two species that are strongly and oppositely associated 
with a third species (i.e., one has a strong positive association the other a strong negative 
association). This pitfall can be subverted by simply utilizing a network inference technique that 
computes the conditional independence between bacteria. These pitfalls in bacterial association 
network constructed are all addressed in this dissertation research and is discussed in greater 
detail within chapter two.  
Once associations between bacteria have appropriately been inferred, the bacterial 
community structure can be modeled as a weighted graph (i.e., a network of associations). In a 
weighted graph, species are represented as nodes, and the association between those species are 








Figure 5: Bacterial association network modeled as a weighted graph. Within the graph, bacterial 
species are represented as nodes, and the edge existing between two nodes is the weighted 
association (green = positive, red = negative) occurring between those two species.  
Source: Mark Loftus 
 
 
Network modeling of bacterial associations has previously been shown to reveal critical aspects 
of microbial ecosystems such as bacterial niches, important species (e.g., keystone species), 
functional species groups, and alternative community configurations (Faust & Raes, 2012; Steele 
et al., 2011). In the following chapters, I will discuss our findings from studying bacterial 
association networks constructed from WGS sequenced fecal samples provided by multiple 




Dissertation Research Focus and Study Design 
This chapter introduces the human gut microbiome, the bacterial community, their 
services, sequencing data, CRC, how bacteria within the gut microbiome can influence CRC 
initiation and progression, bacteria as a cancer treatment aid, and how bacterial community 
structure is inferred. Subsequently, the following chapters of this dissertation detail my research 
and findings of the bacterial community composition and structure in the healthy and CRC-
associated gut microbiomes and some possible conclusions from these findings. This dissertation 
research is split across two separate studies. The first study aims to expand the current 
understanding of the bacterial community structure in the healthy human gut microbiome. This 
refers mainly to learning how the bacterial community taxonomic and functional composition 
relates to the community structure and if this structure is similar/maintained across multiple 
healthy human populations. In addition, I explore which bacteria species exhibit positive and 
negative associations with one another and which species are potentially the most important for 
maintaining the community structure. It was imperative to find the answer to these questions 
first. They are crucial for the second half of my dissertation research, which focuses on 
understanding how the healthy gut bacterial community structure has been altered in the late-
stage CRC-associated gut microbiome. The findings from this dissertation research will provide 
a much-needed foundation for future researchers wishing to modulate the bacterial community in 
the late-stage colorectal cancer gut microbiome for therapeutic purposes.  
Most of the current understanding of the bacterial community structure is based on 




minimally explored. Regrettably, the bacterial association networks constructed within those 
studies are typically produced from correlations computed directly from sequence data (i.e., 
compositional data), making any conclusions formed from these networks uninformative, 
suspect, and unreliable. Moreover, the few studies that utilize correct (i.e., compositionally 
robust) network inference techniques mainly apply these techniques to bacterial abundances 
produced from lower-taxonomic resolution data (i.e., 16S rRNA sequence data), resulting in 
genus-level networks, not species-level. As such, there is very little high-quality data available 
on the bacterial community structure within the healthy gut microbiome, let alone the CRC-
associated gut microbiome. This gap is that which I hope to fill with the findings from my 
dissertation research. A simplified overview of the dissertation study designs can be seen below 
(Figure 6). We began by collecting WGS fecal sample data originally produced from four large, 
previously published healthy human cohorts (American, European, Indian, and Japanese) and a 
cohort of late-stage (stage III and IV) CRC patients. Collectively, we mapped billions of reads, 
totaling trillions of base pairs, to nearly eleven thousand bacterial reference strain genomes. 
WGS data granted us the ability to explore the taxonomic composition and community structure 
of the gut microbiome at the species-level, while also incorporating information on the functional 
capacities of the whole community and individual species. Overall, by making the bacterial 
community structure a central focus and applying compositionally robust network inference 
techniques to WGS data, the findings discussed in the following chapters of this dissertation are 






Figure 6: A simplified overview of the dissertation research study design. WGS data were 
collected, cleaned, and mapped to 10,839 bacterial reference strain genomes. This resulted in a 
species-level sample-taxa matrix used to study the bacterial community taxonomic composition 
and structure. In addition, bacterial reference genomes were functionally annotated in-house, and 
the functional capacity within WGS reads was measured and explored. Overall, the bacterial 
community taxonomic and functional compositions were analyzed and linked to community 
structure.  
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In a microbial community, associations between constituent members play an important 
role in determining the overall structure and function of the community. The human gut 
microbiome is believed to play an integral role in host health and disease. To understand the 
nature of bacterial associations at the species level in healthy human gut microbiomes, we 
analyzed previously published collections of whole-genome shotgun sequence data, totaling over 
1.6 Tbp, generated from 606 fecal samples obtained from four different healthy human 
populations. Using a Random Forest Classifier, we identified 202 signature bacterial species that 
were prevalent in these populations and whose relative abundances could be used to accurately 
distinguish between the populations. Bacterial association networks were constructed with these 




conserved bacterial associations across populations and a dominance of positive associations 
over negative associations, with this dominance being driven by associations between species 
that are closely related either taxonomically or functionally. Bacterial species that form network 
modules, and species that constitute hubs and bottlenecks, were also identified. Functional 
analysis using protein families suggests that much of the taxonomic variation across human 
populations does not foment substantial functional or structural differences. 
Introduction 
The community of microbial cells in the human gut is estimated to be comparable in 
magnitude to the number of human cells (Sender et al., 2016). This community, deemed the 
human gut microbiome, is mainly composed of bacteria, archaea, fungi, and viruses, with 
bacteria being the largest constituent. These bacterial cells exist in a complex consortium of 
ecological and metabolic interactions that ultimately influence the taxonomic and functional 
profile of the microbial community, as well host health. The gut microbiome of healthy 
individuals is believed to be mainly symbiotic and is known to play important roles in host 
metabolism, immunological modulation and development, cell signaling, pathogen colonization 
resistance, and mucosal regeneration and homeostasis (Kho & Lal, 2018; Kostic et al., 2014; 
Thaiss et al., 2016). The continued stability of this community and its functions, i.e., homeostasis 
(Das & Nair, 2019; Shreiner et al., 2015), is important and its disruption, broadly described as 
‘dysbiosis’ (Petersen & Round, 2014), has been associated with numerous diseases including, but 
not limited to: diabetes (Karlsson et al., 2013), cardiovascular disease (Karlsson et al., 2012; 




(Becker et al., 2015; Franzosa et al., 2019), and various cancers (Kostic et al., 2013). However, it 
remains unclear whether disease onset is the consequence or cause of the microbiome 
community disruption. Furthermore, what constitutes a healthy gut microbiome is still under 
investigation due to the overwhelming amount of bacterial species found in the gut, and the large 
variation in their carriage rates across human populations and individuals (Human Microbiome 
Project Consortium, 2012; A. J. Johnson et al., 2019). These issues are of great importance as 
one of the ultimate goals of microbiome research is to modulate the community from a 
‘dysbiotic’ state into a healthy ‘homeostatic’ one. 
Early research towards this goal chose to limit their focus to taxonomic differences 
between healthy and disease microbiomes (David et al., 2014; Gevers et al., 2014; Villmones et 
al., 2018). While these comparisons are valuable, since the bacterial community taxonomic 
profile generally represents the potential metabolic and transcriptional profiles that are present 
within the ecosystem, simply profiling the community fails to acknowledge the underlying 
bacterial associations and the impact they exert on both the microbial ecosystem and host health. 
In fact, many studies within natural systems and animal hosts have shown that the associations 
(positive and negative) between bacteria are an important foundation for the continued stability 
and proper functioning of these ecosystems (Eiler et al., 2012; Gould et al., 2018; Kara et al., 
2013; Lupatini et al., 2014; Shetty et al., 2017; Zhou et al., 2011). As such, it is of great 
importance to assess the relationships that exist between bacteria within the healthy human gut 
microbiome to better understand the ecological associations important for the structure and 




question: are there similarities in the structural features of bacterial association networks in 
human gut microbiomes across healthy populations, and if so, are there conserved associations? 
Microbial associations in a community are characterized by both direct and indirect 
interactions between the constituents (Hibbing et al., 2010). In this paper, we depict these 
associations using a weighted graph (network) in which the nodes represent bacterial species, 
and an edge between two nodes represents an association between the corresponding species, 
with the edge weight capturing the strength of the association. This framework enables us to 
model both positive and negative associations between species and thus can help to shed light on 
cooperation and competition between species in the community. Once a network is constructed, 
an analysis of the various topological properties of the network can enable us to decipher the 
underlying ecological rules associated with the microbial ecosystem. These networks also 
provide the ability to determine the relative importance of species for ecosystem structure and 
function. Microbial association networks are typically constructed from a sample-taxa count 
matrix generated by collecting multiple samples from the community and determining the taxa 
counts in each sample. With the availability of high-throughput and low-cost DNA sequencing 
technologies, these counts are generated by sequencing the collected biological samples. 
Microbiome sequence data are generated either using a targeted approach, involving the 
sequencing of a taxonomic marker gene (e.g., the 16S ribosomal RNA gene) (Fox et al., 1977) or 
using a whole-genome shotgun sequencing approach (Venter et al., 2004). However, estimates of 
taxa abundances using 16S rRNA sequences can be confounded by several factors, including the 




taxonomic resolution in the selected variable region of the 16S gene (Edgar, 2018; Větrovský & 
Baldrian, 2013). Conversely, WGS data can be used to provide more accurate estimates of 
genome relative abundances as well as higher resolution taxonomic classification, compared to 
16S rRNA data (Laudadio et al., 2018; Ranjan et al., 2016). Regardless of the sequencing 
approach, the taxa count data generated by DNA sequencing are compositional in nature and 
provide only relative abundance information of the constituent taxa (Gloor et al., 2017). This 
poses challenges for inferring associations, and the computation of measures like correlation 
directly from the observed sequence counts can be misleading (Friedman & Alm, 2012). While 
several methods have been proposed for constructing association networks that address this 
challenge (Layeghifard et al., 2017), here we use a Gaussian Graphical Model (GGM) 
framework on Centered Log-Ratio (CLR) transformed count data to construct an association 
network (Aitchison, 1982; Kurtz et al., 2015). We are motivated by the observation that the 
covariance matrix of a multivariate Gaussian distribution used to fit log-
transformed relative count data provides a good approximation to the covariance matrix of the 
log-transformed absolute count data (Aitchison, 1982; Kurtz et al., 2015). The GGM framework 
also enables the modeling of conditional dependencies of the random variables that represent 
taxa abundances. The adjacency matrix of the association network that we construct is 
the inverse covariance matrix (i.e., the precision matrix) of the underlying multivariate Gaussian 
distribution used in the GGM. This graph has the property that an edge exists between two nodes 
if and only if the corresponding entry in the precision matrix is non-zero. A zero-entry in the 
precision matrix indicates conditional independence between the two corresponding random 




sparse association networks using the graphical lasso method (glasso) (Friedman et al., 2008). In 
this study, we investigate bacterial association networks in gut microbiomes across four healthy 
human populations. Previous studies analyzing bacterial association networks have mainly used 
16S rRNA data, and given its lower taxonomic resolution, these studies have analyzed 
associations at the genus level (Falony et al., 2016). Instead, here we use a large collection of 
WGS samples from multiple human populations to investigate bacterial associations at the 
species level. We use a machine-learning algorithm to identify a set of signature species that can 
accurately distinguish between the different healthy populations. Using these signature species, 
we construct networks by employing a glasso method that incorporates a bootstrapping approach 
to reduce the number of false-positive edges inferred (Efron & Tibshirani, 1986). We analyze 
these networks to assess the theoretical ecology and potential importance of species within 
healthy human gut microbial communities. 
Materials and Methods 
Data Acquisition 
We utilized 606 WGS fecal samples (1.68 trillion base pairs), which were obtained from 
four previously published human gut microbiome studies (cohorts) from four different healthy 
human populations (APPENDIX B). Three cohort datasets were downloaded from the NCBI 
Sequence Read Archive (SRA): American (PRJNA48479; 202 samples) (Human Microbiome 
Project Consortium, 2012), Indian (PRJNA397112; 106 samples) (Dhakan et al., 2019), and 




dataset was downloaded from the DDBJ Sequence Read Archive (DRA): Japanese (PRJDB4176; 
178 samples) (Figure 7) (Yachida et al., 2019). All cohort sample groups had similar male-to-
female frequencies, except for the European cohort (American: 0.53/0.47; Indian: 0.50/0.50; 




Figure 7: Count plot of total samples provided from each healthy cohort.  





Figure 8: Subject sex frequencies within each healthy cohort. A bar plot representing the 
proportion of samples originating from female and male subjects within each healthy cohort. 










Reads from all samples were first trimmed using Trimmomatic (Bolger et al., 
2014) (version 0.36) utilizing a 4:15 sliding window approach where a read is clipped once the 
average quality score within a sliding window of 4 base pairs drops below a quality score of 15. 
Afterward, human reads were filtered using BowTie2 (Langmead & Salzberg, 2012) (version 
5.4.0) and the GRCh38.p12 (https://www.ncbi.nlm.nih.gov/assembly/GCF_000001405.38/) 
human reference genome (Genome Reference Consortium, 2017). After removal of human reads 
15.9 billion high-quality reads remained: American (10,664,999,408), Indian (467,601,528), 





Figure 9: The total, mapped, and percent mapped of reads from samples from each healthy 
cohort. (a) Each dot represents the total reads in an individual sample. The dashed black line in 
each boxplot represents the median reads of the cohort. (b) Each dot represents the mapped reads 
in an individual sample. The dashed black line in each boxplot represents the median mapped 
reads of the cohort. (c) Each dot represents the percent mapped reads in an individual sample. 
The dashed black line in each boxplot represents the median percent of reads mapped for each 
cohort. 





Read Mapping and Species-Level Taxonomic Profiling 
Reads were mapped to a collection of 10,839 bacterial reference strain genomes 
downloaded from RefSeq (O’Leary et al., 2016), using Bowtie2. BowTie2 was run using the 
following settings: --very-sensitive --reorder --mp 1,1 --rfg 1,1 -k 1000 –score-min L,0,-0.1. The 
read mapping information was analyzed using a probabilistic framework based on a mixture 
model to estimate the relative copy number of each reference genome in a sample. This 
framework used an Expectation-Maximization (EM) algorithm to optimize the log-likelihood 
function associated with the model (Loomba et al., 2017; Xia et al., 2011). The EM algorithm 
was found to be highly accurate when benchmarked using simulated WGS reads produced by 
WGSim (https://github.com/lh3/wgsim) (Figure 10). Sub-sampling and benchmark testing of 
sample read mapping counts showed that a read depth of 250,000 mapped reads at a noise 
threshold of 1e−5 correlated well with samples mapping over 5 million mapped reads (R2 > 0.85, 
Figure 11). Any bacterial strain found in a sample below 1e−5 relative abundance was considered 
statistical noise and was dropped to an abundance of 0. Bacterial strain-level assignments were 
rolled back to species-level assignments (by using accession and tax ids with NCBIs taxonomic 
assignments), and relative abundances were summed to produce bacterial species genome 





Figure 10: Expectation-Maximization (EM) Algorithm benchmarking of WGS reads from 
simulated microbial communities. Stacked bar graphs showing benchmarking results of our EM 
algorithm on estimating known genome relative abundances from simulated whole-genome 
shotgun sequences. (a) Strain level results of a mixed E. coli community with Pearson’s R2 = 
0.997 between known genome relative abundances and the EM genome relative abundance 
estimations. (b) Species-level results of a mixed community with a Pearson's R2 = 0.999 between 
the known genome relative abundances and the EM genome relative abundance estimations. 





Figure 11: Read depth sub-sampling graph. Correlation of varying read depths with samples at 
5+ million read depth. Samples with 5+ million reads were sub-sampled to varying depths and 
examined using ordinary least squares linear regression. Samples with 250,000+ reads, on 
average, demonstrate an R2 value greater than 0.85. The red text indicated the chosen threshold 
for subsequent analysis. 





Bacterial Genome Annotation and Functional Profiles 
All bacterial reference genomes were functionally annotated in-house to create reference 
strain functional profiles. Before genome annotation, we utilized CheckM (Parks et al., 2015) 




Figure 12: CheckM bacterial reference genome completeness analysis. All reference genomes 
utilized for read mapping were analyzed for their percentage of genome completeness with 
CheckM. There were 10,839 genomes of which only 38 (0.004%) were designated as below 70% 
complete. One genome was marked as 0.0% complete, although that was due to CheckM not 
having data on the lineage of that organism. 





Prodigal (Hyatt et al., 2010) (version 2.6.3) was used to identify genes and generate protein 
sequence translations, which were then provided to InterProScan (P. Jones et al., 2014) (version 
5.39-77.0) to find matches to protein domains and protein families against the Pfam (El-Gebali et 
al., 2019) (version 32.0) and TIGRFAM (Haft, 2001) (version 15.0) databases, respectively. All 
Pfams and TIGRFAMS found within genomes were counted, and then counts were normalized 
(by total), producing relative abundances. The functional profile for a bacterial species was 
created separately for each cohort. This was computed by first finding the average genome 
abundance of each strain within the cohort, weighing the strain functional profiles based on these 
proportions, and then aggregating the resulting strain profiles. Each species functional profile 











where (x) is the vector of species abundances within each sample, (p) is the total number of 
species. The geometric mean of vector x is defined as:  
𝑔𝑔(𝑥𝑥) = �𝑥𝑥1 × 𝑥𝑥2 × … 𝑥𝑥𝑝𝑝
𝑝𝑝  
TIGRFAM functional annotations were obtained from TIGRFAMs_ROLE_LINK and 
TIGRFAM_ROLE_NAMES (ftp://ftp.jcvi.org/pub/data/TIGRFAMs/14.0_Release/). 
Cohort Sample Functional Profiling 
All Pfams and TIGRFAMS found within genomes were counted, and then counts were 




FeatureCounts (Y. Liao et al., 2014) (Subread package 2.0.0) to find the total features contained 
within the sample reads. Counts of features were subsequently length normalized, summed, and 
re-normalized (by total) for each sample, producing sample functional profiles. Protein families 
were grouped by their TIGRFAM role, and their relative abundances were aggregated and CLR-
transformed to generate the cohort functional role profiles (CFRP). Roles that were a different 
sign (+/-) in one cohort, when compared to all other cohorts, were considered different 
(elevated/reduced). 
Random Forest Classifier 
A random forest analysis is a supervised machine learning algorithm that fits an ensemble 
of decision tree classifiers to various sub-samples from the sample group dataset (Breiman, 
2001). The Random Forest Classifier (RFC) package from Scikit-learn (Pedregosa et al., 2011) 
was used to train random forests on the bacterial species present at different prevalence 
thresholds. The model utilized a 70%-30% train-test split. The model was then randomly re-run 
50 times on the same features, and the mean F1-scores were reported for the model trained at the 
species present at each tested prevalence threshold (0%, 20%, 40%, 50%, 60%, 80%, 90%, 
100%). The F1-score is a function of precision and recall and is defined as: 




𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑖𝑖𝑠𝑠𝑖𝑖𝑠𝑠𝑠𝑠 =  
𝑇𝑇𝑃𝑃𝑇𝑇𝑃𝑃 𝑃𝑃𝑠𝑠𝑠𝑠𝑖𝑖𝑃𝑃𝑖𝑖𝑃𝑃𝑃𝑃





𝑅𝑅𝑃𝑃𝑃𝑃𝑅𝑅𝑅𝑅𝑅𝑅 =  
𝑇𝑇𝑃𝑃𝑇𝑇𝑃𝑃 𝑃𝑃𝑠𝑠𝑠𝑠𝑖𝑖𝑃𝑃𝑖𝑖𝑃𝑃𝑃𝑃
𝑇𝑇𝑃𝑃𝑇𝑇𝑃𝑃 𝑃𝑃𝑠𝑠𝑠𝑠𝑖𝑖𝑃𝑃𝑖𝑖𝑃𝑃𝑃𝑃 + 𝐹𝐹𝑅𝑅𝑅𝑅𝑠𝑠𝑃𝑃 𝑁𝑁𝑃𝑃𝑔𝑔𝑅𝑅𝑃𝑃𝑖𝑖𝑃𝑃𝑃𝑃
 
The AUC (Area Under the Receiver-Operator Curve) was utilized to measure the accuracy of 
trained forests. The AUC is an estimator of the true and false positive prediction rates of our 
RFC. 
Construction of Bacterial Association Networks 
For each cohort, a sample-taxa matrix was constructed containing the relative abundances 
of the signature species in each sample. The bacterial association network for a cohort was 
constructed from its CLR transformed sample-taxa matrix using the GGM framework. In each 
case, a sparse precision matrix was computed using the R (R Core Team, 2020) huge (Zhao et al., 
2016) package, and this matrix formed the adjacency matrix of the association network. The 
tuning parameter ρ in the l1-penalty model for sparse precision matrix estimation was chosen 
using the stability approach to regularization (StARS) method (Liu et al., 2010). To reduce the 
number of false positives, the estimated sparse precision matrix Ω was processed further using a 
bootstrap method as follows: s bootstrap datasets, each with n samples, were generated from the 
original CLR-transformed matrix by random sampling with replacement. A sparse precision 
matrix was estimated from each bootstrap dataset using the same previously chosen value of the 
tuning parameter ρ used to estimate Ω. The final precision matrix Ω’ is derived from Ω as 
follows: (a) if Ω[i,j]=0, then Ω’[i,j] = 0. (b) if Ω[i,j] ≠ 0, then Ω’[i,j] = Ω[i,j] if the entry [i,j] is 
non-zero in at least f*s precision matrices estimated from the bootstrap datasets. Otherwise 











The value (f) is a preset threshold (0 ≤ f ≤ 1). We used s = 50 (bootstrap replicates) and f = 0.8 
(e.g., association must be non-zero >80% of the time) in our analysis. Partial correlation matrices 
were parsed using python, and all associations below a magnitude of .01 were considered 
statistical noise and removed. 
Network Property, Clique, and Module Analysis 
For each cohort network, the following properties were computed using NetworkX 
(Hagberg et al., 2008) (version 2.4): average shortest path length (ASPL), transitivity, 
modularity, degree assortativity, degree centrality, betweenness centrality, and genera 





where (V) is the set of all nodes in the graph (G), D[s,t] is the shortest path from s to t, and (TN) 
is the total number of nodes in G. The transitivity (T) of a network is the fraction of all possible 





triangles are a clique (a subset of nodes within a network where each node is adjacent to all other 




xyz with edges (x,y) and (y,z) where the edge (x,z) can be present or absent) (Hagberg et al., 
2008; Newman, 2010). Finally, the modularity (Q) (Clauset et al., 2004) of a network was 
calculated as: 












where (M) is all modules of a graph partition, (m) is an individual module from the partition, (e) 
is the total number of edges of the graph (G), (Lm) is the total intra-module edges, and (km) is the 
sum of edges of all nodes within the module (m). Networks were first partitioned into modules 
before modularity could be calculated (for module detection, see Module Functional Profiles 
below).  Assortative mixing is a predilection of nodes to form connections with other nodes that 
are like (assortative) or unlike (disassortative) themselves. We measured node mixing preference 
according to node degree (degree assortativity) and node genus classification (genera 
assortativity). Degree assortativity is calculated using the standard Pearson correlation 
coefficient: 
r =
∑ 𝑥𝑥𝑥𝑥𝑥𝑥 𝑦𝑦�𝐽𝐽[𝑥𝑥,𝑦𝑦] − 𝑅𝑅𝑥𝑥𝑏𝑏𝑥𝑥�
σ𝑎𝑎σ𝑏𝑏
 
Where (J) is the joint probability distribution matrix, (J[x,y]) is the fraction of all edges in the 
graph that connects nodes with degree values (x) and (y), (ax), and (by) are the fraction of edges 
that start and end at nodes with values (x) and (y), and (σa) and (σb) are the standard deviations of 
the distributions (ax) and (by).
 
The value of (r) can be any value between –1 (perfect 








Where (J) is the joint probability distribution matrix whose elements are (J[i,j]) (the fraction of 
all edges in the graph that connects nodes of genus type i to genus type j), Tr is the trace of the 
matrix J, and ||J|| signifies the sum of all elements of the matrix J (Newman, 2003). Modules 
within each network were found utilizing the label_propagation_communities algorithm, based 
on the asynchronous label propagation algorithm (aLPA) (Cordasco & Gargano, 2011) from 
NetworkX. To quantify the ability of the aLPA to partition the data, we utilized the performance 





where (Lm) is the total intra-module edges, (Li) is the total inter-module non-edges, and (𝐸𝐸𝑝𝑝) is 
the total potential edges (Fortunato, 2010). Monte Carlo simulations were utilized to test for 
statistical significance of network property differences where 1,000 (GTN,h) random networks 
were generated for comparison to each cohort network where (TN) was the total number of 
nodes within the cohort network and (h) the density of edges within the cohort network. Three-
member cliques and modules within each network were found using NetworkX. Module 
functional profiles (MFP) were created by aggregating the functional profiles of species 




Network Node Centrality (“Hubs” and “Bottlenecks”) Analysis 
Degree centrality is defined as the degree (total edges) of a node. The node within each 
network module exhibiting the highest degree centrality was designated as a module “hub”. If 
two or more species were found to have equal degree centrality then centrality measurements of 
those nodes were re-computed in the context of the entire network. The top ten nodes exhibiting 
the highest betweenness centrality within each network were designated as “bottlenecks”. To find 
“bottleneck” species, betweenness centrality was computed for each node. Betweenness 






where the betweenness centrality of a node (υ) is the sum of the fraction of all-pairs shortest 
paths that pass through (υ), (V) is the set of all nodes, u(s,t) is the number of shortest paths, and 








Signature Species in the Healthy Human Gut Microbiome 
For each cohort, the prevalence of individual species across all samples was measured 
and plotted. All cohorts exhibited a skewed bi-modal distribution (Figure 13a). The first peak in 
the distribution was centered around a prevalence of 10%, while the second peak occurred 
around a prevalence of 90%. This skewed bi-modal distribution has been previously observed in 
a microbial community, and organisms that were highly prevalent were deemed the ‘abundant 








Figure 13: Healthy cohort ‘abundant core’ and signature species. (a) All cohorts exhibit a 
bimodal distribution for species prevalence. Species prevalent in 90% or more samples within a 
cohort are considered a member of that cohort’s ‘abundant core.’ (b) The proportion of total 
sample relative abundance of each cohort’s ‘abundant core’ species and the union of all 
‘abundant cores’ species (i.e., Signature Species/Sig). The ‘abundant core’ microbiota is shown 
to account for the bulk of reads mapped within each sample. Each dot represents a sample from 
that cohort. (c) PCA demonstrating the lack of distinct clustering of samples from different 
cohorts based on the CLR-transformed relative abundance data of the signature species. Samples 
from the Indian and American cohorts appear to separate from the rest of the cohorts; however, 
samples from the other two cohorts demonstrate little separation. The diamonds indicate cluster 
centroids. 




The 90% prevalent species set for each cohort consisted of 127 (American), 109 (Indian), 182 
(European), and 146 (Japanese) species, respectively. These species were found to account for a 
large majority of the total sample proportions, the median values for the cohorts were 0.93 
(American), 0.93 (Indian), 0.87 (European), and 0.81 (Japanese) (Fig. 13b). We utilized an RFC 
framework to determine the effect of prevalence threshold values on the ability to distinguish 
between cohorts using the taxonomic profiles of the constituent samples. For each prevalence 
threshold value, a single input feature set was generated to construct the classifier; this feature set 
was produced by taking the union of the bacterial species sets for the four cohorts (at that 
prevalence threshold value). The RFC was able to distinguish between cohorts with an F1-score 
> 0.85 for all tested prevalence thresholds (0%, 20%, 40%, 50%, 60%, 80%, 90%, 100%), but 
demonstrated the highest F1-score at the 90% threshold, even though less than 10% of the 
original species remained (Figure 14). Based on this analysis, we define the set of signature 
species to be the union of the prevalent (> 90%) species sets from the four cohorts. The signature 
species set consisted of 202 species and was used for constructing the bacterial association 
network for each cohort. We explored the variability in signature species relative abundance 
between samples using principal components analysis (PCA) applied to the CLR-transformed 
data (Fig. 13c). PCA showed evidence for the separation of samples from the Indian and 
American cohorts, but ultimately the PCA only explained a small amount of the total variance 






Figure 14: RFC bar graph and multi-class ROC. (a) The 90% bacterial prevalence threshold 
enables the most accurate distinction between cohorts. Bacterial species used for RFC-based 
classification were determined by the prevalence of bacteria in the samples. The 90% prevalence 
threshold offers a slightly better ability to distinguish between the cohorts based on their 
taxonomic profiles while removing over 1,800 features. The 90% prevalence threshold was then 
randomly permuted (RandPermute) and added to the plot as a reference. Utilizing only species 
that were present in 100% of samples led to diminished accuracy while removing relatively few 
features. (b) A Multi-class Receiver Operator Characteristic graph was created for each cohort. 
Each cohort displayed a large AUC indicating that the model was able to accurately distinguish 
the different cohorts from each other using the taxonomic profiles alone. The multi-class AUC 
was weighted by sample size for each cohort. 




Bacterial Association Networks 
Before its application on the cohort data, the network inference method with 
bootstrapping was tested on synthetic data (see methods). Notably, most graph-types were 
inferred with an F1-score above 0.7 (band: 0.974, hub: 0.885, random: 711, cluster: 0.692, scale-
free: 0.416) (Figure 15a). Furthermore, we demonstrate that as the sample-to-taxa ratio increases, 
F1-scores approach 1, and all groups demonstrate mean F1-scores above 0.9 (Figure 15a). 
Finally, we observe that our network inference method tends to underestimate edge weights, and 
on average, the estimated edge weights are 53.23% of the actual edge weights (Figure 15b). A 
bacterial association network was constructed for each cohort using the CLR-transformed 
relative abundances of the signature species (see “Methods”). Each network was modeled as an 










Figure 15: GGM algorithm benchmarking. Average F1 scores of the GGM algorithm for various 
graph-types and sample-to-taxa ratios.  Synthetic data was modeled on the CLR-transformed 
means and sample-to-taxa ratios present in the real data sets. A sample-to-taxa ratio of 10 was 
added to demonstrate the effect adding additional samples has on the accuracy of the GGM. (a) 
The average F1-score for all graph types is 0.74. The hub and band networks consistently exhibit 
the highest accuracy. An overt increase in accuracy is demonstrated as the sample-to-taxa ratio 
increases for all graph-types, with no graph-type have an F1-score <0.9 at a sample-to-taxa ratio 
of 10. (b) GGM consistently underestimates the magnitude of associations. As the sample-to-taxa 
ratio increases, there is an appreciable increase in the accuracy of association magnitude 
estimation in all but the cluster and scale-free, graph-types. 





Figure 16: Healthy cohort species-level bacterial association networks. Network modeling of 
associations between (173/202) signature species within each network. A total of 29 species were 
not shown as they had zero edges in all networks. Node color designates the phylum each species 
belongs to, node size is reflective of node degree, and edge color represents if the association is 
positive (blue) or negative (orange). Nodes are ordered counterclockwise around the circle by the 
alphabetical order of the concatenated string of all taxonomic levels. Nodes that are numbered 
correspond to species with the highest degree centrality within modules, designated as “hubs”. 
Brackets around [Bacteroides] pectinophilus indicate that it is misclassified (i.e., placed 
incorrectly in a higher taxonomic rank and awaiting to be formally renamed). For a full list of 
node species designations, see APPENDIX C.  




At a high level, differences in the structure of the four networks were apparent. The 
European, Japanese, and Indian networks exhibited a high density of edges occurring between 
nodes from the phylum Firmicutes, whereas the American network had the largest density of 
edges existing between nodes from the phylum Bacteroidetes. Positive associations were 
dominant in all networks (American: 0.98, Indian: 0.97, European: 0.96, Japanese: 0.96), and 
negative associations involve nodes from the phylum Firmicutes. Network topology was studied 
by calculating the following network properties: average shortest path length (ASPL), 
transitivity, modularity, degree assortativity, and genera assortativity (see Methods) (Table 1). 
These properties were compared to random networks using Monte Carlo simulations 
(see Methods). All cohort networks were deemed non-random in their topology and exhibited 
significantly low ASPL (all P-values < 0.05), significantly high modularity (all P-values < 0.01), 
significantly high transitivity (all P-values < 0.001), significantly high genera assortativity (all P-
values < 0.001) and significantly high degree assortativity (all P-values < 0.01), relative to the 
random networks. The low ASPL within networks suggests that nodes are connected to one 
another through short paths within the network. The high transitivity and modularity indicate that 
nodes form cliques and networks exhibit compartmentalization (modules), respectively. Lastly, 
the high (assortative) degree assortativity and genera assortativity portrays that nodes tend to 




Table 1: Topological properties of healthy cohort bacterial association networks 




American 202 338 0.017 1.539 (−, ***) 0.487 (+, ***) 0.475 (+, *) 0.338 (+, ***) 0.144 (+, ***) 
Indian 202 273 0.013 1.874 (−, *) 0.452 (+, ***) 0.667 (+, ***) 0.330 (+, ***) 0.163 (+, ***) 
European 202 386 0.019 1.369 (−, ***) 0.353 (+, ***) 0.681 (+, ***) 0.158 (+, *) 0.196 (+, ***) 
Japanese 202 274 0.013 1.444 (−, ***) 0.471 (+, ***) 0.755 (+, ***) 0.308 (+, ***) 0.242 (+, ***) 
Network topological properties were calculated for each healthy cohort’s bacterial association network. The plus (+) or minus 
(−) sign indicates that the network property was greater or lower than the average of 1000 random networks. Stars indicate that 






Theoretical Ecology Based on Bacterial Association Networks 
All cohort networks were found to contain highly similar distributions of association 
(edge) weights, where positive associations were more frequent and greater in magnitude than 
negative associations (Figure 17a). Furthermore, a large percentage of associations (American: 
40%, Indian: 40%, European: 40%, Japanese: 53%) were found to be shared with at least one 
other network. However, the Japanese network shared the largest proportion of associations with 
all other networks (American: 26%, Indian: 22%, European: 33%) and the Indian network the 
least with all other networks (American: 18%, Japanese: 22%, European: 16%) (Figure 18). 
Interestingly all shared associations were positive (Figure 17a). A conserved structure of 14 
associations, composed of 20 species (Figure 17a), mainly from the genus Bacteroides, was 










Figure 17: Healthy cohort network association analysis. (a) The distribution of bacterial 
association weights within each cohort’s network, dots (black and yellow) and (n) represent total 
associations. Yellow dots represent species associations that were found shared across all 
networks. (b) The proportion of associations within each cohort’s network that is unique (red) or 
shared (blue) with at least one other network. (c) Sub-graph displaying only the 20 conserved 
nodes (species) and 14 edges (associations) retained across all cohorts. 






Figure 18: Proportion of associations shared between healthy cohort networks. Heatmap showing 
the proportion of associations within each cohort network that is shared with every other 
network. (n) is equal to the total associations within a cohort network. The figure shows that the 
Japanese network shared the largest proportion of associations with every other cohort network. 






Figure 19: Genera counts of species from conserved associations. When examining the networks 
of all cohorts, there were 14 conserved associations comprised of 20 bacterial species. Species of 
the Bacteroides genus were the most abundant constituents of the bacterial associations 
conserved within all cohorts. 






Many of these conserved associations were associations with relatively higher edge weights 
(Figure 17a). No negative association was retained across networks. However, viewed at the 
higher taxonomic rank for those species involved in negative associations, we observed that 
across all cohort networks, members from the phylum Firmicutes were involved in a large 
percentage of the negative associations (American: 100%, Indian: 100%, European: 62.5%, 
Japanese: 100%), and specifically these negative associations were mainly occurring between 
species from the order Clostridiales (American: 25%, Indian: 89%, European: 56%, Japanese: 
100%) (Figure 20). We next explored the taxonomic relationship between species and their 
association type (positive or negative) (Figure 21a), as well as the genome functional profile 
dissimilarities, according to Bray–Curtis dissimilarity, between network neighbors against their 
association weight (Figure 21b). We found that most positive associations take place between 
bacteria that are more taxonomically and functionally similar, while negative associations were 
never found between species within the same genus or between species with low genome 
functional profile distance (< 0.2), and linear regression showed a negative correlation (p-






Figure 20: Healthy cohort negative associations heatmap. Heatmaps of the proportion of total 
negative associations within each cohort’s network that order member species were found to be 
involved in. Within each cohort, negative associations appear to occur mainly between species 
from the order Clostridiales. 




Figure 21: Taxonomic and functional relationships between species. (a) The proportion of 
associations within each cohort’s network that are either positive or negative at the lowest level 
of taxonomic relation (n = total associations). Most positive associations appear between 
taxonomically similar species. (b) Association weight vs. Bray–Curtis distance of genome 
functional profiles between network partners. Positive associations between functionally similar 
species are both common and greater in strength than negative associations. There appears to be 
a minimal distance between genome functional profiles before a negative association is 
demonstrated. (c) An asynchronous LPA was used to analyze the modules composing the 
networks of each cohort. Each dot represents the aggregated TIGRFAM profiles of an individual 
module found by aLPA, and the diamonds represent the cohort centroids. Four distinct clusters 
were found, and each cohort was represented within each cluster. The American cohort appears 
to be biased towards Cluster IV; however, the other cohorts do not appear overtly biased to any 
one cluster. 





Figure 22: Linear regression on partner genome functionality distance vs. association weight. 
Linear least-squares regression of species genome functional profile distance (Bray-Curtis 
Distance) vs. association weight. All four cohort networks show a slightly negative correlation 
which was statistically significant (Wald Test with t-distribution of the test statistic; American: 
pvalue=2.47e-08, Indian: pvalue=1.52e-05, European: pvalue=1.49e-15, Japanese: 
pvalue=1.86e-06). 








Network Cliques and Module Detection 
As our networks exhibited both high transitivity and modularity, we sought to investigate 
the cliques and modules of species contained within them. We first found all cliques of three 
species (1588 unique cliques) within our networks (see “Methods”). These triadic cliques are 
important to understand because their formation provides stability to the community structures 
existing between species (Stadtfeld et al., 2020; Tsvetovat & Kouznetsov, 2011). Of these 
cliques: 113 were shared in at least one other network, eight were shared across three networks, 
and only 1 (Bacteroides caecimuris, Bacteroides fluxus, Bacteroides thetaiotaomicron) was 
found in all networks. In total, 66 genera were shown to participate in clique formation; however, 
cliques were shown to be mainly (American: 29%, Indian: 72%, European: 64%, Japanese 55%) 
formed between species from differing genera (Figure 23a). Species from the 
genus Bacteroides were found to be involved in the largest percentage of cliques (American: 
21.0%, Indian: 4.0%, European: 4.9%, Japanese: 5.8%) within most cohort networks (Figure 
23b). Interestingly, the cliques that contained species from Bacteroides were also the most 
retained (American: 20.9%, Indian: 8.5%, European: 8.5%, Japanese: 10.8%) across all cohorts 
(Figure 23c). Following clique analysis, we performed module detection utilizing an 
asynchronous Label Propagation Algorithm (aLPA) (see Methods), which identified a total of 49 
modules (American: 10, European: 11, Indian: 14, Japanese: 14) that contained three or more 






Figure 23: Genera involvement in clique formation. (a) Heatmap showing the proportion of intra-
clique taxonomic relationships in which all species are from the same genus (ASSG), only two of 
the three species are from the same genus (TSSG), and where none of the species share the same 
genus (NSSG). (b) Heatmap of the proportion of total cliques found within each cohort’s 
network that genera member species were found to be involved in (n = total three-member 
cliques). Species from the genus Bacteroides tend to be found in most cliques across all cohorts. 
(c) Heatmap of cliques that were retained in at least one other network. Cliques that Bacteroides 
sp. are involved in are highly retained across networks. 





Figure 24: Distribution of cohort network module sizes. Distribution of module sizes found by 
asynchronous LPA, colored by cohort. (a) Distribution of module sizes within the European 
cohort. (b) Distribution of module sizes within the American cohort. (c) Distribution of module 
sizes within the Indian cohort. (d) Distribution of module sizes within the Japanese cohort. 
Source: Sayf Al-Deen Hassouneh 
 
 
The quality of network partitioning by the module detection algorithm (performance) was 
analyzed (American: 0.96, Indian: 0.98, European: 0.94, Japanese: 0.98), showing that most 




examine the variance between Module Functional Profiles (MFP’s) of the different cohorts 
(Figure 21c). This analysis revealed MFPs fell within one of four clusters, and each cohort had 
representation within each cluster. Taxonomic and functional characteristics of the clusters were 
analyzed. Cluster I contained modules formed mainly by the genera Streptococcus and 
Bifidobacterium (Figure 25a). Cluster II modules were mainly composed of species from the 
genera Alistipes, Bacteroides, and Prevotella (Figure 25b). Cluster III modules were dominated 
by the genera Bacteroides (Figure 25c). Cluster IV modules were mainly composed of species 
from the genera Blautia, Eubacterium, Lachnoclostridium, and Ruminococcus (Figure 25d). 
Functional analysis of clusters revealed unique roles in each cluster. Cluster I displayed an 
increase in roles linked to toxin production, protein secretion, anaerobic metabolism, nucleic acid 
metabolism, and a decrease in roles linked to thiamine biosynthesis. Cluster II displayed an 
increase in roles linked to cellular metabolism and protein degradation, displayed a decrease in 
roles linked to cell division and signal transduction. Cluster III displayed an increase in roles 
linked to chemoautotrophy, sulfur and phosphorous metabolism, and DNA metabolism. Lastly, 
cluster IV displayed an increase in roles tied to transcription factors and a decrease in roles 






             
Figure 25: Pie plots of functional module cluster taxonomy. Pie plots demonstrating genus-level 
taxonomic compositions within each of the module clusters. Clusters were determined using 
PCA of module functional profiles for each module. (a) Cluster I is dominated by members of 
the Streptococcus and Bifidobacterium genera, and no genus represents less than 3% relative 
abundance. (b) Members of the Bacteroides genus are also the most abundant in Cluster II; 
however, the Prevotella and Alistipes genera are also abundant and account for > 70% of 
abundance when combined with Bacteroides. There are six genera with relative abundances 
below 3%. (c) Members of the Bacteroides genus are the most abundant in Cluster III, and there 
are 49 genera with relative abundances below 3%. (d) There are only five genera above 3% 
relative abundance and 44 genera below 3%, with no one genus showing greater than 15% 
relative abundance. Genera with < 3% relative abundance were placed in the ‘Others’ category. 




Table 2: Relative differences in functional roles within module clusters. 
Cluster Function Status 
Cluster 1 Degradation of polysaccharides Elevated 
Cluster 1 Central intermediary metabolism: Other Elevated 
Cluster 1 Toxin productions and resistance Elevated 
Cluster 1 Aerobic metabolism Elevated 
Cluster 1 Nucleic acid metabolism Elevated 
Cluster 1 DNA regulation Elevated 
Cluster 1 Peptide secretion and trafficking Elevated 
Cluster 1 Thiamine biosynthesis Reduced 
Cluster 2 Cellular processes: Other Elevated 
Cluster 2 Biosynthesis and degradation of surface polysaccharides and 
lipopolysaccharides 
Elevated 
Cluster 2 Lipoate biosynthesis Elevated 
Cluster 2 Biosynthesis of menaquinone and ubiquinone Elevated 
Cluster 2 Methanogenesis Elevated 
Cluster 2 Degradation of proteins, peptides, and glycopeptides Elevated 




Cluster Function Status 
Cluster 2 Transposon functions Reduced 
Cluster 2 Regulatory functions: Other Reduced 
Cluster 2 Anion transport and binding Reduced 
Cluster 2 Cell division Reduced 
Cluster 2 Protein fate: Other Reduced 
Cluster 2 Small molecule regulation Reduced 
Cluster 2 DNA metabolism: Other Reduced 
Cluster 2 Signal transduction: Other Reduced 
Cluster 3 Chemoautotrophy Elevated 
Cluster 3 Sulfur metabolism Elevated 
Cluster 3 Amino acid and amine metabolism Elevated 
Cluster 3 Phosphorous metabolism Elevated 
Cluster 3 Transport and binding proteins: Unknown substrate Elevated 
Cluster 3 DNA metabolism: Restriction/modification Elevated 
Cluster 4 Transcription factors Elevated 




Roles that were different signs (+/-) in one cohort relative to all other cohorts were deemed 
different. If the sign was negative after CLR transformation, the role was considered reduced, 
and if the sign was positive, the role is considered elevated. The different clusters appear to have 
overt functional differences, possibly indicating the importance of the existence of modules from 
each cluster in a cohort for the healthy functioning of the gut microbiome. 
 
 
We next analyzed the sample functional profiles using PCA (Figure 26). PCA explained a 
modest amount of variance (PC1: 27.82%; PC2: 5.99%), although samples between cohorts were 
found to overlap. When analyzing the Cohort Functional Role Profiles (CFRP’s), only 11 
differences, when comparing the signs (+/−), out of the 113 found roles were found, and only the 






Figure 26: PCA of healthy cohort sample functional profiles. Cohorts do not cluster distinctly 
based on cohort functional profiles. PCA was performed by analyzing the aggregated cohort 
functional profiles of each cohort. The cohorts have a large amount of overlap and do not appear 
to distinctly separate.  









Table 3: Healthy cohort functional role differences. 
Cohort Function Status 
American Energy Metabolism: Amino acids and amines Elevated 
American Mobile and extrachromosomal element functions: Transposon 
functions 
Reduced 
Indian Mobile and extrachromosomal element functions: Transposon 
functions 
Elevated 
European Protein fate: Protein and peptide secretion and trafficking Elevated 
European Central intermediary metabolism: Sulfur metabolism Reduced 
European Central intermediary metabolism: Other Reduced 
European Biosynthesis of cofactors: prosthetic groups and carriers: Other Reduced 
European Transport and binding proteins: Amino acids, peptides, and 
amines 
Reduced 
European Cellular processes: Detoxification Reduced 
European Signal transduction: Two-component systems Reduced 
Japanese Fatty acid and phospholipid metabolism: Other Reduced 
Few differences in TIGR functional roles were demonstrated between the different cohorts. The 
American and European cohorts were the only cohorts that had more than one difference, and 





Node Centrality Analysis 
We utilized degree and betweenness centrality measurements to identify “hub” and 
“bottleneck” nodes, respectively, within our networks (see Methods). These centrality 
measurements were selected because ‘hubs’ and ‘bottlenecks’ are nodes that could have strong 
influence within a network and have been utilized previously to identify important species within 
microbial ecosystems (Kara et al., 2013; Lupatini et al., 2014; Prettejohn et al., 2011). 
Considering all cohort networks were deemed assortative in respect to their degree assortativity, 
we did not expect to find network “hub” nodes. However, we did find that nearly all modules 
within each cohort were disassortative in their degree assortativity, which hinted at “hub” nodes 






Figure 27: Bar plot of degree assortativity within network species modules. Distribution of the 
degree assortativity of modules within cohort networks. Most modules were disassortative in 
respect to their degree assortativity hinting at "hub" species existing within modules. 
Source: Mark Loftus 
 
For these reasons, we chose to select the node within each module that exhibited the highest 
degree (see Figure 16) and the top 10 nodes within each network with the highest betweenness. 
Across all cohorts, we found variation in the species deemed module ‘hubs’ and ‘bottlenecks’ 
(Figure 28a), although, at the genus level, there was a large amount of agreement (Figure 28b). 




Eubacterium, Parabacteroides, and Streptococcus were designated as ‘hubs’, whereas species 







Figure 28: Bacterial association network “hubs” and "bottlenecks.” (a) Heatmaps of species that 
are designated as “hubs” (highest degree centrality) and “bottlenecks” (highest betweenness 
centrality) within each cohort’s network. (b) Heatmap of genera proportions of “hubs” and 
“bottlenecks” within each healthy cohort network. 





In this study, we used WGS data in conjunction with a network inference method that is 
robust to sequence data compositionality to analyze the associations occurring between species 
within the healthy human gut microbiome across different populations. The association networks 
were constructed utilizing the signature species. We demonstrated that bacterial association 
networks across all cohorts do not have the same properties as random networks. However, 
relative to each other, the networks of the four cohorts display similar properties. Random 
networks are known to contain short average path lengths, low node clustering, and high 
modularity (Guimerà et al., 2004; Prettejohn et al., 2011). Compared to random networks, each 
cohort network was found to exhibit significantly shorter average shortest path lengths, 
significantly higher transitivity (clustering), significantly higher modularity, significantly higher 
degree assortativity, and significantly higher genera assortativity. We posit that the similarities in 
network properties reflect an organization of the bacterial community that is important to 
underlying ecological processes. For instance, the short average path lengths within our networks 
could imply rapid signaling between bacterial species, potentially facilitating swift changes in 
community metabolism. This is supported by previous studies demonstrating that the human gut 
microbiome exhibits rapid alterations in bacterial metabolism and abundance in conjunction with 
a change in host diet (David et al., 2014). 
In addition to exhibiting similar properties, cohort networks also shared a large 
percentage of associations (American: 40%, Indian: 40%, European: 40%, Japanese: 53%), 




associations may be indicative of strong partner fidelity, important ecological relationships, or 
potentially obligate partnerships. Furthermore, we found that taxonomically and functionally 
similar species tended to have positive associations. This finding was unexpected as some 
previous studies on microbial ecosystems, including the human gut (Berry & Widder, 2014; 
Trosvik & de Muinck, 2015; Verster & Borenstein, 2018), have shown negative interactions 
between bacteria (competition, predation, etc.) should be the dominant form of interaction 
(Foster & Bell, 2012), especially when those bacteria are taxonomically or functionally alike 
(Nemergut et al., 2013). The differences between our results and the aforementioned research 
may be due to their use of non-transformed data and pairwise analysis. It has been noted that 
compositional data exhibit a negative correlation bias (Gloor et al., 2017), and thus, failing to 
account for the compositional nature of sequencing data may lead to inferring more negative 
associations than those that actually exist. In fact, a previous comparison of compositionally 
robust network methodologies demonstrated that the majority of associations for these 
methodologies are positive (Kurtz et al., 2015). Our findings would suggest that kin-
selection (positively associating with those of similar lineage to directly or indirectly pass on 
one’s genes) (Hamilton, 1964), as opposed to competitive exclusion (bacteria with similar 
lineage or functionality are more likely to compete within a habitat) (Hardin, 1960), is more 
prevalent within the healthy gut microbiome. This observation cannot be excluded as there is 
precedence within microbial ecosystems for the co-occurrence of bacteria with similar genetic 
traits (Jackson et al., 2018; Nemergut et al., 2013), and studies on bacterial dynamics in the gut 




into the community, i.e., phylogenetic under-dispersion (nepotism) hypothesis (Darcy et al., 
2019). 
Within all cohorts, positive associations were not only the most dominant form of 
association, but also the only associations that were shared across networks. This finding seems 
logical as within the anoxic environment of the gut, bacterial energy production is limited which 
would make positive associations, such as mutual cross-feeding, preferable in order to produce 
and utilize energy more efficiently (Pacheco et al., 2019). In addition, ecological community 
theory suggests that partitioning of resources in space and time drive coexistence (Chase & 
Leibold, 2002), and bacteria within the human gut microbiota are known to exhibit diurnal 
fluctuations (Zarrinpar et al., 2014) and exist in distinct spatial organizations (Donaldson et al., 
2016; Fung et al., 2014; Mark Welch et al., 2017). Furthermore, positive associations between 
species are also known to alleviate ecosystem stresses and allow for a greater diversity of 
organisms to coexist (Stachowicz, 2001), and the healthy gut microbiome has a high level of 
biodiversity (Lozupone et al., 2012). However, it is Important to be cognizant that a positive 
association between species does not rule out the presence of a negative interaction completely, 
as negative interactions between species can still have a net positive result if an increased 
survival rate is occurring, as well as to understand that these positive associations are not always 
indicative of cooperative activities as they could simply reflect a common preferred 
environmental niche (Stachowicz, 2001). In contrast to the large proportion of shared positive 
associations, negative associations were always unique to a specific cohort; however, as we 




found that across all cohorts most negative associations were occurring between species from the 
order Clostridiales. Species from the order Clostridiales are known to be largely cellulolytic, in 
that they mainly hydrolyze the polysaccharide cellulose (Lynd et al., 2002). This limited 
nutritional niche could theoretically create competition between Clostridiales sp., and in any 
case, these associations might be important for community stability as negative associations 
within microbial communities are thought to be an important stabilizing force (Berry & Widder, 
2014). In our analysis, 29 (out of the 202) species were found to exhibit no associations (positive 
or negative) across all networks. It may be possible that these species have very low strengths of 
association with some of the other species (i.e., partial correlation values below the detection 
threshold). It is also possible that some of these species occupy a unique metabolic niche in 
which they can utilize a specific resource for their metabolic requirement that is inaccessible to 
other microorganisms thereby limiting any cooperative or competitive actions. 
While the healthy human gut microbiome is indeed routinely described as stable 
(Lozupone et al., 2012), the low abundance of negative associations within our networks 
suggests that the gut microbiome would be more vulnerable to positive feedback loops between 
species which could result in instability (Berry & Widder, 2014). We hypothesize that the high 
modularity found within all cohort networks could mitigate the vulnerability to positive feedback 
loops as high network modularity has been shown to have a stabilizing effect. We used a module 
detection algorithm to identify groups of highly connected species within our networks. The 
algorithm identifies modules of species that have previously been noted to benefit by growing 




module functional profiles, using PCA, we found that modules gravitated towards one of four 
clusters. Although some cohorts had a greater proportion of modules within certain clusters, all 
cohorts had some level of representation within each cluster. Upon further analysis, we were able 
to find distinct functional and taxonomic differences between module clusters, but we were not 
able to distinguish overt functional differences between CFRP’s. This implies that a general set 
of functions is present in each healthy population regardless of taxonomic differences. These 
module clusters may be indicative of niches that are retained in the healthy human gut 
microbiome, and the redundancy of multiple modules of a cohort falling within a cluster is 
potentially a further stabilizing force for the ecosystem. These findings agree with previous 
studies showing comparable communities and high functional redundancy across gut 
microbiome data sets (Hall et al., 2019; Jackson et al., 2018). 
Lastly, we identified species that acted as “hubs” or “bottlenecks” within the structure of 
cohort networks. These node types are important for maintaining network structure and thereby 
also potentially important species for community structure within the human gut microbiome 
(Layeghifard et al., 2017). Notably, we found Bacteroides sp. were designated as both “hubs” 
and “bottlenecks” across all networks. Interestingly, Bacteroides sp. were also found to be the 
largest constituent of bacterial cliques and these cliques were the most retained across all cohorts. 
Additionally, of the 20 species from the 14 conserved associations found across networks, most 
were species belonging to Bacteroides. These findings suggest that Bacteroides sp. are important 
drivers of the ecosystem within the healthy human gut microbiome. Interestingly, previous 




stercosis, as potentially important (keystone) species within the human gut microbiome (Fisher 
& Mehta, 2014).  
It is important to consider the limitations of our study. Our samples originated from 
different geographical locations and utilized different preparation procedures both of which are 
known to introduce biases (M. B. Jones et al., 2015; Lahti et al., 2014; Shetty et al., 2017). 
Another limitation is the presence of potential confounding variables within the cohorts, such as 
age and sex. Additionally, due to the cross-sectional nature of our data, we are only able to 
capture snapshots of the gut microbiome and are unable to examine the dynamics of the 
ecosystem. Furthermore, we utilized a reference-based mapping approach for taxonomic 
classification, potentially causing our classifications to be limited by the genomes available. 
Finally, the constructed bacterial networks were undirected, and the study was non-mechanistic 
which prevents us from being able to examine the influence individual species have on one 
another (unidirectional ecological interactions). 
In closing, we have demonstrated that bacterial communities across healthy human 
populations are similar in their organization and functional capacities. We have also revealed that 
positive associations regularly occur between taxonomically and functionally related species 
despite bacterial carriage differences, healthy human gut microbiomes across populations exhibit 
less variation (structural and functional) than previously believed. Our future research will build 
upon these findings to better understand how bacterial associations change within the disease 
microbiome. Also, by using the prevalent species, we can minimize the ‘noise’ of bacterial 




nature (Saunders et al., 2016). This could be advantageous as it has been suggested that the most 
abundant organisms are the ones that act as “ecosystem engineers” (Nemergut et al., 2013), and 
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Abstract 
Background: Colorectal cancer is a leading cause of cancer-related deaths worldwide. 
The human gut microbiome has become an active area of research for understanding the 
initiation, progression, and treatment of colorectal cancer. Despite multiple studies having found 
significant alterations in the carriage of specific bacteria within the gut microbiome of colorectal 
cancer patients, no single bacterium has been unequivocally connected to all cases. Whether 
alterations in species carriages are the cause or outcome of cancer formation is still unclear, but 
what is clear is that focus should be placed on understanding changes to the bacterial community 
structure within the cancer-associated gut microbiome.  
Results: By applying a novel set of analyses on 252 previously published whole-genome 
shotgun sequenced fecal samples from healthy and late-stage colorectal cancer subjects, we 
identify taxonomic, functional, and structural changes within the cancer-associated human gut 
microbiome. Bacterial association networks constructed from these data exhibited widespread 




cancer associated gut microbiomes. Within the cancer-associated ecosystem, bacterial species 
were found to form associations with other species that are taxonomically and functionally 
dissimilar to themselves, as well as form modules functionally geared towards potential changes 
in the tumor-associated ecosystem. Bacterial community profiling of these samples revealed a 
significant increase in species diversity within the cancer-associated gut microbiome, and an 
elevated relative abundance of species classified as originating from the oral microbiome 
including, but not limited to, Fusobacterium nucleatum, Peptostreptococcus stomatis, Gemella 
morbillorum, and Parvimonas micra. Differential abundance analyses of community functional 
capabilities revealed an elevation in functions linked to virulence factors and peptide 
degradation, and a reduction in functions involved in amino-acid biosynthesis within the 
colorectal cancer gut microbiome.  
 Conclusions: We utilize whole-genome shotgun sequenced fecal samples provided from a 
large cohort of late-stage colorectal cancer and healthy subjects to identify a number of 
potentially important taxonomic, functional, and structural alterations occurring within the 
colorectal cancer associated gut microbiome. Our analyses indicate that the cancer-associated 
ecosystem influences bacterial partner selection in the native microbiota, and we highlight 







The human gastrointestinal tract harbors a highly diverse community of bacterial cells 
thought to be in comparable abundance to those of its human host, making it the largest and most 
complex community of bacteria found associating with the human body (Sender et al., 2016). 
These bacteria are typically regarded as commensal or symbiotic in that they generally cause no 
harm and provide fundamental services for their host’s nutrition and continued health. The most 
important of these services include the creation of metabolic by-products (short-chain fatty acids, 
hormones, vitamins, etc.), aiding in proper intestinal tissue and immune system development and 
regulation, and protecting the gut from colonization by pathogenic organisms (Kho & Lal, 2018; 
Thaiss et al., 2016). Many diseases have been associated with the disruption of the gut 
microbiome’s bacterial community, one of which is colorectal cancer (CRC) (Ahn et al., 2013; 
Feng et al., 2015; Kostic et al., 2012; S. Li et al., 2017).  
CRC is one of the leading causes of cancer-related deaths worldwide (Siegel et al., 2020) 
and is characterized by the uncontrolled growth of epithelial cells within the colon or rectum. 
The transformation of epithelial cells from noncancerous to cancerous growth commonly begins 
with the formation of a polyp, which over a 10-to-20-year period may or may not progress to 
become invasive cancer (S. Jones et al., 2008). CRC initiation is understood as being the result of 
a combination of both genetic and environmental factors (diet, smoking, alcohol, etc.) (Botteri et 
al., 2008; Fedirko et al., 2011; Thanikachalam & Khan, 2019), although the majority (around 
75%) of CRC cases are spontaneous, with genetic risk factors being attributed to less than 10% 




evidence supporting the hypothesis that the human gut microbiome plays a prominent role in 
relation to cancer initiation, progression, and in the efficacy of its treatment (Dzutsev et al., 2015; 
Gopalakrishnan et al., 2018; Kostic et al., 2012; Matson et al., 2018; Sears & Pardoll, 2011; T. 
Yu et al., 2017). One of the leading hypotheses is the “driver-passenger” model (Tjalsma et al., 
2012), which postulates that a “driver” bacterium such as Fusobacterium nucleatum, Bacteroides 
fragilis, or Escherichia coli promotes genomic instability (damage) to the DNA of epithelial 
cells, potentially through some virulence factor, which leads to cellular mutation and eventually 
tumor formation. Following tumor formation, the changes in micro-environmental conditions 
around the tumor mass (tumor microenvironment; TME) would optimize the growth of 
“passenger” microbes who are better suited to this niche facilitating their colonization, and 
eventual out-competing of the “driver” species as well as the native microbiota leading to a 
depletion in protective commensal species. These “passenger” microbes could either be 
pathogens that exist normally in the healthy gut microbiome in low abundance, or simply 
commensal bacteria that have acquired pathogenic characteristics due to the alteration in the 
local intestinal ecology. As of now, there is no consistent cancer-associated community profile 
that has been observed leaving researchers with limited understanding of the full extent the 
microbiota plays in CRC. Nevertheless, the modulation of the bacterial community within the 
cancer-associated gut microbiome is the next logical step in possible CRC treatment and 
prevention strategies.  
To one day utilize the bacterial community toward these purposes, it is important to know 




understand how the associations between bacterial species have been affected. These 
associations are shaped by both direct and indirect interactions taking place in the community 
(e.g., cooperation or competition), and are important as they are the bedrock upon which the 
community services, as well as the structure and function, are founded on (Gould et al., 2018; 
Hibbing et al., 2010). In this study, we represent these bacteria associations using a weighted 
graph (network). Bacterial association networks are constructed from a GGM framework applied 
to a CLR-transformed sample-taxa count matrix to model the conditional dependencies between 
species to construct association networks (Kurtz et al., 2015). Prior studies that investigated the 
associations between bacteria within the CRC-associated gut microbiome have either not dealt 
appropriately with compositional data (for instance, application of correlation directly to 
untransformed data), or have utilized low taxonomic resolution data (16S rRNA data) which 
should be used cautiously to assign taxonomic classifications beneath genus-level (Ai et al., 
2019; Edgar, 2018; Feng et al., 2015; Flemer et al., 2017; H. Liao et al., 2020; Warren et al., 
2013). For the analysis presented here, we utilize 252 whole-genome shotgun sequenced fecal 
samples provided by healthy and late-stage (stage III and IV) CRC subjects from a previously 
published study (Yachida et al., 2019) to investigate bacterial associations at the species level 
(Ranjan et al., 2016). The authors of that study originally performed metagenomic and 
metabolomic analyses to assess any taxonomic and functional differences of the gut microbiota, 
and metabolites, as well as find diagnostic markers for CRC. For their analyses, these researchers 
only focused on finding alterations of the microbiota pertaining to species currently known to be 
culturable and constructed bacterial association networks using correlation (Spearman’s) at the 




comprehensive collection of nearly eleven thousand bacterial strain reference genomes from 
NCBI’s RefSeq database to calculate the genome relative abundance of bacterial species in each 
sample using an EM algorithm. Subsequently, species were selected based on their prevalence, 
relative abundance, and feature importance, and were used to construct bacterial association 
networks using the glasso approach (Friedman et al., 2008). These networks were then analyzed 
to assess the differences in bacterial community structure between the healthy and late-stage 
CRC-associated gut microbiome. Taxonomic and functional analysis was performed to highlight 
differences in gut microbiome bacterial community functional capabilities and species carriages. 
Our results not only identify both individual and groups (modules) of species potentially capable 
of aiding tumor progression, but also shows how the bacterial community structure has 
dramatically altered in response to potential ecological changes occurring within the CRC-
associated gut microbiome. 
Materials and Methods 
Data Acquisition and Cohort Description 
For this study, 252 whole-genome shotgun sequenced fecal samples (see APPENDIX D) 
were retrieved from DDBJ Sequence Read Archive (DRA) under the project ID PRJDB4176 
(Yachida et al., 2019). The original study population of this cohort consisted of healthy and 
early/advanced colorectal cancer stage patients who were undergoing total colonoscopy at the 
National Cancer Center Hospital, Tokyo, Japan. Fecal samples were collected immediately 




patients who had or were thought to have a hereditary disease, an inflammatory bowel disease, 
an abdominal surgery history, or whose stool samples were insufficient for data collection were 
excluded from the original study. Samples chosen to be utilized within this study came from 178 
healthy and 74 late-stage (52 stage III / 22 stage IV) colorectal cancer (CRC) subjects. Sample 
groups had comparable male to female frequencies (Healthy: 56.18/43.82; CRC: 58.11/41.89) 
(Figure 29a) and subject ages (Healthy median age: 62; CRC median age: 61) (Figure 29b). For 
sample read pre-processing, see Data Pre-Processing in the Materials and Methods section within 






Figure 29: Subject age and sex distributions within sample groups. (a) Boxplots of Healthy and 
CRC sample group subject ages. (b) Bar plots of Healthy and CRC sample group subject sex 
frequencies. The age (Healthy sample group median age: 62; CRC sample group median age: 61) 
and sex (Healthy: Male 56.18%, Female: 43.82 %; CRC: Male: 58.11 %, Female: 41.89) of 
subjects are similar in both sample groups. 




Species-Level Community Taxonomic Profiling 
For bacterial community taxonomic profiling of WGS reads, we elected to utilize a 
reference-based mapping approach (see Chapter 2, Materials and Methods, Read Mapping and 
Species-Level Taxonomic Profiling, Methods Section). In total, over 3.5 billion (3,515,063,526) 
reads were mapped. Next, a probabilistic framework based on a mixture model (Loomba et al., 
2017; Xia et al., 2011) was used to analyze the read mapping information to estimate the relative 
copy number of each reference genome in a sample (see Chapter 2, Materials and Methods, Read 
Mapping and Species-Level Taxonomic Profiling, Methods Section). Principal components 
analysis was performed using Scikit-learn (version 0.23.2). Before PCA, species relative 
abundances within the sample-taxa matrix were first Centered Log-Ratio (CLR) transformed (all 
zero values were replaced with 1e-10 before transformation) (Chapter 2, Materials and Methods, 
Bacterial Genome Annotation and Functional Profiles).  
Random Forest Analysis 
An RFC (package from Scikit-learn (Pedregosa et al., 2011)) was used to classify 
samples as either CRC or Healthy and select features (species) important towards this 
classification. Random forests were trained and tested with a 70% training and 30% testing 
sample split and 100 trees per forest. One-hundred RFCs were constructed to deem a species as 
significantly ‘important’. First, a ‘random’ feature was created from randomly selected CLR-
transformed species sample relative abundances to assist in the selection of significantly 
‘important’ species, as default importance measurements from random forest classifiers are 




species provided from all 100 RFCs were compared to those of the 100 ‘random’ feature 
importances. The Gini importance (also called the Mean Decrease in Impurity) is a general 
indicator of species relevance for sample classification prediction performance; the higher the 
Gini importance, the more important the species (Menze et al., 2009). Only species with 
statistically significant higher ‘importance’ according to a Mann-Whitney U test and Benjamini-
Hochberg (FDR) multiple testing correction (MWU-FDR: qvalue<0.05) were deemed 
significantly ‘important.’ AUC and Classification Accuracy (Jaccard index) were both utilized to 
measure the accuracy of trained forests. The Classification Accuracy computes subset accuracy 
(where a prediction for a set of labels must exactly match those from the known true 
corresponding label set). 
Bacterial Species Diversity Analysis 
To measure the diversity of species found within each sample, total bacterial richness 
(total species found in a sample), the Shannon index (Shannon, 1948), and the Simpson index 
were calculated. The Shannon index (H) is calculated as: 
Shannon Index (H) =−∑ 𝑃𝑃𝑖𝑖
𝑝𝑝
𝑖𝑖=1 ⋅ 𝑅𝑅𝑠𝑠𝑃𝑃𝑖𝑖 
where (p) is the total number of species, (i) an individual species, and (Pi) is the proportion of 
that species within the sample. The Simpson index of species diversity is calculated as: 
 










Where (n) is the count of each species in a sample and (N) is the total sum of species counts 
within a sample. To convert relative species abundances to counts samples relative abundance 
profiles were multiplied by one million.  
Differential Relative Abundance of Species  
Species relative abundances within the sample-taxa matrix were first CLR-transformed 
(all zero values were replaced with 1e-10 before transformation). Mann-Whitney U test and FDR 
correction were utilized to test for significant species relative abundance differences between 
groups. Only species with a qvalue < 0.05 and a sample prevalence greater than 10% within at 
least one group were deemed truly differentially abundant.  
Bacterial Species Functional Profiles 
Species functional profiles were created separately for Healthy and CRC sample groups 
(see Chapter 2, Materials and Methods, Bacterial Genome Annotation and Functional Profiles).  
Sample Functional Profiling 
To explore the bacterial community functional capabilities contained in each sample, a 
sample-function matrix for Healthy and CRC sample groups was created (see Chapter 2, 
Materials and Methods, Bacterial Genome Annotation and Functional Profile). Mann-Whitney U 




differences between groups. Only functions with a qvalue < 0.05 were deemed significantly 
different. 
Species Selection for Association Network Construction 
Species selected for network inference were either highly prevalent/abundant species (the 
union of species exhibiting >90% sample prevalence within both groups) or species that were 
deemed as both significantly ‘important’ by random forests and differentially abundant. In total, 
there were 165 species selected for network construction. 
Bacterial Association Network Inference 
For each sample group, a bacterial association network was constructed from the CLR-
transformed sample-taxa matrix using a Gaussian Graphical Model (GGM) framework without 
bootstrapping (see Chapter 2, Materials and Methods, Construction of Bacterial Association 
Networks).  
Network Topology Comparison 
For each network, the following properties were computed using NetworkX (Hagberg et 
al., 2008) (version 2.4): average shortest path length (ASPL), transitivity, and modularity (see 




Taxonomic Relationship Analysis of Species Associations 
 For each association, the lowest common taxonomic relationship between species was 
characterized by using the NCBI taxonomic assignments. Monte Carlo simulations were utilized 
to test for significance and produce pvalues. First, 1000 random (GTN,e) networks were produced, 
using NetworkX, for comparison to each group network. Within these networks, (TN) was equal 
to the group network node total, and (e) the total edges (associations) within-group networks. 
Next, species names and association weights from group networks were randomly assigned to 
nodes and edges within each random network. Lastly, the total of each lowest common 
taxonomic relationship between nodes in each random network was computed and compared to 
those found within group networks.  
Module Functional Profiles 
Species modules were first detected within networks utilizing an asynchronous label 
propagation algorithm for module detection (see Chapter 2, Materials and Methods, Network 
Property, Clique, and Module Analysis). The module detection algorithm was allowed to 
partition the graph into modules 100 times. The modules produced from the partition resulting in 
the highest ‘performance’ were kept for subsequent analyses (see Chapter 2, Materials and 
Methods, Network Property, Clique, and Module Analysis). Following module detection, module 
functional profiles were created by weighing the species functional profile (Pfam or TIGRFAM) 
of each species within a module by that species mean relative abundance within a group (Healthy 




Module Cluster Functional Analysis 
 Module functional profiles were CLR-transformed before PCA. To find module 
clusters, modules were partitioned by performing K-means clustering, from Scikit-learn, on the 
PCA. Silhouette analysis, from Scikit-learn, was used to find the optimal K for K-means 
clustering. Silhouette coefficients (SC) range from [-1,1], where a positive SC near 1 indicates 
that a module within our PCA is far away from neighboring clusters, and a high average 
silhouette score is indicative of well-defined clusters. After clusters were defined, the distinct 
functionality of clusters was examined. First, PCA was run in a pairwise fashion on the modules 
from each cluster to find the most important functional features (Pfams or TIGRFAMS), which 
made a cluster distinct from every other cluster. Across all PCAs, the features which separated 
each cluster along the first principal component exhibiting importance above a magnitude of 0.01 
were noted and summed. Afterward, the top 100 TIGRFAMS with the highest importance within 
each cluster were selected, and the main and sub-roles of each TIGRFAM were elucidated. 
TIGRFAM main and sub role abundance importances were created by summing the importances 
of all TIGRFAMS that were assigned to that main and sub role, then normalizing by total. Lastly, 
the top 10 Pfams with the highest total importance were utilized for a more in-depth inspection 
of a cluster’s distinct functionality.  
Node Centrality ‘Hub’ Analysis 
Degree centrality was used to find bacterial ‘Hubs’ within modules by choosing the 




graphs that exhibited disassortative mixing in respect to degree (degree assortativity < 0), as 
measured by NetworkX, were selected for examination. 
Statistical Significance Testing 
A two-tailed nonparametric t-test (Mann-Whitney U test) (Mann & Whitney, 1947) was 
used to compare groups for statistical significance. Benjamini-Hochberg (False discovery rate; 
FDR) (Benjamini & Hochberg, 1995) was used for multiple testing correction. 
Results 
Bacterial Community Taxonomic Profiling 
Following sample pre-processing (see methods), we computed the relative abundance of 
species within each sample using an EM-based method to construct a sample-taxa matrix (see 
methods). This sample-taxa matrix was then used to investigate the bacterial community 
diversity in the two sample groups (Healthy and late-stage CRC) by measuring the bacterial 
richness and Shannon index of each sample. Samples originating from the CRC group exhibited 
significantly greater diversity, both richness and Shannon index, (Mann-Whitney U test: MWU); 
Richness: MWU pvalue=0.0005 and Shannon Index: MWU pvalue=0.0009) compared to those 





Figure 30: Species diversity within healthy and CRC samples.  (a) Boxplot of sample species 
richness (total species) showing significantly greater species richness within the CRC sample 
group. (b) Boxplot of sample Shannon diversity shows significantly greater species diversity 
within the CRC sample group. Black dots represent individual samples, and stars (***) denote 
statistical significance (MWU pvalue < 0.001). 
Source: Mark Loftus 
 
 
Considering that measures of species diversity differ in their sensitivity to species evenness and 
richness (K. V.-A. Johnson & Burnet, 2016), we additionally applied the Simpson index of 
diversity to compute species diversity within sample groups. These results were congruent with 
our previous analyses showing a statistically significant (MWU: pvalue=0.0238) higher species 







Figure 31: Simpson index of species diversity within healthy and CRC samples. Boxplots 
displaying the Simpson index of Diversity (1-Dominance) for each sample from the healthy and 
CRC sample groups. CRC samples were shown to contain a statistically significant higher 
species diversity (Mann-Whitney U test pvalue=0.023878) compared to those within healthy 
samples. 
Source: Mark Loftus 
 
 
We next assessed the differences in bacterial community taxonomic profiles between the healthy 
and late-stage CRC-associated gut microbiomes. Prior to performing further analyses, we applied 
a CLR transformation to our sample-taxa matrix (see methods). Taxonomic profile-based sample 
ordination was carried out using Principal Components Analysis (PCA). The first two principal 




(Figure 32), and the linear transformation based on PCA did not show evidence for separation of 




Figure 32: PCA of healthy and CRC sample taxonomic profiles. Principal components analysis 
of CLR-transformed bacterial species relative abundance sample profiles. Gold and grey circles 
represent healthy and CRC samples, respectively. PCA exhibited little variance between healthy 
and CRC-associated gut microbiome sample species relative abundance profiles. 





However, we were able to distinguish between the two sample groups using a Random Forest 
Classifier (RFC) (AUC = 0.87) (Figure 33a). While RFCs rank features (species) based on their 
importance, these default measures of importance are known to be biased and lead to the return 
of suboptimal predictor features (Strobl et al., 2007). To obtain statistical significance for species 
importances provided by the RFC we applied a technique where we included a “random” feature 
into our feature set (see methods). By using an ensemble of 100 RFCs, we uncovered 17 
bacterial species that were statistically (MWU and False Discovery Rate Multiple Testing 
Correction; MWU-FDR: qvalue<0.05) more ‘important’ (deemed significantly ‘important’) than 
the random feature for distinguishing groups (Figure 33b). We found that the accuracy 
classification score of 100 RFCs trained on the 17 significantly ‘important’ species was on 
average greater than that of the 100 RFCs trained on all species (All Species Mean Accuracy: 
74%; 17 significantly ‘important’ Species Mean Accuracy: 80%) (Figure 33c). We next 
performed species differential abundance analysis (see methods) which revealed 174 species 
significantly (MWU-FDR qvalue<0.05) reduced in relative abundance, and 10 species 
significantly elevated in relative abundance within the CRC-associated gut microbiome 
compared to the Healthy gut microbiome. These 174 bacterial species are from a diverse 
background of 84 genera, although the largest fraction of species were from the genera 
Enterobacter (6.8%), Klebsiella (6.3%), Streptococcus (5.2%), Lactobacillus (5.1%), Citrobacter 





Figure 33: Healthy and CRC taxonomic profiling. (a) Random Forest Classifier (RFC) ROC 
showing an AUC = 0.87. (b) Seventeen statistically significant (MWU-FDR qvalue< 0.05) 
‘important’ species from 100 RFCs compared to a random feature. (c) Classification accuracy of 
100 RFCs using either all species or the 17 significantly ‘important’ species. (d) Distribution of 
total oral microbes within healthy and CRC sample groups. A significantly (MWU pvalue< 0.05) 
greater total population of oral microbes was found in the CRC-associated gut microbiome. 
Bacterial species were classified as oral microbes by using the expanded Human Oral Microbe 
Database (eHOMD). 







Figure 34: Genera of 174 species reduced in relative abundance in CRC. Heatmap showing the 
genera proportion of 174 species found in reduced relative abundance within the CRC gut 
microbiome compared to healthy. 




The 10 species significantly elevated in relative abundance within CRC were: Parvimonas micra 
(qvalue=3.09e-09), Peptostreptococcus stomatis (qvalue=4.51e-08), Gemella morbillorum 
(qvalue=4.55e-08), Fusobacterium nucleatum (qvalue=1.08e-06), Streptococcus anginosus 
(qvalue=1.13e-03), Dialister pneumosintes (qvalue=1.37e-03), Peptostreptococcus anaerobius 
(qvalue=4.74e-03), Streptococcus sp. KCOM 2412 (Streptococcus periodonticum) 
(qvalue=7.18e-03), Ruminococcus torques (qvalue=1.55e-02), and Filifactor alocis 
(qvalue=2.85e-02) (Table 4, Figure 35a,b).  
 
 
Table 4: Ten bacterial species in CRC significantly elevated in relative abundance 
Species Healthy Median CRC Median qvalue 
Parvimonas micra 2.99134076 10.52770475 3.0967e-09 
Peptostreptococcus stomatis -2.57600371 10.29005040 4.5116e-08 
Gemella morbillorum -2.68677473 9.731965005 4.5598e-08 
Fusobacterium nucleatum -3.11339406 9.405303965 1.0849e-06 
Streptococcus anginosus -2.59775877 9.654938454 0.0011 
Dialister pneumosintes -2.94049161 8.240590013 0.0013 
Peptostreptococcus anaerobius -2.75121822 8.270922133 0.0047 
Streptococcus sp KCOM 2412 -2.69451377 8.58768744 0.0072 
Ruminococcus torques 13.13926386 13.9765340 0.0156 
Filifactor alocis -2.75119607 8.72705699 0.0285 
These ten bacterial species were found to be significantly (MWU-FDR qvalue<0.05) elevated in 
relative abundance within the CRC-associated gut microbiome compared to the healthy gut 
microbiome. The median CLR-transformed relative abundance of species within healthy and 





Figure 35: Species exhibiting elevated relative abundance in CRC. (a) Sample prevalence of 
those within the healthy and CRC sample groups. (b) Median relative abundance of those species 
within the healthy and CRC sample groups. 




Interestingly, many of the species that were deemed both significantly ‘important’ and elevated 
in relative abundance within CRC are also found in the oral microbiome and noted to be 
associated with oral diseases (periodontitis, periapical lesions, root canal infections, oral cancers, 
etc.) which have been associated with increased risks of CRC (Chattopadhyay et al., 2019; 
Contreras et al., 2000; Horiuchi et al., 2020; Lauritano, 2017; D. Lee et al., 2018; Michaud et al., 
2017; Momen-Heravi et al., 2017; Neilands et al., 2019; Oswal et al., 2020; Schlafer et al., 
2010). Subsequently, we utilized the expanded Human Oral Microbe Database (eHOMD) 
(Escapa et al., 2018) to classify all oral species within our samples and found a significant 
increase in the total oral microbe population richness existing within the CRC-associated gut 
microbiome in comparison to that of the Healthy group (MWU: pvalue=6.51e-05) (Figure 33d).  
Bacterial Community Functional Profiling 
To analyze the differences in community functional capabilities between the Healthy and 
CRC gut microbiomes we measured the relative abundance of protein families (TIGRFAMs 
(Haft, 2001)) and protein domains (Pfams (El-Gebali et al., 2019)) within our WGS samples 
creating a sample-function matrix (see methods). A CLR transformation was applied to this 
matrix, and then PCA was performed. PCA showed evidence of inter-group clustering of samples 
(Healthy and CRC) and ultimately only explained a moderate variance (PC1: 27.19%, PC2: 






Figure 36: PCA of healthy and CRC sample functional profiles. Principal component analysis of 
CLR-transformed sample (Pfam) functional relative abundance profiles. Gold and grey dots 
represent healthy or CRC samples, respectively. 
Source: Mark Loftus 
 
 
Differential abundance analysis was performed using the CLR-transformed sample-function 
matrix, which showed 12 Pfams (7 elevated and 5 reduced in CRC compared to Healthy) and 
two TIGRFAMs (1 elevated and 1 reduced in CRC compared to Healthy) to be statistically 




Table 5: Pfams and TIGRFAMs found in differential relative abundance. 
Pfam or TIGRFAM Description Healthy Median CRC Median qvalue 
PF08191 LRR adjacent -5.673367 3.484002 1.2247e-06 
PF09403 Adhesion protein FadA -5.73872 2.727507 1.2545e-05 
PF07087 Protein of unknown function 
(DUF1353) 
-6.0322 -3.256442 5.2957e-05 
PF04122 Putative cell wall binding repeat 
2 
2.123856 3.819037 0.00086 
PF17886 HSP20-like domain found in 
ArsA 
-6.0322 -5.534243 0.01749 
PF16728 Domain of unknown function 
(DUF5066) 
-6.061185 -5.613685 0.01749 
PF01345 Domain of unknown function 
(DUF11) 
4.196018 4.807215 0.02123 
PF08254 Threonine leader peptide 0.656293 -6.235979 1.1108e-14 
PF14255 Cysteine-rich CPXCG -5.356354 -6.229333 4.4355e-10 
PF11962 Peptidase_G2, IMC 
autoproteolytic cleavage domain 
-1.925865 -6.141857 1.2247e-06 
PF06308 23S rRNA methylastransferase 
leader peptide (ErmCL)  
4.5233989 3.441621 0.01748 
PF14104 Domain of unknown function 
(DUF4277) 
-5.712807 -6.183273 0.01748 
TIGR02077 Thr_lead_pep: thr operon leader 
peptide 
0.357274 -8.00791 3.7926e-15 
TIGR01249 Pro imino pep 1: prolyl 
aminopeptidase 
-1.014171 0.430146 0.01262 
The table shows the 12 Pfams and 2 TIGRFAMs found to be differentially abundant between 
healthy and CRC sample groups. Sample function relative abundances profiles were first CLR-






Pfams that were significantly elevated within the CRC gut microbiome were linked to bacterial 
invasins and adhesins (ex: FadA), while those that were significantly reduced were tied to 
antibiotic resistance, bacteriophage maturation, and threonine biosynthesis. The single 
TIGRFAM significantly elevated in CRC was linked to proline iminopeptidase, while the only 
TIGRFAM significantly reduced was again linked to threonine biosynthesis. 
Bacterial Association Networks  
Species chosen for network construction were selected based on their prevalence, 
abundance, and ‘importance.’ First, the prevalence of each species was calculated across all 
samples within each group (Figure 37a). The distributions of bacterial species prevalence counts 
within groups were found to exhibit a bi-modal distribution, with one peak occurring at the 90% 
prevalence threshold. Going forward, we refer to the species found above 90% sample 
prevalence within groups as the highly prevalent species (HPS). A large majority of species 
within each group’s HPS were found to be shared (Healthy: 97% and CRC: 95%) (Figure 37b). 
The five unique HPS in the Healthy group were: Hespellia stercorisuis, Clostridium 
saccharolyticum, Monoglobus pectinilyticus, Streptococcus sp. oral taxon 431, and Odoribacter 
laneus. The eight HPS unique to the CRC associated group were: Intestinibacillus massiliensis, 
Prevotella copri, Haemophilus parainfluenzae, Ruminococcus bicirculans, Streptococcus mitis, 
Neglecta timonensis, Bifidobacterium catenulatum, and Anaerotignum neopropionicum. 
Interestingly, Streptococcus mitis and Haemophilus parainfluenzae are both classified by the 
eHOMD as oral microbes. The relative abundances of HPS were found to account for the 





Figure 37: Highly prevalent and abundant species within sample groups. (a) Bi-modal 
distribution of species prevalence counts across samples within the healthy and CRC sample 
groups. (b) Stacked-bar plot showing the total unique and shared species of the highly prevalent 
(> 90% prevalence) species within the healthy and CRC sample groups. (c) Boxplot of the total 
sample relative abundance accounted for by the highly prevalent species within groups. Black 
dots represent individual samples. 
Source: Mark Loftus 
 
 
Moving forward, we utilized the union of HPS within groups for network construction. In 
addition to these highly prevalent and abundant species, we wanted to incorporate the species 
that were both deemed significantly ‘important’ by our RFCs and found in differential 
abundance. This led to the addition of 8 species (Parvimonas micra, Peptostreptococcus 
stomatis, Gemella morbillorum, Fusobacterium nucleatum, Streptococcus anginosus, Dialister 
pneumosintes, Peptostreptococcus anaerobius, and Ruminococcus torques) to our species group 
(165 species total) used in network construction. Bacterial association networks were then 
constructed from the CLR-transformed relative abundance of these selected species (see 




by comparing multiple network properties (average shortest path length, transitivity, and 
modularity) to those displayed from random networks (see methods). Compared to random 
networks, the Healthy and CRC networks both exhibited statistically significant (Monte Carlo 
Simulation; MCS) shorter average shortest path lengths (ASPL) (Healthy and CRC: MCS 
pvalue<0.001), higher transitivity (Healthy and CRC: MCS pvalue<0.001), and higher 
modularity (Healthy and CRC: MCS pvalue<0.001) (Table 6).  
 
 
Table 6: Network properties of healthy and CRC bacterial association networks. 
 
Both healthy and CRC networks were found to exhibit significantly shorter Average Shortest 
Path Lengths (ASPL), higher Transitivity, and higher Modularity than 1000 random networks. 
Stars (***) denote statistical significance (Monte Carlo simulation pvalue < 0.001). 
 
 
These results indicate that networks constructed displayed properties that were 
significantly non-random and that species within networks: are connected through short paths, 
have positive associations with the neighbors of their neighbors (friends of friends), and form 
modules (i.e., a group or cluster of species) that are characterized by the majority of associations 
occurring between species within the same module, and few associations existing with species 
Network Nodes Edges Density ASPL Transitivity Modularity 
CRC 165 324 0.024 *** 1.687 *** 0.379 *** 0.689 




outside the module. Group networks contained similar distributions of association weights, with 
positive associations being in greater abundance than negative associations (Figure 38a). 
Notably, the CRC network contained a greater total of negative associations compared to that 
found in the Healthy network. Interestingly, 29% of these negative associations involved a 
species deemed as an oral microbe, whereas within the Healthy network, zero negative 
associations were found to involve oral microbes. Surprisingly, most associations found within 
networks were unique to that network (Healthy: 69%, CRC: 72%) (Figure 38b). We 
hypothesized that this dramatic difference in community structure could reflect changes in the 
ecosystem and proceeded to analyze the taxonomic relationship between species within networks 










Figure 38: Healthy and CRC Network Associations. (a) Distribution of bacterial association 
weights within healthy and CRC networks. (b) Stacked-bar plot of the proportion of associations 
(edges) that are unique and shared between healthy and CRC networks. (c) Bar plots 
representing the proportion of total associations within the lowest common taxonomic 
relationship between bacterial species. Stars (***) indicate statistical significance (Monte Carlo 
simulation pvalue < 0.001), star color (green or red) indicate higher or lower than that found in 
random networks, respectively. 





Both networks exhibited significantly (MCS pvalue<0.05) more positive relationships between 
species within the same genera (Healthy: MCS pvalue=0.00099, CRC: MCS pvalue=0.00099) 
and family (Healthy: MCS pvalue=0.00099, CRC: MCS pvalue=0.00099) compared to those 
found in a random network (see methods). However, only within the Healthy network did 
species still have significantly more positive associations with other species from the same order 
more so than random (Healthy: MCS pvalue=0.00099, CRC: MCS pvalue=0.44). The CRC 
network also exhibited a larger abundance in taxonomically distant (outside phylum) 
relationships compared to the Healthy network (Healthy: 4%, CRC: 17%), although positive 
associations between taxonomically distant microbes were still significantly less in Healthy 
(Within Phylum: MCS pvalue=0.00099, Outside Phylum: MCS pvalue=0.00099) and CRC 
(Within Phylum: MCS pvalue= 0.00099, Outside Phylum: MCS pvalue=0.00099) than random 
networks. We next examined the dissimilarity between functional profiles of associating species 
within the Healthy and CRC networks (Figure 39a-c). Interestingly, many of the bacterial 
associations that are unique to the CRC network were shown to be occurring between species 










Figure 39: Bacterial partner genome functional distance vs. association weight. (a,b,c) 
Scatterplots showing Bray-Curtis distance between network partner bacterial genome functional 
(Pfam) profiles versus association weight. (a) Displays all associations within healthy and CRC 
networks. (b) Highlights associations unique to the healthy network in green. (c) Highlights 
associations unique to the CRC network in red. The unique associations within the CRC network 
appear to occur between species with dissimilar genome functional profiles. 




Considering that our networks exhibited high modularity and that community functions 
in microbial environments are driven through polymicrobial synergy (Bottery et al., 2020; 
D’Souza et al., 2018), we applied a module detection algorithm to our networks and proceeded to 
analyze the obtained species modules within our networks (see methods). We first started by 
comparing the potential functional capabilities of modules by constructing CLR-transformed 
module functional profiles (see methods). PCA of module functional (protein domain) profiles 
exhibited large variance (PC1: 33.73%, PC2: 14.53%), and modules appeared to form clusters 
which contained representation from both groups (Figure 40a). To define clusters of modules, 
silhouette analysis was performed, which estimated five clusters as the optimal K to use for K-
means clustering (Figure 40b). After module clusters were defined by K-means clustering 









Figure 40: Species module functional clusters within group networks. (a) Principal component 
analysis of module functional profiles. Gold and grey dots represent individual modules from 
healthy or CRC networks, respectively. (b) Silhouette analysis showing K = 5 having the highest 
average silhouette coefficient. (c) K-means clustering of the module functional profile PCA using 
K = 5. 
Source: Mark Loftus 
 
 
Across networks, modules that fell within the same cluster were found to be taxonomically 
similar, excluding cluster 1 and cluster 5, which exhibited a shift in species occupancy where 
some species found within cluster 1 in the Healthy network were shown to be within cluster 5 in 
the CRC network, and vice-versa (Figure 41a,b,c,g). However, both networks had strong 
agreement on the species found within clusters 2, 3, and 4. Species within cluster 2 were only 
‘pathobiont’ (i.e., species that are generally not harmful but contain the capacity to cause disease 




& Mazmanian, 2009)) oral microbes (Figure 41d), whereas cluster 3 was mainly Streptococcus 













Figure 41: Taxonomic profiling of species module clusters within group networks. (a) Heatmap 
showing presence (dark green) and absence (light green) of species within module clusters of 
both group networks. (b) Jaccard dissimilarity of group module cluster presence/absence 
profiles. (c,d,e,f,g). Heatmaps showing genera proportion of species found within module cluster 
1,2,3,4, or 5, respectively. 




Subsequently, cluster functional analysis was performed to find protein domains, as well as the 
main roles and sub-roles of protein families, which made clusters functionally ‘distinct’ from one 
another (see methods) (Table 7, Figure 42a,b).  
 
 
Table 7: Top ten Pfams of each module cluster with the highest total importance. 




PF00563 EAL domain 0.110935 Cluster 1 
PF00990 Diguanylate cyclase, GGDEF domain 0.106661 Cluster 1 
PF04647 Accessory gene regulator B 0.105438 Cluster 1 
PF04026 SpoVG 0.104271 Cluster 1 
PF06686 Stage III sporulation protein AC/AD protein family 0.103678 Cluster 1 
PF12673 Domain of unknown function (DUF3794) 0.103487 Cluster 1 
PF03862 SpoVAC/SpoVAEB sporulation membrane protein 0.103018 Cluster 1 
PF07873 YabP family 0.102995 Cluster 1 
PF08769 Sporulation initiation factor Spo0A C terminal 0.102861 Cluster 1 
PF07561 Domain of unknown function 0.102153 Cluster 1 
PF05658 Head domain of trimeric autotransporter adhesin 0.308103 Cluster 2 
PF05662 Coiled stalk of trimeric autotransporter adhesin 0.297109 Cluster 2 
PF03895 YadA-like membrane anchor domain 0.297109 Cluster 2 
PF03938 Outer membrane protein (OmpH-like) 0.280834 Cluster 2 
PF03709 Orn/Lys/Arg decarboxylase, N-terminal domain 0.280834 Cluster 2 
PF00395 S-layer homology domain 0.276507 Cluster 2 
PF13018 Extended Signal Peptide of Type V secretion system 0.273046 Cluster 2 
PF02472 Biopolymer transport protein ExbD/TolR 0.273046 Cluster 2 
PF03544 Gram-negative bacterial TonB protein C-terminal 0.273046 Cluster 2 
PF03797 Autotransporter beta-domain 0.273046 Cluster 2 
PF17966 Mub B2-like domain 0.119519 Cluster 3 
PF04270 Streptococcal histidine triad protein 0.118665 Cluster 3 
PF17965 Mucin binding domain 0.117271 Cluster 3 
PF04650 YSIRK type signal peptide 0.116951 Cluster 3 
PF17998 Cell surface antigen I/II C2 terminal domain 0.116889 Cluster 3 
PF17961 Bacterial Ig domain 0.112198 Cluster 3 
PF05975 Bacterial ABC transporter protein EcsB 0.112161 Cluster 3 
PF03083 Sugar efflux transporter for intercellular exchange 0.111894 Cluster 3 
PF07006 Protein of unknown function (DUF1310) 0.111844 Cluster 3 
PF15507 Domain of unknown function (DUF4649) 0.111046 Cluster 3 








PF13776 Domain of unknown function (DUF4172) 0.079257 Cluster 4 
PF09093 Lyase, catalytic 0.078629 Cluster 4 
PF09092 Lyase, N-terminal 0.078603 Cluster 4 
PF14112 Immunity protein 22 0.077783 Cluster 4 
PF14294 Domain of unknown function (DUF4372) 0.076095 Cluster 4 
PF12812 PDZ-like domain 0.075434 Cluster 4 
PF18291 HU domain fused to wHTH, Ig, or Glycine-rich motif 0.075120 Cluster 4 
PF14423 Immunity protein Imm5 0.074952 Cluster 4 
PF16306 Domain of unknown function (DUF4948) 0.074932 Cluster 4 
PF04951 D-aminopeptidase 0.077659 Cluster 5 
PF11299 Protein of unknown function (DUF3100) 0.073806 Cluster 5 
PF03401 Tripartite tricarboxylate transporter family receptor 0.073089 Cluster 5 
PF01970 Tripartite tricarboxylate transporter TctA family 0.072784 Cluster 5 
PF07331 Tripartite tricarboxylate transporter TctB family 0.072589 Cluster 5 
PF04346 Ethanolamine utilization protein, EutH 0.719928 Cluster 5 
PF07715 TonB-dependent Receptor Plug Domain 0.071852 Cluster 5 
PF13715 CarboxypepD_reg-like domain 0.0711103 Cluster 5 
PF03682 Uncharacterized protein family (UPF0158) 0.0701018 Cluster 5 
PF14344 Domain of unknown function (DUF4397) 0.070898 Cluster 5 
This table shows the top 10 Pfams for each module cluster with the greatest importance. Pfam 













Figure 42: Module cluster functional profiling. (a) Heatmap showing the proportion of the total 
top 100 TIGRFAM feature importances TIGRFAM main roles account for within clusters. (b) 
Heatmap showing the proportion of the total top 100 TIGRFAM feature importances TIGRFAM 
sub-roles account for within clusters. 




Functional capabilities (protein domains and protein family main/sub roles) distinguishing 
cluster 1 were linked to cell surface adhesion, counter-conflict strategies, tyrosine recombinases, 
degradation of polysaccharides, glycosaminoglycan binding, tumor protease inhibition, 
peroxidase functions, carbohydrate/cellulose-binding activities, and amino acid biosynthesis. 
Cluster 2’s distinguishing functions were linked to adherence to host cells and extracellular 
matrix, cellular infection, collagen binding, complement resistance, ornithine/lysine/arginine 
decarboxylase (tissue putrefaction/polyamine synthesis/acidic environment resistance), 
metallopeptidases, type V secretion systems, ammonia production, and excretion of poisonous 
metal ions (copper efflux system), cell envelope, DNA metabolism, fatty acid and phospholipid 
metabolism, biosynthesis and degradation of surface polysaccharides and lipopolysaccharides. 
Cluster 3’s distinguishing functions were linked to mucin binding, zinc scavenging/uptake, cell-
surface adhesion, glucose binding/transport, and copper binding, protein and peptide 
fate/synthesis/secretion, degradation of polysaccharides/carbohydrates, organic alcohols, and 
acids. Cluster 4’s distinguishing functions were linked to metal binding, diguanylate 
cyclase/phosphodiesterase, quorum sensing, carbohydrate-binding, and cysteine/papain 
proteases, nucleosides and nucleotides, transport and binding proteins, TCA cycle, iron carrying, 
and the degradation and biosynthesis of surface polysaccharides. Lastly, cluster 5’s 
distinguishing functions were linked to aminopeptidases, tripartite tricarboxylate receptors, 
ethanolamine transportation, starch utilization, and xyloglucan/polysaccharide binding, energy 
metabolism, amino acids and amines, cation and iron compounds, electron transport, and the 
biosynthesis and degradation of surface polysaccharides and lipopolysaccharides. The abundance 




cluster 1 (33%), cluster 2 (2%), cluster 3 (5%), cluster 4 (26%), cluster 5 (7%), no cluster (27%); 
CRC: cluster 1 (19%), cluster 2 (3%), cluster 3 (3%), cluster 4 (12%), cluster 5 (30%), no cluster 




Figure 43: Healthy and CRC bacterial association networks. Bacterial association networks are 
presented in a circular layout. Edge color (green or red) represent positive or negative 
associations, respectively. The far-left network (Shared Associations Network) shows the 
associations (edges) found in both the healthy and CRC network. Node color within that network 
represents the phylum of the species. The two networks on the right are displaying the 
associations unique only to the healthy or CRC network. Node color within these networks 
represents the module cluster this species was found within. Node size is a function of the node’s 
degree (total associations). For a list of node species designations, see Appendix E. 





Our findings showed that within the CRC network, there was an increase in the total species 
found within a module of cluster types 2 and 5 and a reduction of species in cluster types 1, 3, 
and 4 compared to the Healthy. These results are also reflected in our findings of a statistically 
significant change in the total sample relative abundance that species within clusters accounted 
for between groups (Cluster 1: MWU pvalue=4.29e-12; Cluster 2: MWU pvalue=3.16e-16; 
Cluster 3: MWU pvalue=0.0002; Cluster 4: MWU pvalue=2.62e-13; Cluster 5: MWU 
pvalue=2.81e-29; No Cluster Species: MWU pvalue=4.40e-17) (Figure 44). Moreover, the 
majority of negative associations within networks (Healthy: 100%, CRC: 96%) were found to 
occur between species that occupy modules within different cluster types (Figure 45). 
Interestingly, only within the CRC network did an intra-cluster negative association arise 







Figure 44: Cluster Species Total Sample Relative Abundance. Boxplots of the total sample 
relative abundance that all species within each module cluster account for within groups. The 
species within module clusters 1, 3, and 4 account for a significantly greater total sample relative 
abundance within the Healthy network compared to the CRC network. The species within 
module clusters 2 and 5 and no cluster account for a significantly greater total sample relative 
abundance within the CRC network compared to the Healthy network. Stars (***) indicate 
statistical significance (MWU pvalue < 0.001). 





Figure 45: Negative Associations Between Network Module Clusters. Heatmaps are showing the 
proportion of negative associations occurring between species from each module cluster type 
within Healthy and CRC networks. Within the CRC network, we see the first occurrence of an 
intra-cluster negative association between species (cluster 1). 
Source: Mark Loftus 
 
 
Influential Bacterial Species Within Networks 
Finally, we examined which species potentially have the greatest influence on the 
structure of our networks, and therefore possibly within the ecosystem as well, by identifying 
‘Hub’ nodes. ‘Hub’ nodes are species with many associations that serve as a central point of 
connection between many other species (Newman, 2010; Steele et al., 2011). Most modules 
within networks (Healthy: 84.6%; CRC: 87.5%) were found to be disassortative with respect to 






Figure 46: Distribution of degree assortativity of network modules. Distribution of the degree 
assortativity of module subgraphs within healthy and CRC networks. This graph shows most 
modules within networks have a degree assortativity below 0 suggesting ‘Hub’ nodes exist 
within these modules. 









We proceeded to identify ‘Hub’ species by selecting the species with the largest degree centrality 
within all modules exhibiting a degree assortativity below zero (see methods). In total, 22 unique 
‘Hub’ species were identified, and of these ‘Hubs,’ only two, Bacteroides fluxus and Bacteroides 
pectinophilus were shared between Healthy and CRC networks. We noted that Bacteroides fluxus 
and Bacteroides pectinophilus also maintained their position as ‘Hubs’ within the same module 






Figure 47: Mean sample relative abundance of “Hub” species within healthy and CRC networks.  
The mean relative abundance of “Hub” nodes found within healthy (a) and CRC (b) networks. 
The color of the “Hub” species name represents which cluster their module was associated with 
(Cluster 1-5). Only within the CRC network were oral microbes found to be “Hubs.” 




Interestingly, only within the CRC network were oral microbes, Peptostreptococcus stomatis, 
and Streptococcus parasanguinis, designated as ‘Hub’ nodes. The module Peptostreptococcus 
stomatis is a ‘Hub’ within is particularly fascinating as it is the only CRC cluster 2, ‘pathobiont’ 
cluster, module where all species are both oral microbes (Gemella morbillorum, Parvimonas 
micra, and Dialister pneumosintes) and found to be significantly elevated in relative abundance. 
Moreover, Anaerotruncus colihominis, a ‘Hub’ species only within the Healthy network, was 
found to be negatively associated with Gemella morbillorum within this module in the CRC 










Figure 48: The ‘pathobiont’ oral microbe module within healthy and CRC networks. Modules of 
‘pathobiont’ oral microbes within the healthy and CRC Networks. The CRC oral microbe 
module shows the addition of Dialister pneumosintes and a change in topology. Within this 
network, Peptostreptococcus stomatis has become a ‘Hub’ node. This module has also gained a 
negative association with Anaerotruncus colihominis, a ‘Hub’ only within the healthy network. 
Node color denotes the module cluster this species is found within (Orange = Cluster 2, Red = 
Cluster 5). Nodes are sized by their degree (total associations). Black edges are positive 
associations found within both networks, while green and red are positive or negative 
associations unique to networks, respectively. 











In this study, WGS data available from healthy and late-stage colorectal cancer subjects 
were utilized in conjunction with community profiling and network inference techniques to 
better understand the alterations in bacterial community ecology that have occurred within the 
late-stage cancer-associated human gut microbiome. Our study uncovered key distinctions in 
both the bacterial species and genomic functional capabilities that were different between the two 
communities, suggesting an overgrowth of potentially pathogenic species classified as oral 
microbes. We also observed a dramatic difference in bacterial community structure which we 
believe to be due to an alteration in bacteria partner selection in response to probable ecosystem 
changes occurring within the CRC-associated gut microbiome. 
Our study showed that the CRC gut microbiome contained a significantly higher bacterial 
diversity. This higher diversity was somewhat unexpected since a high bacterial diversity is 
regularly associated with the healthy gut microbiome (Lozupone et al., 2012), and previous 
studies have described a lower diversity within the CRC gut microbiome (Ahn et al., 2013; Ai et 
al., 2019), although, these findings are still in contention as other studies have also found a 
higher bacterial richness (Thomas et al., 2019). In either case, this discrepancy in species 
diversity estimations between studies could be due to differences in the sequence data type 
(amplicon vs. shotgun) used as 16S rRNA data is known to highly skew estimates of bacterial 
diversity (Edgar, 2017). We hypothesized that this higher species diversity was due to the 
formation (or expansion) of a bacterial niche in the cancer-associated ecosystem, most likely 




the tumor microenvironment (TME) niche would be exposed to a hostile environment 
characterized by low oxygen, high acidity, and an abundance of oxidative stressors (Corbet & 
Feron, 2017; Harris, 2002). These environmental conditions are in part created by the altered 
metabolism of tumor cells, which would lead to the reduction in the typical proteins, 
carbohydrates, and lipids available (nutrient scarcity) in the surrounding microenvironment 
(Beloribi-Djefaflia, 2016; Commisso et al., 2013; Kamphorst et al., 2016; Warburg et al., 1927). 
Tumor cells will also scavenge for any additionally needed resources by degrading the 
extracellular matrix (ECM) and cannibalizing the surrounding necrotic intestinal tissue to fuel 
their metabolism (Finicle et al., 2018). These degradation products could provide certain 
microbiota capable of utilizing them a rich assortment of free resources, including amino acids, 
membrane proteins, phospholipids, and some sugars. As our CRC samples were obtained from 
late-stage cancer subjects, this TME niche could be widespread across the colon having 
repercussions for even microbes not involved in the colonization of this niche. Our findings from 
using machine learning, differential abundance testing, and network inference point towards 
species capable of filling this niche, functions likely to promote its formation, and the potential 
impact that the creation of this niche has on the gut microbiota.  
Species differential abundance testing between groups found 174 species significantly 
reduced and 10 species significantly elevated in relative abundance within the CRC-associated 
gut microbiome compared to the Healthy gut microbiome. Of the 10 species, six (Parvimonas 
micra, Peptostreptococcus stomatis, Gemella morbillorum, Fusobacterium nucleatum, 




relative abundance by the research study that generated the data analyzed here (Yachida et al., 
2019). However, we additionally found Dialister pneumosintes, Streptococcus sp. KCOM 2412 
(Streptococcus periodonticum), Ruminococcus torques, and Filifactor alocis as being 
significantly elevated in relative abundance within the CRC sample group. This discrepancy in 
findings is most likely due to differences in both read mapping and species relative abundance 
calculations. That study mapped reads to the All-Species Living Tree Project (LTP) of the SILVA 
database (Yilmaz et al., 2014), assigning taxonomy to the species which provided the lowest E-
value, and calculated species relative abundances as the number of reads assigned to the species 
divided by the total number of aligned reads within the sample. In contrast, we mapped reads to a 
comprehensive collection of bacterial reference strain genomes downloaded from RefSeq 
(O’Leary et al., 2016) and calculated species relative abundances utilizing an accurate 
probabilistic framework (Loomba et al., 2017). To our knowledge, this is the first time Filifactor 
alocis has been shown to have elevated relative abundance within CRC. Filifactor alocis, 
previously known as Fusobacterium alocis, is a gram-positive obligate anaerobe that has 
routinely been discovered in periodontitis and endodontic infections and is described as an 
excellent marker organism for periodontal disease (Aruni et al., 2015; Jalava & Eerola, 1999; 
Schlafer et al., 2010). Interestingly, all 10 of the species found significantly elevated in relative 
abundance within CRC were classified as oral microbes, and despite normally existing within the 
Healthy gut microbiome these species are considered ‘pathobionts’ as they have numerous 
associations with infections (Contreras et al., 2000; Rousee et al., 2002) and even CRC (Baxter 
et al., 2016; Dai et al., 2018, p.; Drewes, 2017; Flemer et al., 2018; Mima et al., 2016; Thomas et 




with colonic tumor tissues (Mima et al., 2016) and possess the capability to colonize the TME 
niche as they are: anaerobic (Takahashi, 2005), regularly form biofilms together (Horiuchi et al., 
2020; Socransky & Haffajee, 2002), and exhibit asaccharolytic metabolism (Takahashi, 2005). 
Since oral microbes exhibit an asaccharolytic metabolism, they target peptides and amino acids 
for their digestion (Takahashi, 2005) and, in doing so, produce ammonia which would raise the 
local pH helping their colonization within the acidic TME. In this way, these species would be 
optimized for growth in the hostile TME niche. Outside of just these 10 oral species, we also 
uncovered a significantly higher richness of bacteria classified as oral microbes within the CRC 
gut microbiome. This finding suggests that oral microbes have become increasingly more 
capable of colonizing the gut within the CRC-associated ecosystem. 
Interestingly, of the few bacterial community functions (Pfams and TIGRFAMS) found in 
differential abundance between the CRC and Healthy gut microbiomes, many could precipitate 
cancer progression or aid in the colonization of the TME niche. Multiple protein functions found 
to be significantly reduced within the CRC gut microbiome were tied to threonine biosynthesis. 
Threonine is an essential amino acid; therefore, it must be provided exogenously from the gut 
microbiota’s metabolism (Abubucker et al., 2012). It is also an important amino acid in the 
production of short-chain fatty acids (SCFAs) since it can be utilized for the formation of acetate, 
butyrate, or propionate (Neis et al., 2015). Interestingly, of the 174 species found significantly 
reduced in CRC many are from genera (Lactobacillus, Bacteroides, Bifidobacteria, Clostridium, 
Eubacterium, etc.) shown to be linked to the production of SCFAs (Hopkins et al., 2003; Koh et 




could drive tumor progression as SCFAs (e.g., butyrate) have been shown to have anti-oncogenic 
and anti-inflammatory properties (Canani, 2011). Of the functions found significantly elevated in 
relative abundance in the CRC gut microbiome, many were tied to adhesins and invasins. These 
protein functions would allow bacteria to adhere to epithelial cells, especially those that are 
being sloughed off the intestinal wall, to gather nutrients. They would also assist in the invasion 
of the intestinal barrier, which would drive inflammation and could cause DNA damage, thereby 
inducing unwanted cellular mutation. For example, FadA, an adhesin found significantly 
elevated in relative abundance, is unique to the oral lineage of Fusobacterium nucleatum’s 
phylum (Fusobacteria) and has previously been shown to promote binding and invasion into host 
epithelial cells (Xu et al., 2007), as well as driving cancer initiation (Rubinstein et al., 2019; 
Yang et al., 2017). Additionally, we found a significantly elevated relative abundance of a protein 
function linked to proline iminopeptidase (PIP), an enzyme that catalyzes the release of proline 
residues from peptides. Proline is an important stress substrate in cancer metabolism as it is 
utilized in many critical functions related to apoptosis, autophagy, and nutrient/oxygen 
deprivation (Phang et al., 2015). Tumor cells can harvest the proline they require by 
metabolizing collagen contained within the extracellular matrix (ECM), as nearly 25% of the 
collagen is proline (Dixit et al., 1977). Interestingly, in our study, a few of the oral species found 
significantly elevated in relative abundance (Peptostreptococcus stomatis, Gemella morbillorum, 
Parvimonas micra, and Dialister pneumosintes) were shown to form a network module with the 




Only a few associations were shared between the bacterial association networks for the 
two sample groups, which suggested there was a large difference in the bacterial community 
structure within Healthy and CRC-associated gut microbiomes. Part of the difference in 
community structure occurring within the CRC-associated gut microbiome is due to positive 
associations forming less between species that were taxonomically similar and more between 
functionally dissimilar species compared to those found in the Healthy gut microbiome. 
Moreover, we found a greater number of negative associations within the CRC network, and in 
many of these negative associations, an oral microbe was found to be involved, whereas, in the 
healthy network, no such negative associations with oral microbes were occurring. This suggests 
that competitive exclusion between taxonomically and functionally similar species within the 
CRC-associated gut microbiome has increased, and oral microbes have become more 
competitive within this ecosystem. Additionally, as oral microbes are also found to be present 
within the Healthy gut microbiome, but negative associations against oral microbes were not, we 
hypothesized that the native microbiota has shifted towards utilizing similar resources to those 
targeted by oral microbes within the CRC gut microbiome. Our analysis of species modules 
within networks reflects this notion. Using PCA and K-means clustering, species modules within 
networks were found to fall into one of five distinct clusters depending on their functional 
capabilities. However, both Healthy and CRC networks contained representation (at least one 
module) within all clusters suggesting the niches that these clusters target are maintained across 
Healthy and CRC-associated gut microbiomes in some capacity. Yet, despite cluster retention, 
there was a dramatic shift in both the proportion of total species and the total sample relative 




network, we found clusters functionally geared towards amino acid biosynthesis, carbohydrate 
degradation, protein binding/uptake, and tumor inhibition contained a greater number of species 
and represented a larger total sample relative abundance. Whereas, in the CRC network, we 
observed a species shift towards forming modules functionally equipped for protein degradation, 
amino acid uptake, biosynthesis and degradation of surface polysaccharides and 
lipopolysaccharides, and ethanolamine utilization. Interestingly, Klebsiella species have been 
tied to ethanolamine usage in the healthy gut (Garsin, 2010; Tsoy et al., 2009) and were found in 
reduced relative abundance in the CRC gut microbiome suggesting that these species were 
potentially outcompeted. In any case, this shift in species cluster membership and cluster total 
sample relative abundance suggests that the bacterial community structure has been reorganized 
to aid in the formation of modules of specific cluster types that contain functional capabilities 
better suited for life in the CRC-associated gut environment.  
As mentioned previously, one module cluster (cluster 2) drew our attention as it was 
comprised solely of ‘pathobiont’ oral species and contained distinct functions which would allow 
these species to not only flourish within the TME niche but aid in cancer progression. These 
functions included: adherence to host cells and extracellular matrix, collagen-binding, 
complement resistance, ornithine/lysine/arginine decarboxylase (tissue putrefaction/ polyamine 
synthesis/acidic environment resistance), metallopeptidases, type V secretion systems, ammonia 
production, excretion of poisonous metal ions (copper efflux system), DNA metabolism, fatty 
acid and phospholipid metabolism, and biosynthesis and degradation of surface polysaccharides 




network, all species existing within the CRC module (Peptostreptococcus stomatis, Gemella 
morbillorum, Parvimonas micra, and Dialister pneumosintes) were found to be significantly 
elevated in relative abundance. It is also important to note that this module in the CRC network 
grew with the addition of another oral species, Dialister pneumosintes. This suggests these oral 
species are indeed thriving in the CRC-associated gut microbiome and, through their metabolic 
actions, potentially driving tumor progression. It could be prudent to preemptively target 
Peptostreptococcus stomatis for elimination from the gut microbiome as it was the ‘hub’ species 
within the module. By doing so this could lead to the dissipation of the associations between 
these species and potentially dampen tumor progression. In any case, future in vivo studies 
should be performed to elucidate the extent that polymicrobial synergy between these species 
contributes to tumorigenesis.  
 In summary, our analysis of whole-genome shotgun sequenced fecal samples provided 
from a large cohort of late-stage colorectal cancer, and healthy subjects revealed key differences 
in the bacterial community within Healthy and CRC-associated gut microbiomes. We showed a 
higher species diversity exists within the CRC-associated gut microbiome that is potentially due 
to the formation of a tumor-associated niche, and this niche is most likely occupied by species 
originating from the oral cavity. Moreover, we highlighted Peptostreptococcus stomatis as an 
influential ‘hub’ node within a ‘pathobiont’ oral species module where every species within the 
module were found in elevated relative abundance in CRC. Our results also indicated that tumor 




formation of modules that contain functional capabilities better suited for life in the CRC-








CHAPTER 4: CONCLUSIONS 
Within this dissertation, I have introduced a portion of the existing literature providing 
evidence linking individual bacterium and their functions, from the gut microbiome to the 
initiation and progression of colorectal cancer. However, as I have explained in previous 
chapters, the complex web of relationships (i.e., associations) that exist between bacteria 
ultimately shapes the distribution, abundance, and function of species within the gut microbiome. 
As such, the goal of our research was to understand better how the network of bacteria 
associations is structured in healthy human populations and how it has been altered within the 
late-stage colorectal cancer-associated gut microbiome.  
Chapter 2 discussed how we first focused on understanding the network of bacterial 
associations that normally exist within the gut microbiomes of multiple healthy human 
populations. This research was necessary because without first establishing how the bacteria 
community in the healthy human gut microbiome is typically structured and what similarities in 
this structure are maintained across human populations, we would not be able to elucidate how 
bacterial relationships have been altered within the late-stage colorectal cancer-associated gut 
microbiome. We utilized previously produced WGS fecal samples taken from multiple healthy 
human populations (i.e., American, Indian, Japanese, and European) for that study. Using WGS 
data, we were able to study the bacterial community at the species level and explore the 
communities’ genomic functional capabilities. We first showed that bacterial communities' 




human populations. We then utilized a compositionally robust network inference technique that 
provided us with conditional independencies between these species to construct bacterial species 
association networks. The structure of these association networks was shown to be significantly 
non-random and surprisingly similar across the healthy human populations. Additionally, we 
showed that bacterial species tended to be positively associated with other species from similar 
taxonomic lineages and species that contained genomic functional capabilities like themselves. 
Furthermore, as we explored the overall network structure of bacterial associations, we found 
that species formed modules (highly connected groups in networks) that contained specific 
taxonomic and functional profiles, which we deemed module functional profile clusters 
(MFPCs). Interestingly, these MFPCs were maintained across the multiple healthy human 
populations. As discussed in chapter 2, our study constructed and explored these bacterial 
community structures in greater detail than any other study previously had, which gave us an 
exceptional starting foundation for examining the bacterial community structure in the late-stage 
CRC-associated gut microbiome.  
In chapter 3, we similarly continued our research using previously published WGS fecal 
samples provided from healthy and late-stage (stage III and IV) colorectal cancer Japanese 
subjects. We started by exploring the taxonomic and functional compositional differences 
between these two groups. We found that the functional capacity of the bacterial community 
within the CRC-associated gut microbiome was surprisingly like that of the bacterial community 
within the healthy-associated gut microbiome. Additionally, we showed that only a few species, 




abundance within the CRC-associated gut microbiome. This population of oral microbes 
consisted of multiple bacterial species that have previously been associated with CRC, including 
the infamous Fusobacterium nucleatum. However, we were the first study to associate the 
potential periodontal pathogen Filifactor alocis with CRC. In contrast, we found nearly 200 
bacterial species in the CRC-associated gut microbiome whose relative abundances were 
significantly reduced compared to the healthy gut microbiome. These species were found to be 
from bacterial genera linked to the production of SCFAs. This significant reduction in relative 
abundance for hundreds of bacterial species was most likely related to another finding that the 
CRC-associated gut microbiome contained a greater species diversity. We believe this greater 
diversity in bacterial species within the CRC-associated gut microbiome is possibly an outcome 
of the reduction in commensal bacteria relative abundance combined with the growth expansion 
of the oral bacterial population. Following community profiling, we inferred bacterial 
associations, using the same compositionally robust network inference technique we used in the 
previous study to construct bacterial association networks. The CRC-associated bacterial 
association network exhibited dramatic differences compared to the bacterial association network 
of the healthy human population. Within the CRC-associated bacterial association network, we 
found a greater abundance of negative associations, many of which were found to occur with an 
oral microbe. Interestingly, we found zero negative associations happening with oral microbes in 
the healthy network. This finding suggested that oral microbes were either being targeted for 
colonization resistance by the commensal bacteria or that these species had now become 
ecological competitors in the cancer-associated gut microbiome. Additionally, we showed that 




like themselves within the CRC-associated gut microbiome. This discovery contrasted with our 
previous findings from healthy human gut bacterial association networks. Lastly, we explored 
how this alteration in commensal bacteria partner selection affected the species modules formed 
within both networks (i.e., MFPCs). Like the findings from our first study, we found CRC-
associated and healthy bacterial association networks contained species modules with similar 
functional profiles. However, we found that the MFPC a species was found within was a good 
indicator of their total sample relative abundance. For example, within the CRC-associated gut 
microbiome, species from MFPCs which exhibited distinguished functional capabilities linked to 
protein and amino acid catabolism were shown to account for a greater total sample relative 
abundance. In contrast, species from MFPCs related to protein biosynthesis accounted for 
significantly less total sample relative abundance. Interestingly, one MFPCs was composed of 
only oral bacterial species and was shown to contain a distinguished functional capability well 
suited for potential ecosystem alterations associated with tumor formation. Moreover, within the 
CRC-associated network, negative associations had arisen between species from modules within 
the same MFPC type linked to functional capabilities less suited for the tumor-associated 
environment. Altogether, we believe these findings suggest that the bacterial community within 
the CRC-associated gut microbiome has become more hostile, and commensal bacteria species 
have modulated their survival strategy to form connections with taxonomic and functional 
dissimilar species originating from MFPCs containing functional capabilities better suited to 




Overall, our two bodies of work have provided an abundance of new information to the 
gut microbiome field for better understanding the bacterial community structure within the 
healthy and late-stage CRC-associated gut microbiome. We hope that by examining differences 
in the two extremes of the disease spectrum, healthy and late-stage CRC, our findings can be 
leveraged to create new diagnostic tests and therapeutic strategies. Ultimately, our comparison 
across multiple healthy human populations showed that the bacterial community structure and 
potential functional capabilities were still highly similar despite slight taxonomic differences. 
This finding is exciting as it suggests future therapeutic strategies could potentially be less host-
specific and more widely applicable across a range of subjects. Our study focused on the late-
stage CRC-associated gut microbiome revealed that the oral microbes we found significantly 
elevated in relative abundance could be utilized toward diagnostic testing purposes as we showed 
their use in conjunction with a machine learning model resulted in a high classification accuracy 
of gut microbiome samples from healthy and CRC-associated individuals. This would allow 
quicker and cheaper screening of individuals just from a fecal sample. We also showed that most 
normal healthy-associated commensal bacteria are still retained, albeit in lower relative 
abundances. This finding is important for potential therapeutic strategies hoping to modulate the 
bacterial community as probiotics may not be needed to replace the commensal bacterial 
community. We believe it may be more beneficial to provide a specifically designed prebiotic to 
target the growth of commensal species from MFPCs less suited to the tumor-associated 
environment. Hopefully, this might result in lessening hostilities (i.e., negative associations) 
between commensal species and the reversing of some of the alterations in bacterial partner 




between taxonomically and functional alike species). Additionally, we put forth the suggestion 
that it might be prudent to selectively target a small subset of the bacterial microbiota for 
elimination, the oral microbes, in hopes of dampening the influence of their asaccharolytic 
metabolism (as well as their immunogenic functional capabilities) could be having on driving 
tumor progression.  
Despite the rich amount of information that we could glean from using only WGS 
sequencing data, our studies would have benefited immensely by including data produced from 
additional “-omic” based techniques, such as transcriptomic or metabolomic sequencing. If we 
were to integrate our study techniques with data produced from these other “-omic” technologies, 
it would allow us to relate bacterial community structure alterations with bacterial gene 
expression changes or metabolite production in the late-stage CRC environment. We hope future 
studies, whether performed by our lab or by others, will do just this. Nevertheless, all work 
performed within our studies was computationally based. As such, further work using in-vitro 
and in-vivo models will need to be performed to assess how any of the modulations we put forth 





























Below are the samples utilized within the study, “Bacterial associations in the healthy human 
gut microbiome across populations” (Chapter 2): 
 
Cohort Samples 
American SRS011061, SRS011084, SRS011134, SRS011239, SRS011271, SRS011302, SRS011405, 
SRS011529, SRS011586, SRS012273, SRS012902, SRS012969, SRS013098, SRS013158, 
SRS013215, SRS013476, SRS013521, SRS013687, SRS013800, SRS013951, SRS014235, 
SRS014287, SRS014313, SRS014459, SRS014613, SRS014683, SRS014923, SRS014979, 
SRS015065, SRS015133, SRS015190, SRS015217, SRS015264, SRS015369, SRS015431, 
SRS015578, SRS015663, SRS015782, SRS015794, SRS015854, SRS015960, SRS016018, 
SRS016056, SRS016095, SRS016203, SRS016267, SRS016335, SRS016495, SRS016517, 
SRS016753, SRS016954, SRS016989, SRS017103, SRS017191, SRS017247, SRS017307, 
SRS017433, SRS017521, SRS017701, SRS017821, SRS018133, SRS018313, SRS018351, 
SRS018427, SRS018575, SRS018656, SRS018817, SRS019030, SRS019068, SRS019161, 
SRS019267, SRS019381, SRS019397, SRS019582, SRS019601, SRS019685, SRS019787, 
SRS019910, SRS019968, SRS020233, SRS020328, SRS020869, SRS021484, SRS021948, 
SRS022071, SRS022137, SRS022524, SRS022609, SRS022713, SRS023176, SRS023346, 
SRS023526, SRS023583, SRS023829, SRS023914, SRS023971, SRS024009, SRS024075, 
SRS024132, SRS024265, SRS024331, SRS024388, SRS024435, SRS024549, SRS024625, 
SRS042284, SRS042628, SRS043001, SRS043411, SRS043701, SRS045004, SRS045528, 
SRS045645, SRS045713, SRS045739, SRS047014, SRS047044, SRS048164, SRS048870, 
SRS049164, SRS049402, SRS049712, SRS049896, SRS049900, SRS049959, SRS049995, 
SRS050026, SRS050299, SRS050422, SRS050752, SRS050925, SRS051031, SRS051882, 
SRS052027, SRS052697, SRS053214, SRS053335, SRS053398, SRS053573, SRS053649, 
SRS054590, SRS054956, SRS055982, SRS056259, SRS056273, SRS056519, SRS057478, 
SRS057717, SRS058070, SRS058723, SRS058770, SRS062427, SRS063040, SRS063985, 
SRS064276, SRS064557, SRS064645, SRS065504, SRS074670, SRS074964, SRS075078, 
SRS075341, SRS075398, SRS076929, SRS077086, SRS077335, SRS077502, SRS077552, 
SRS077730, SRS077753, SRS077849, SRS078176, SRS078242, SRS078419, SRS078665, 
SRS098514, SRS098717, SRS100021, SRS101376, SRS101433, SRS103987, SRS104197, 
SRS104400, SRS105153, SRS140492, SRS140513, SRS140645, SRS142503, SRS142505, 
SRS142712, SRS142890, SRS143342, SRS143417, SRS143598, SRS143876, SRS143991, 
SRS144537, SRS145497, SRS147445, SRS147652, SRS147766, SRS147919 
Indian SRR5898908, SRR5898909, SRR5898910, SRR5898911, SRR5898912, SRR5898913, 
SRR5898914, SRR5898915, SRR5898916, SRR5898917, SRR5898918, SRR5898919, 
SRR5898920, SRR5898921, SRR5898922, SRR5898923, SRR5898924, SRR5898925, 
SRR5898926, SRR5898927, SRR5898928, SRR5898929, SRR5898930, SRR5898931, 
SRR5898932, SRR5898933, SRR5898934, SRR5898935, SRR5898936, SRR5898937, 
SRR5898938, SRR5898939, SRR5898940, SRR5898941, SRR5898942, SRR5898943, 
SRR5898944, SRR5898945, SRR5898946, SRR5898947, SRR5898948, SRR5898949, 
SRR5898950, SRR5898951, SRR5898952, SRR5898953, SRR5898954, SRR5898955, 
SRR5898956, SRR5898957, SRR5898958, SRR5898959, SRR5898960, SRR5898961, 
SRR5898962, SRR5898963, SRR5898964, SRR5898965, SRR5898966, SRR5898967, 
SRR5898968, SRR5898969, SRR5898970, SRR5898971, SRR5898972, SRR5898973, 
SRR5898974, SRR5898976, SRR5898977, SRR5898978, SRR5898979, SRR5898980, 




SRR5898987, SRR5898988, SRR5898989, SRR5898990, SRR5898991, SRR5898992, 
SRR5898993, SRR5898994, SRR5898995, SRR5898996, SRR5898997, SRR5898998, 
SRR5899000, SRR5899001, SRR5899004, SRR5899005, SRR5899006, SRR5899007, 
SRR5899008, SRR5899009, SRR5899010, SRR5899011, SRR5899012, SRR5899013, 
SRR5899014, SRR5899015, SRR5899016, SRR5899017 
European ERR011089, ERR011090, ERR011091, ERR011092, ERR011093, ERR011094, ERR011101, 
ERR011102, ERR011103, ERR011104, ERR011109, ERR011110, ERR011111, ERR011114, 
ERR011115, ERR011116, ERR011117, ERR011118, ERR011119, ERR011120, ERR011121, 
ERR011122, ERR011123, ERR011126, ERR011127, ERR011128, ERR011131, ERR011132, 
ERR011133, ERR011140, ERR011141, ERR011142, ERR011143, ERR011148, ERR011150, 
ERR011153, ERR011156, ERR011160, ERR011162, ERR011164, ERR011168, ERR011173, 
ERR011177, ERR011178, ERR011179, ERR011180, ERR011181, ERR011183, ERR011184, 
ERR011185, ERR011186, ERR011187, ERR011188, ERR011190, ERR011191, ERR011192, 
ERR011193, ERR011195, ERR011196, ERR011197, ERR011198, ERR011199, ERR011200, 
ERR011201, ERR011202, ERR011203, ERR011204, ERR011206, ERR011207, ERR011208, 
ERR011210, ERR011211, ERR011212, ERR011214, ERR011216, ERR011217, ERR011218, 
ERR011219, ERR011220, ERR011221, ERR011222, ERR011223, ERR011224, ERR011226, 
ERR011228, ERR011230, ERR011231, ERR011232, ERR011233, ERR011234, ERR011235, 
ERR011236, ERR011237, ERR011238, ERR011239, ERR011241, ERR011242, ERR011245, 
ERR011247, ERR011248, ERR011249, ERR011250, ERR011251, ERR011252, ERR011253, 
ERR011254, ERR011255, ERR011256, ERR011257, ERR011258, ERR011261, ERR011263, 
ERR011264, ERR011265, ERR011266, ERR011268, ERR011269, ERR011270, ERR011271, 
ERR011272 
Japanese DRR127524, DRR127532, DRR127535, DRR127537, DRR127546, DRR127552, DRR127583, 
DRR127588, DRR127596, DRR127597, DRR127613, DRR127616, DRR127619, DRR127628, 
DRR127634, DRR127649, DRR127672, DRR127683, DRR127692, DRR127704, DRR127707, 
DRR127713, DRR127721, DRR127724, DRR127728, DRR127731, DRR127736, DRR127748, 
DRR127751, DRR127752, DRR127755, DRR127756, DRR127762, DRR127763, DRR127776, 
DRR127777, DRR162775, DRR162776, DRR171467, DRR171469, DRR171474, DRR171477, 
DRR171479, DRR171487, DRR171488, DRR171497, DRR171499, DRR171500, DRR171503, 
DRR171506, DRR171509, DRR171513, DRR171514, DRR171515, DRR171517, DRR171518, 
DRR171523, DRR171525, DRR171527, DRR171530, DRR171538, DRR171539, DRR171543, 
DRR171545, DRR171546, DRR171552, DRR171555, DRR171560, DRR171563, DRR171567, 
DRR171568, DRR171569, DRR171571, DRR171572, DRR171576, DRR171578, DRR171580, 
DRR171581, DRR171585, DRR171586, DRR171587, DRR171588, DRR171589, DRR171591, 
DRR171592, DRR171594, DRR171598, DRR171599, DRR171601, DRR171604, DRR171605, 
DRR171606, DRR171607, DRR171608, DRR171610, DRR171613, DRR171616, DRR171617, 
DRR171619, DRR171620, DRR171621, DRR171628, DRR171629, DRR171631, DRR171637, 
DRR171639, DRR171640, DRR171641, DRR171642, DRR171643, DRR171644, DRR171645, 
DRR171646, DRR171647, DRR171648, DRR171650, DRR171651, DRR171652, DRR171653, 
DRR171654, DRR171655, DRR171656, DRR171657, DRR171659, DRR171662, DRR171663, 
DRR171673, DRR171676, DRR171686, DRR171689, DRR171691, DRR171694, DRR171698, 
DRR171700, DRR171705, DRR171710, DRR171711, DRR171724, DRR171725, DRR171726, 
DRR171727, DRR171733, DRR171737, DRR171741, DRR171745, DRR171747, DRR171755, 
DRR171762, DRR171763, DRR171765, DRR171770, DRR171771, DRR171772, DRR171773, 
DRR171777, DRR171779, DRR171782, DRR171783, DRR171786, DRR171791, DRR171793, 
DRR171796, DRR171798, DRR171801, DRR171802, DRR171807, DRR171810, DRR171812, 
DRR171813, DRR171816, DRR171817, DRR171953, DRR171954, DRR171957, DRR171959, 











This appendix contains additional information about the bacterial association networks found 
within the study, “Bacterial associations in the healthy human gut microbiome across 
populations” (Chapter 2): 
The bacterial species directly below were not displayed in network models as they had zero 
edges (associations) across all networks:  
 
Rikenella microfusus, Anaerotignum neopropionicum, Escherichia coli, Butyricimonas 
synergistica, Phascolarctobacterium succinatutens, Eubac-terium oxidoreducens, Merdibacter 
massiliensis, Traorella massiliensis, Parasutterella excrementihominis, Blautia 
hydrogenotrophica, Catenibacterium mitsuokai, Bariatricus massiliensis, Solobacterium moorei, 
Mageeibacillus indolicus, Massilimicrobiota timonensis, Streptococcus thermophilus, 
Holdemanella biformis, Eubacterium nodatum, Odoribacter laneus, Johnsonella ignava, 
Eisenbergiella tayi, Clostridium saccharolyticum, Dialister sp Marseille-P5638, Faecalibaculum 
rodentium, Intestinibacter bartlettii, Lachnospira multipara, Eubacterium uniforme, 













Below are the node number designations of species shown in bacterial association network 
models:  
 
1: Schaalia odontolytica, 2: Bifidobacterium catenulatum, 3: Bifidobacterium adolescentis, 4: 
Bifidobacterium pseudocatenulatum, 5: Bifidobacterium longum, 6: Cellulomonas carbonis, 7: 
Collinsella aerofaciens, 8: Eggerthella lenta, 9: Bacteroides faecichinchillae, 10: Bacteroides 
plebeius, 11: Bacteroides caecimuris, 12: Bacteroides pyogenes, 13: Bacteroides coprocola, 14: 
Bacteroides zoogleoformans, 15: Bacteroides salyersiae, 16: Bacteroides caccae, 17: 
Bacteroides nordii, 18: Bacteroides dorei, 19: Bacteroides coprophilus, 20: Bacteroides 
uniformis, 21: Bacteroides ovatus, 22: Bacteroides vulgatus, 23: Bacteroides stercoris, 24: 
Bacteroides reticulotermitis, 25: Bacteroides cellulosilyticus, 26: Bacteroides thetaiotaomicron, 
27: Bacteroides fluxus, 28: Bacteroides helcogenes, 29: Bacteroides heparinolyticus, 30: 
Bacteroides salanitronis, 31: Bacteroides barnesiae, 32: Bacteroides fragilis, 33: Mediterranea 
massiliensis, 34: Barnesiella intestinihominis, 35: Barnesiella viscericola, 36: Coprobacter 
fastidiosus, 37: Coprobacter secundus, 38: Butyricimonas faecalis, 39: Culturomica 
massiliensis, 40: Odoribacter splanchnicus, 41: Paraprevotella xylaniphila, 42: Prevotella 




Prevotella stercorea, 47: Prevotella timonensis, 48: Prevotella buccalis, 49: Prevotella disiens, 
50: Prevotellamassilia timonensis, 51: Alistipes putredinis, 52: Alistipes finegoldii, 53: Alistipes 
shahii, 54: Alistipes megaguti, 55: Alistipes obesi, 56: Alistipes senegalensis, 57: Alistipes inops, 
58: Alistipes timonensis, 59: Alistipes ihumii, 60: Parabacteroides distasonis, 61: 
Parabacteroides johnsonii, 62: Parabacteroides sp CT06, 63: Parabacteroides goldsteinii, 64: 
Granulicatella adiacens, 65: Lactobacillus rogosae, 66: Lactobacillus ruminis, 67: 
Streptococcus salivarius, 68: Streptococcus parasanguinis, 69: Streptococcus sp oral taxon 431, 
70: Streptococcus sp FDAARGOS 192, 71: Streptococcus sp A12, 72: Christensenella 
massiliensis, 73: Christensenella minuta, 74: Butyricicoccus pullicaecorum, 75: Clostridium 
phoceensis, 76: Clostridium sporogenes, 77: Hungatella hathewayi, 78: Lactonifactor 
longoviformis, 79: Massilioclostridium coli, 80: Mordavella sp Marseille-P3756, 81: 
Emergencia timonensis, 82: Mogibacterium diversum, 83: Eubacterium eligens, 84: 
Eubacterium plexicaudatum, 85: Eubacterium ramulus, 86: Eubacterium coprostanoligenes, 87: 
Eubacterium ventriosum, 88: Intestinibacillus massiliensis, 89: Anaerobutyricum hallii, 90: 
Anaerostipes hadrus, 91: Anaerotignum lactatifermentans, 92: Blautia hansenii, 93: Blautia 
obeum, 94: Ruminococcus gnavus, 95: Blautia producta, 96: Blautia schinkii, 97: Blautia sp 
N6H1-15, 98: Ruminococcus torques, 99: Butyrivibrio crossotus, 100: Catonella morbi, 101: 
Coprococcus eutactus, 102: Coprococcus comes, 103: Dorea formicigenerans, 104: Dorea 
longicatena, 105: Faecalicatena contorta, 106: Fusicatenibacter saccharivorans, 107: Hespellia 
stercorisuis, 108: Lachnoanaerobaculum saburreum, 109: Clostridium aminophilum, 110: 
Clostridium citroniae, 111: Clostridium bolteae, 112: Lachnoclostridium sp YL32, 113: 
Clostridium glycyrrhizinilyticum, 114: Lachnoclostridium phocaeense, 115: Clostridium 
asparagiforme, 116: Clostridium scindens, 117: Clostridium symbiosum, 118: Marvinbryantia 
formatexigens, 119: Merdimonas faecis, 120: Roseburia inulinivorans, 121: Roseburia 
intestinalis, 122: Roseburia faecis, 123: Roseburia hominis, 124: Sellimonas intestinalis, 125: 
Stomatobaculum longum, 126: Tyzzerella nexilis, 127: Lachnospiraceae bacterium Choco86, 
128: Lachnospiraceae bacterium GAM79, 129: Eubacterium rectale, 130: Oscillibacter sp 
PEA192, 131: Oscillibacter ruminantium, 132: Acetivibrio ethanolgignens, 133: Agathobaculum 
desmolans, 134: Anaerotruncus colihominis, 135: Angelakisella massiliensis, 136: Bittarella 
massiliensis, 137: Faecalibacterium prausnitzii, 138: Flavonifractor plautii, 139: Fournierella 
massiliensis, 140: Gemmiger formicilis, 141: Massilimaliae massiliensis, 142: Negativibacillus 
massiliensis, 143: Neglecta timonensis, 144: Phocea massiliensis, 145: Provencibacterium 
massiliense, 146: Pseudoflavonifractor capillosus, 147: Ruminococcus flavefaciens, 148: 
Ruminococcus callidus, 149: Ruminococcus lactaris, 150: Ruminococcus champanellensis, 151: 
Ruminococcus bicirculans, 152: Ruminococcus bromii, 153: Ruminococcus faecis, 154: 
Ruthenibacterium lactatiformans, 155: Subdoligranulum variabile, 156: Clostridium leptum, 
157: Eubacterium siraeum, 158: Clostridium methylpentosum, 159: Monoglobus pectinilyticus, 
160: Bacteroides pectinophilus, 161: Intestinimonas butyriciproducens, 162: Clostridiales 
bacterium CCNA10, 163: Levyella massiliensis, 164: Absiella dolichum, 165: Clostridium 
saccharogumia, 166: Clostridium innocuum, 167: Faecalicoccus pleomorphus, 168: 
Faecalitalea cylindroides, 169: Holdemania massiliensis, 170: Erysipelotrichaceae bacterium 










Below are the 252 Healthy/CRC whole-genome shotgun sequenced fecal samples which were 
retrieved from DDBJ Sequence Read Archive (DRA) under the bioproject ID PRJDB4176, and 
utilized within the study, “Bacterial community structure alterations within the colorectal cancer 
gut microbiome” (Chapter 3): 
 
Healthy Samples: 
Run BioProject BioSample Experiment 
DRR127546 PRJDB4176 SAMD00114792 DRX120290 
DRR171724 PRJDB4176 SAMD00114718 DRX162336 
DRR171783 PRJDB4176 SAMD00114796 DRX162395 
DRR171629 PRJDB4176 SAMD00164939 DRX162241 
DRR127524 PRJDB4176 SAMD00114770 DRX120268 
DRR171741 PRJDB4176 SAMD00114741 DRX162353 
DRR171786 PRJDB4176 SAMD00114800 DRX162398 
DRR171640 PRJDB4176 SAMD00164950 DRX162252 
DRR127634 PRJDB4176 SAMD00114880 DRX120378 
DRR171777 PRJDB4176 SAMD00114789 DRX162389 
DRR171467 PRJDB4176 SAMD00164727 DRX162079 
DRR171733 PRJDB4176 SAMD00114730 DRX162345 
DRR171628 PRJDB4176 SAMD00164938 DRX162240 
DRR127731 PRJDB4176 SAMD00114977 DRX120475 
DRR171727 PRJDB4176 SAMD00114721 DRX162339 
DRR171953 PRJDB4176 SAMD00115018 DRX162565 
DRR171755 PRJDB4176 SAMD00114757 DRX162367 
DRR171964 PRJDB4176 SAMD00115032 DRX162576 
DRR127707 PRJDB4176 SAMD00114953 DRX120451 




Run BioProject BioSample Experiment 
DRR171617 PRJDB4176 SAMD00164927 DRX162229 
DRR171954 PRJDB4176 SAMD00115019 DRX162566 
DRR171653 PRJDB4176 SAMD00164963 DRX162265 
DRR171645 PRJDB4176 SAMD00164955 DRX162257 
DRR171779 PRJDB4176 SAMD00114791 DRX162391 
DRR127724 PRJDB4176 SAMD00114970 DRX120468 
DRR171959 PRJDB4176 SAMD00115027 DRX162571 
DRR171639 PRJDB4176 SAMD00164949 DRX162251 
DRR171747 PRJDB4176 SAMD00114747 DRX162359 
DRR171637 PRJDB4176 SAMD00164947 DRX162249 
DRR171762 PRJDB4176 SAMD00114769 DRX162374 
DRR171500 PRJDB4176 SAMD00164806 DRX162112 
DRR171503 PRJDB4176 SAMD00164809 DRX162115 
DRR127751 PRJDB4176 SAMD00114997 DRX120495 
DRR171499 PRJDB4176 SAMD00164805 DRX162111 
DRR127776 PRJDB4176 SAMD00115022 DRX120520 
DRR171642 PRJDB4176 SAMD00164952 DRX162254 
DRR171588 PRJDB4176 SAMD00164898 DRX162200 
DRR171770 PRJDB4176 SAMD00114779 DRX162382 
DRR171694 PRJDB4176 SAMD00165004 DRX162306 
DRR171546 PRJDB4176 SAMD00164856 DRX162158 
DRR171610 PRJDB4176 SAMD00164920 DRX162222 
DRR127777 PRJDB4176 SAMD00115023 DRX120521 
DRR171619 PRJDB4176 SAMD00164929 DRX162231 
DRR127728 PRJDB4176 SAMD00114974 DRX120472 
DRR171673 PRJDB4176 SAMD00164983 DRX162285 
DRR171659 PRJDB4176 SAMD00164969 DRX162271 
DRR171698 PRJDB4176 SAMD00165008 DRX162310 
DRR171616 PRJDB4176 SAMD00164926 DRX162228 




Run BioProject BioSample Experiment 
DRR171691 PRJDB4176 SAMD00165001 DRX162303 
DRR127756 PRJDB4176 SAMD00115002 DRX120500 
DRR171497 PRJDB4176 SAMD00164803 DRX162109 
DRR127583 PRJDB4176 SAMD00114829 DRX120327 
DRR171594 PRJDB4176 SAMD00164904 DRX162206 
DRR171613 PRJDB4176 SAMD00164923 DRX162225 
DRR171620 PRJDB4176 SAMD00164930 DRX162232 
DRR171686 PRJDB4176 SAMD00164996 DRX162298 
DRR171782 PRJDB4176 SAMD00114795 DRX162394 
DRR127713 PRJDB4176 SAMD00114959 DRX120457 
DRR171601 PRJDB4176 SAMD00164911 DRX162213 
DRR171631 PRJDB4176 SAMD00164941 DRX162243 
DRR171663 PRJDB4176 SAMD00164973 DRX162275 
DRR127752 PRJDB4176 SAMD00114998 DRX120496 
DRR171606 PRJDB4176 SAMD00164916 DRX162218 
DRR171676 PRJDB4176 SAMD00164986 DRX162288 
DRR171965 PRJDB4176 SAMD00115033 DRX162577 
DRR171469 PRJDB4176 SAMD00164729 DRX162081 
DRR171791 PRJDB4176 SAMD00114807 DRX162403 
DRR171710 PRJDB4176 SAMD00165020 DRX162322 
DRR127763 PRJDB4176 SAMD00115009 DRX120507 
DRR171538 PRJDB4176 SAMD00164848 DRX162150 
DRR171641 PRJDB4176 SAMD00164951 DRX162253 
DRR171725 PRJDB4176 SAMD00114719 DRX162337 
DRR171608 PRJDB4176 SAMD00164918 DRX162220 
DRR171580 PRJDB4176 SAMD00164890 DRX162192 
DRR171651 PRJDB4176 SAMD00164961 DRX162263 
DRR171607 PRJDB4176 SAMD00164917 DRX162219 
DRR171957 PRJDB4176 SAMD00115025 DRX162569 




Run BioProject BioSample Experiment 
DRR171655 PRJDB4176 SAMD00164965 DRX162267 
DRR171644 PRJDB4176 SAMD00164954 DRX162256 
DRR171807 PRJDB4176 SAMD00114824 DRX162419 
DRR171648 PRJDB4176 SAMD00164958 DRX162260 
DRR171652 PRJDB4176 SAMD00164962 DRX162264 
DRR171509 PRJDB4176 SAMD00164819 DRX162121 
DRR127616 PRJDB4176 SAMD00114862 DRX120360 
DRR171810 PRJDB4176 SAMD00114830 DRX162422 
DRR171572 PRJDB4176 SAMD00164882 DRX162184 
DRR171621 PRJDB4176 SAMD00164931 DRX162233 
DRR171793 PRJDB4176 SAMD00114809 DRX162405 
DRR171657 PRJDB4176 SAMD00164967 DRX162269 
DRR127721 PRJDB4176 SAMD00114967 DRX120465 
DRR171643 PRJDB4176 SAMD00164953 DRX162255 
DRR171506 PRJDB4176 SAMD00164814 DRX162118 
DRR127755 PRJDB4176 SAMD00115001 DRX120499 
DRR171488 PRJDB4176 SAMD00164774 DRX162100 
DRR171773 PRJDB4176 SAMD00114785 DRX162385 
DRR127683 PRJDB4176 SAMD00114929 DRX120427 
DRR171598 PRJDB4176 SAMD00164908 DRX162210 
DRR171591 PRJDB4176 SAMD00164901 DRX162203 
DRR171796 PRJDB4176 SAMD00114812 DRX162408 
DRR171737 PRJDB4176 SAMD00114736 DRX162349 
DRR171477 PRJDB4176 SAMD00164756 DRX162089 
DRR127672 PRJDB4176 SAMD00114918 DRX120416 
DRR171604 PRJDB4176 SAMD00164914 DRX162216 
DRR127704 PRJDB4176 SAMD00114950 DRX120448 
DRR127628 PRJDB4176 SAMD00114874 DRX120372 
DRR171812 PRJDB4176 SAMD00114832 DRX162424 




Run BioProject BioSample Experiment 
DRR171711 PRJDB4176 SAMD00165021 DRX162323 
DRR162775 PRJDB4176 SAMD00154991 DRX153394 
DRR171567 PRJDB4176 SAMD00164877 DRX162179 
DRR127736 PRJDB4176 SAMD00114982 DRX120480 
DRR171662 PRJDB4176 SAMD00164972 DRX162274 
DRR127613 PRJDB4176 SAMD00114859 DRX120357 
DRR127537 PRJDB4176 SAMD00114783 DRX120281 
DRR127649 PRJDB4176 SAMD00114895 DRX120393 
DRR127588 PRJDB4176 SAMD00114834 DRX120332 
DRR171592 PRJDB4176 SAMD00164902 DRX162204 
DRR171552 PRJDB4176 SAMD00164862 DRX162164 
DRR171813 PRJDB4176 SAMD00114833 DRX162425 
DRR171599 PRJDB4176 SAMD00164909 DRX162211 
DRR171515 PRJDB4176 SAMD00164825 DRX162127 
DRR171605 PRJDB4176 SAMD00164915 DRX162217 
DRR171656 PRJDB4176 SAMD00164966 DRX162268 
DRR171765 PRJDB4176 SAMD00114773 DRX162377 
DRR171585 PRJDB4176 SAMD00164895 DRX162197 
DRR171726 PRJDB4176 SAMD00114720 DRX162338 
DRR171700 PRJDB4176 SAMD00165010 DRX162312 
DRR127596 PRJDB4176 SAMD00114842 DRX120340 
DRR171801 PRJDB4176 SAMD00114818 DRX162413 
DRR171527 PRJDB4176 SAMD00164837 DRX162139 
DRR127692 PRJDB4176 SAMD00114938 DRX120436 
DRR171555 PRJDB4176 SAMD00164865 DRX162167 
DRR171587 PRJDB4176 SAMD00164897 DRX162199 
DRR171798 PRJDB4176 SAMD00114815 DRX162410 
DRR171816 PRJDB4176 SAMD00114837 DRX162428 
DRR171654 PRJDB4176 SAMD00164964 DRX162266 




Run BioProject BioSample Experiment 
DRR171474 PRJDB4176 SAMD00164748 DRX162086 
DRR127532 PRJDB4176 SAMD00114778 DRX120276 
DRR171563 PRJDB4176 SAMD00164873 DRX162175 
DRR171763 PRJDB4176 SAMD00114771 DRX162375 
DRR171586 PRJDB4176 SAMD00164896 DRX162198 
DRR127619 PRJDB4176 SAMD00114865 DRX120363 
DRR171487 PRJDB4176 SAMD00164773 DRX162099 
DRR171817 PRJDB4176 SAMD00114838 DRX162429 
DRR127597 PRJDB4176 SAMD00114843 DRX120341 
DRR171569 PRJDB4176 SAMD00164879 DRX162181 
DRR171650 PRJDB4176 SAMD00164960 DRX162262 
DRR173016 PRJDB4176 SAMD00136648 DRX163627 
DRR171571 PRJDB4176 SAMD00164881 DRX162183 
DRR171802 PRJDB4176 SAMD00114819 DRX162414 
DRR171479 PRJDB4176 SAMD00164758 DRX162091 
DRR171772 PRJDB4176 SAMD00114784 DRX162384 
DRR162776 PRJDB4176 SAMD00154992 DRX153395 
DRR171514 PRJDB4176 SAMD00164824 DRX162126 
DRR171705 PRJDB4176 SAMD00165015 DRX162317 
DRR171689 PRJDB4176 SAMD00164999 DRX162301 
DRR171513 PRJDB4176 SAMD00164823 DRX162125 
DRR171745 PRJDB4176 SAMD00114745 DRX162357 
DRR171771 PRJDB4176 SAMD00114780 DRX162383 
DRR171539 PRJDB4176 SAMD00164849 DRX162151 
DRR171525 PRJDB4176 SAMD00164835 DRX162137 
DRR127535 PRJDB4176 SAMD00114781 DRX120279 
DRR127552 PRJDB4176 SAMD00114798 DRX120296 
DRR171523 PRJDB4176 SAMD00164833 DRX162135 
DRR171568 PRJDB4176 SAMD00164878 DRX162180 




Run BioProject BioSample Experiment 
DRR171543 PRJDB4176 SAMD00164853 DRX162155 
DRR171517 PRJDB4176 SAMD00164827 DRX162129 
DRR171545 PRJDB4176 SAMD00164855 DRX162157 
DRR171647 PRJDB4176 SAMD00164957 DRX162259 
DRR171589 PRJDB4176 SAMD00164899 DRX162201 
DRR171518 PRJDB4176 SAMD00164828 DRX162130 
DRR171560 PRJDB4176 SAMD00164870 DRX162172 




Run BioProject BioSample Experiment 
DRR171910 PRJDB4176 SAMD00114957 DRX162522 
DRR171750 PRJDB4176 SAMD00114750 DRX162362 
DRR171784 PRJDB4176 SAMD00114797 DRX162396 
DRR127515 PRJDB4176 SAMD00114761 DRX120259 
DRR171702 PRJDB4176 SAMD00165012 DRX162314 
DRR127485 PRJDB4176 SAMD00114731 DRX120229 
DRR171871 PRJDB4176 SAMD00114907 DRX162483 
DRR127481 PRJDB4176 SAMD00114727 DRX120225 
DRR127519 PRJDB4176 SAMD00114765 DRX120263 
DRR127476 PRJDB4176 SAMD00114722 DRX120220 
DRR171767 PRJDB4176 SAMD00114775 DRX162379 
DRR162778 PRJDB4176 SAMD00154994 DRX153397 
DRR127517 PRJDB4176 SAMD00114763 DRX120261 
DRR171697 PRJDB4176 SAMD00165007 DRX162309 




Run BioProject BioSample Experiment 
DRR127521 PRJDB4176 SAMD00114767 DRX120265 
DRR127720 PRJDB4176 SAMD00114966 DRX120464 
DRR171704 PRJDB4176 SAMD00165014 DRX162316 
DRR171661 PRJDB4176 SAMD00164971 DRX162273 
DRR171794 PRJDB4176 SAMD00114810 DRX162406 
DRR127536 PRJDB4176 SAMD00114782 DRX120280 
DRR127789 PRJDB4176 SAMD00115035 DRX120533 
DRR127674 PRJDB4176 SAMD00114920 DRX120418 
DRR127767 PRJDB4176 SAMD00115013 DRX120511 
DRR127754 PRJDB4176 SAMD00115000 DRX120498 
DRR171805 PRJDB4176 SAMD00114822 DRX162417 
DRR127559 PRJDB4176 SAMD00114805 DRX120303 
DRR171667 PRJDB4176 SAMD00164977 DRX162279 
DRR127478 PRJDB4176 SAMD00114724 DRX120222 
DRR127580 PRJDB4176 SAMD00114826 DRX120324 
DRR171672 PRJDB4176 SAMD00164982 DRX162284 
DRR171665 PRJDB4176 SAMD00164975 DRX162277 
DRR127509 PRJDB4176 SAMD00114755 DRX120253 
DRR127579 PRJDB4176 SAMD00114825 DRX120323 
DRR127625 PRJDB4176 SAMD00114871 DRX120369 
DRR127685 PRJDB4176 SAMD00114931 DRX120429 
DRR171685 PRJDB4176 SAMD00164995 DRX162297 
DRR171858 PRJDB4176 SAMD00114891 DRX162470 
DRR127666 PRJDB4176 SAMD00114912 DRX120410 
DRR127646 PRJDB4176 SAMD00114892 DRX120390 
DRR171683 PRJDB4176 SAMD00164993 DRX162295 
DRR171693 PRJDB4176 SAMD00165003 DRX162305 
DRR171764 PRJDB4176 SAMD00114772 DRX162376 
DRR171472 PRJDB4176 SAMD00164745 DRX162084 




Run BioProject BioSample Experiment 
DRR171859 PRJDB4176 SAMD00114894 DRX162471 
DRR171891 PRJDB4176 SAMD00114933 DRX162503 
DRR171666 PRJDB4176 SAMD00164976 DRX162278 
DRR171905 PRJDB4176 SAMD00114949 DRX162517 
DRR127774 PRJDB4176 SAMD00115020 DRX120518 
DRR171519 PRJDB4176 SAMD00164829 DRX162131 
DRR127718 PRJDB4176 SAMD00114964 DRX120462 
DRR171909 PRJDB4176 SAMD00114956 DRX162521 
DRR127594 PRJDB4176 SAMD00114840 DRX120338 
DRR127647 PRJDB4176 SAMD00114893 DRX120391 
DRR171800 PRJDB4176 SAMD00114817 DRX162412 
DRR171819 PRJDB4176 SAMD00114841 DRX162431 
DRR127507 PRJDB4176 SAMD00114753 DRX120251 
DRR162777 PRJDB4176 SAMD00154993 DRX153396 
DRR171459 PRJDB4176 SAMD00164694 DRX162071 
DRR171688 PRJDB4176 SAMD00164998 DRX162300 
DRR171684 PRJDB4176 SAMD00164994 DRX162296 
DRR127617 PRJDB4176 SAMD00114863 DRX120361 
DRR127700 PRJDB4176 SAMD00114946 DRX120444 
DRR127557 PRJDB4176 SAMD00114803 DRX120301 
DRR127638 PRJDB4176 SAMD00114884 DRX120382 
DRR127603 PRJDB4176 SAMD00114849 DRX120347 
DRR127708 PRJDB4176 SAMD00114954 DRX120452 
DRR127669 PRJDB4176 SAMD00114915 DRX120413 
DRR162779 PRJDB4176 SAMD00154995 DRX153398 
DRR171680 PRJDB4176 SAMD00164990 DRX162292 
DRR127491 PRJDB4176 SAMD00114737 DRX120235 
DRR127514 PRJDB4176 SAMD00114760 DRX120258 










This appendix contains additional information about the bacterial association networks found 
within the study, “Bacterial community structure alterations within the colorectal cancer gut 
microbiome” (Chapter 3). 
 
Bacterial Association Networks: 
These bacterial species were not shown in network models due to them having a degree of zero 
(0; no associations) in both Healthy and CRC networks: 
• Prevotella stercorea, Holdemanella biformis, Clostridium saccharolyticum,  
Intestinibacter bartlettii, Hespellia stercorisuis, Intestinibacillus massiliensis, 
Bacteroides zoogleoformans, Bifidobacterium catenulatum, Prevotella copri, 
Fusobacterium nucleatum, Peptostreptococcus anaerobius, Ruminococcus torques, 
Lachnoanaerobaculum saburreum, Streptococcus anginosus, Clostridium_sp_SY8519, 










Bacteria species shown below begin at node one (1) and continue counterclockwise around the 
network model: 
• (1) Schaalia_odontolytica, Collinsella_aerofaciens, Eggerthella_lenta, 
Bacteroides_faecichinchillae, Bacteroides_coprophilus, Bacteroides_caecimuris, 
Bacteroides_fluxus, Bacteroides_vulgatus, Bacteroides_ovatus, 
Bacteroides_thetaiotaomicron, Bacteroides_fragilis, Bacteroides_helcogenes, 
Bacteroides_cellulosilyticus, Bacteroides_plebeius, Bacteroides_nordii, 
Bacteroides_stercoris, Bacteroides_barnesiae, Bacteroides_coprocola, 
Bacteroides_salanitronis, Bacteroides_pyogenes, Bacteroides_caccae, 
Bacteroides_salyersiae, Bacteroides_uniformis, Bacteroides_dorei, 
Bacteroides_heparinolyticus, Mediterranea_massiliensis, Barnesiella_intestinihominis, 
Barnesiella_viscericola, Coprobacter_fastidiosus, Coprobacter_secundus, 
Butyricimonas_faecalis, Culturomica_massiliensis, Odoribacter_splanchnicus, 
Paraprevotella_xylaniphila, Prevotellamassilia_timonensis, Alistipes_putredinis, 
Alistipes_shahii, Alistipes_senegalensis, Alistipes_obesi, Alistipes_finegoldii, 
Parabacteroides_distasonis, Parabacteroides_sp_CT06, Parabacteroides_goldsteinii, 
Gemella_morbillorum, Granulicatella_adiacens, Lactobacillus_rogosae, 
Streptococcus_sp_FDAARGOS_192, Streptococcus_mitis, 
Streptococcus_sp_oral_taxon_431, Streptococcus_sp_A12, Streptococcus_salivarius, 
Streptococcus_parasanguinis, Christensenella_minuta, Butyricicoccus_pullicaecorum, 
Clostridium_phoceensis, Clostridium_sporogenes, Hungatella_hathewayi, 
Lactonifactor_longoviformis, Massilioclostridium_coli, Mordavella_sp_Marseille-
P3756, Emergencia_timonensis, Mogibacterium_diversum, Eubacterium_ramulus, 
Eubacterium_ventriosum, Eubacterium_plexicaudatum, Eubacterium_eligens, 
Anaerobutyricum_hallii, Anaerostipes_hadrus, Anaerotignum_lactatifermentans, 
Anaerotignum_neopropionicum, Bariatricus_massiliensis, Blautia_sp_N6H1-15, 
Blautia_schinkii, Blautia_producta, Blautia_hansenii, Ruminococcus_gnavus, 
Blautia_obeum, Blautia_hydrogenotrophica, Butyrivibrio_crossotus, 
Coprococcus_comes, Coprococcus_eutactus, Dorea_formicigenerans, 
Dorea_longicatena, Faecalicatena_contorta, Fusicatenibacter_saccharivorans, 
Johnsonella_ignava, Clostridium_citroniae, Clostridium_asparagiforme, 
Clostridium_glycyrrhizinilyticum, Clostridium_bolteae, Clostridium_symbiosum, 
Clostridium_scindens, Lachnoclostridium_phocaeense, Lachnoclostridium_sp_YL32, 
Marvinbryantia_formatexigens, Merdimonas_faecis, Roseburia_hominis, 
Roseburia_intestinalis, Roseburia_inulinivorans, Roseburia_faecis, 
Sellimonas_intestinalis, Tyzzerella_nexilis, Lachnospiraceae_bacterium_GAM79, 
Eubacterium_rectale, Lachnospiraceae_bacterium_Choco86, Oscillibacter_sp_PEA192, 
Clostridioides_difficile, Peptostreptococcus_stomatis, Acetivibrio_ethanolgignens, 
Agathobaculum_desmolans, Anaerotruncus_colihominis, Angelakisella_massiliensis, 
Faecalibacterium_prausnitzii, Flavonifractor_plautii, Fournierella_massiliensis, 
Gemmiger_formicilis, Negativibacillus_massiliensis, Neglecta_timonensis, 
Phocea_massiliensis, Provencibacterium_massiliense, Pseudoflavonifractor_capillosus, 




Ruthenibacterium_lactatiformans, Subdoligranulum_variabile, Clostridium_leptum, 
Clostridium_methylpentosum, Intestinimonas_butyriciproducens, 
Monoglobus_pectinilyticus, Bacteroides_pectinophilus, 
Clostridiales_bacterium_CCNA10, Absiella_dolichum, Clostridium_innocuum, 
Clostridium_saccharogumia, Faecalitalea_cylindroides, Holdemania_massiliensis, 
Merdibacter_massiliensis, Solobacterium_moorei, Traorella_massiliensis, 
Erysipelotrichaceae_bacterium_GAM147, Phascolarctobacterium_succinatutens, 







LIST OF REFERENCES 
Abdali, Z. I., Roberts, T. E., Barton, P., & Hawkey, P. M. (2020). Economic evaluation of Faecal 
microbiota transplantation compared to antibiotics for the treatment of recurrent 
Clostridioides difficile infection. EClinicalMedicine, 24, 100420. 
https://doi.org/10.1016/j.eclinm.2020.100420 
Abubucker, S., Segata, N., Goll, J., Schubert, A. M., Izard, J., Cantarel, B. L., Rodriguez-
Mueller, B., Zucker, J., Thiagarajan, M., Henrissat, B., White, O., Kelley, S. T., Methé, 
B., Schloss, P. D., Gevers, D., Mitreva, M., & Huttenhower, C. (2012). Metabolic 
Reconstruction for Metagenomic Data and Its Application to the Human Microbiome. 
PLOS Computational Biology, 8(6), e1002358. 
https://doi.org/10.1371/journal.pcbi.1002358 
Agrawal, R., Imieliński, T., & Swami, A. (1993). Mining Association Rules Between Sets of 
Items in Large Databases. Proceedings of the 1993 ACM SIGMOD International 
Conference on Management of Data, 207–216. https://doi.org/10.1145/170035.170072 
Ahn, J., Sinha, R., Pei, Z., Dominianni, C., Wu, J., Shi, J., Goedert, J. J., Hayes, R. B., & Yang, 
L. (2013). Human Gut Microbiome and Risk for Colorectal Cancer. JNCI: Journal of the 
National Cancer Institute, 105(24), 1907–1911. https://doi.org/10.1093/jnci/djt300 
Ai, D., Pan, H., Li, X., Gao, Y., Liu, G., & Xia, L. C. (2019). Identifying Gut Microbiota 
Associated With Colorectal Cancer Using a Zero-Inflated Lognormal Model. Frontiers in 




Aitchison, J. (1982). The Statistical Analysis of Compositional Data. Journal of the Royal 
Statistical Society. Series B (Methodological), 44(2), 139–177. JSTOR. 
Aruni, A. W., Mishra, A., Dou, Y., Chioma, O., Hamilton, B. N., & Fletcher, H. M. (2015). 
Filifactor alocis – a new emerging periodontal pathogen. Microbes and Infection, 17(7), 
517–530. https://doi.org/10.1016/j.micinf.2015.03.011 
Attene-Ramos, M. S., Wagner, E. D., Plewa, M. J., & Gaskins, H. R. (2006). Evidence That 
Hydrogen Sulfide Is a Genotoxic Agent. Molecular Cancer Research, 4(1), 9–14. 
https://doi.org/10.1158/1541-7786.MCR-05-0126 
Backhed, F. (2005). Host-Bacterial Mutualism in the Human Intestine. Science, 307(5717), 
1915–1920. https://doi.org/10.1126/science.1104816 
Banna, G. L., Torino, F., Marletta, F., Santagati, M., Salemi, R., Cannarozzo, E., Falzone, L., 
Ferraù, F., & Libra, M. (2017). Lactobacillus rhamnosus GG: An Overview to Explore 
the Rationale of Its Use in Cancer. Frontiers in Pharmacology, 8, 603. 
https://doi.org/10.3389/fphar.2017.00603 
Baquero, F., & Nombela, C. (2012). The microbiome as a human organ. Clinical Microbiology 
and Infection, 18, 2–4. https://doi.org/10.1111/j.1469-0691.2012.03916.x 
Barba, M., Czosnek, H., & Hadidi, A. (2014). Historical Perspective, Development and 
Applications of Next-Generation Sequencing in Plant Virology. Viruses, 6(1), 106–136. 
https://doi.org/10.3390/v6010106 
Baxter, N. T., Ruffin, M. T., Rogers, M. A. M., & Schloss, P. D. (2016). Microbiota-based model 
improves the sensitivity of fecal immunochemical test for detecting colonic lesions. 




Becker, C., Neurath, M. F., & Wirtz, S. (2015). The Intestinal Microbiota in Inflammatory Bowel 
Disease. ILAR Journal, 56(2), 192–204. https://doi.org/10.1093/ilar/ilv030 
Bellis, M. (2019). Biography of Antonie van Leeuwenhoek, Father of Microbiology. Retrieved 
from. https://www.thoughtco.com/anton-van-leeuwenhoek-1991633 
Beloribi-Djefaflia, S. (2016). Lipid metabolic reprogramming in cancer cells. 10. 
Benjamini, Y., & Hochberg, Y. (1995). Controlling the False Discovery Rate: A Practical and 
Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society. Series B 
(Methodological), 57(1), 289–300. 
Bercik, P., Verdu, E. F., Foster, J. A., Macri, J., Potter, M., Huang, X., Malinowski, P., Jackson, 
W., Blennerhassett, P., Neufeld, K. A., Lu, J., Khan, W. I., Corthesy-Theulaz, I., Cherbut, 
C., Bergonzelli, G. E., & Collins, S. M. (2010). Chronic gastrointestinal inflammation 
induces anxiety-like behavior and alters central nervous system biochemistry in mice. 
Gastroenterology, 139(6), 2102-2112.e1. https://doi.org/10.1053/j.gastro.2010.06.063 
Bergman, E. N. (1990). Energy contributions of volatile fatty acids from the gastrointestinal tract 
in various species. Physiological Reviews, 70(2), 567–590. 
https://doi.org/10.1152/physrev.1990.70.2.567 
Berry, D., & Widder, S. (2014). Deciphering microbial interactions and detecting keystone 
species with co-occurrence networks. Frontiers in Microbiology, 5. 
https://doi.org/10.3389/fmicb.2014.00219 
Bevins, C. L., & Salzman, N. H. (2011). Paneth cells, antimicrobial peptides and maintenance of 





Bikard, D., Euler, C. W., Jiang, W., Nussenzweig, P. M., Goldberg, G. W., Duportet, X., Fischetti, 
V. A., & Marraffini, L. A. (2014). Exploiting CRISPR-Cas nucleases to produce 
sequence-specific antimicrobials. Nature Biotechnology, 32(11), 1146–1150. 
https://doi.org/10.1038/nbt.3043 
Bokulich, N. A., Chung, J., Battaglia, T., Henderson, N., Jay, M., Li, H., D. Lieber, A., Wu, F., 
Perez-Perez, G. I., Chen, Y., Schweizer, W., Zheng, X., Contreras, M., Dominguez-Bello, 
M. G., & Blaser, M. J. (2016). Antibiotics, birth mode, and diet shape microbiome 
maturation during early life. Science Translational Medicine, 8(343), 343ra82-343ra82. 
https://doi.org/10.1126/scitranslmed.aad7121 
Bolger, A. M., Lohse, M., & Usadel, B. (2014). Trimmomatic: A flexible trimmer for Illumina 
sequence data. Bioinformatics, 30(15), 2114–2120. 
https://doi.org/10.1093/bioinformatics/btu170 
Bonnet, M., Buc, E., Sauvanet, P., Darcha, C., Dubois, D., Pereira, B., Déchelotte, P., Bonnet, R., 
Pezet, D., & Darfeuille-Michaud, A. (2014). Colonization of the Human Gut by E. coli 
and Colorectal Cancer Risk. Clinical Cancer Research, 20(4), 859–867. 
https://doi.org/10.1158/1078-0432.CCR-13-1343 
Botteri, E., Iodice, S., Bagnardi, V., Raimondi, S., Lowenfels, A. B., & Maisonneuve, P. (2008). 
Smoking and Colorectal Cancer: A Meta-analysis. JAMA, 300(23), 2765. 
https://doi.org/10.1001/jama.2008.839 
Bottery, M. J., Pitchford, J. W., & Friman, V.-P. (2020). Ecology and evolution of antimicrobial 





Brandes, U. (2001). A faster algorithm for betweenness centrality*. The Journal of Mathematical 
Sociology, 25(2), 163–177. https://doi.org/10.1080/0022250X.2001.9990249 
Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., 
Bienenstock, J., & Cryan, J. F. (2011). Ingestion of Lactobacillus strain regulates 
emotional behavior and central GABA receptor expression in a mouse via the vagus 
nerve. Proceedings of the National Academy of Sciences of the United States of America, 
108(38), 16050–16055. PubMed. https://doi.org/10.1073/pnas.1102999108 
Breiman, L. (2001). Random Forests. Machine Learning, 45(1), 5–32. 
https://doi.org/10.1023/A:1010933404324 
Brownlee, G. G., Sanger, F., & Barrell, B. G. (1968). The sequence of 5 s ribosomal ribonucleic 
acid. Journal of Molecular Biology, 34(3), 379–412. https://doi.org/10.1016/0022-
2836(68)90168-X 
Brüssow, H. (2020). Problems with the concept of gut microbiota dysbiosis. Microbial 
Biotechnology, 13(2), 423–434. https://doi.org/10.1111/1751-7915.13479 
Bry, L., Falk, P. G., Midtvedt, T., & Gordon, J. I. (1996). A model of host-microbial interactions 
in an open mammalian ecosystem. Science (New York, N.Y.), 273(5280), 1380–1383. 
https://doi.org/10.1126/science.273.5280.1380 
Canani, R. B. (2011). Potential beneficial effects of butyrate in intestinal and extraintestinal 





Carabotti, M., Scirocco, A., Maselli, M. A., & Severi, C. (2015). The gut-brain axis: Interactions 
between enteric microbiota, central and enteric nervous systems. Annals of 
Gastroenterology, 28(2), 203–209. 
Cebra, J. J. (1999). Influences of microbiota on intestinal immune system development. The 
American Journal of Clinical Nutrition, 69(5), 1046s–1051s. 
https://doi.org/10.1093/ajcn/69.5.1046s 
Cerf-Bensussan, N., & Gaboriau-Routhiau, V. (2010). The immune system and the gut 
microbiota: Friends or foes? Nature Reviews Immunology, 10(10), 735–744. 
https://doi.org/10.1038/nri2850 
Chase, J. M., & Leibold, M. A. (2002). Spatial scale dictates the productivity–biodiversity 
relationship. Nature, 416(6879), 427–430. https://doi.org/10.1038/416427a 
Chattopadhyay, I., Verma, M., & Panda, M. (2019). Role of Oral Microbiome Signatures in 
Diagnosis and Prognosis of Oral Cancer. Technology in Cancer Research & Treatment, 
18, 153303381986735. https://doi.org/10.1177/1533033819867354 
Cheng, W. T., Kantilal, H. K., & Davamani, F. (2020). The Mechanism of Bacteroides fragilis 
Toxin Contributes to Colon Cancer Formation. The Malaysian Journal of Medical 
Sciences : MJMS, 27(4), 9–21. https://doi.org/10.21315/mjms2020.27.4.2 
Cheng, W. Y., Wu, C.-Y., & Yu, J. (2020). The role of gut microbiota in cancer treatment: Friend 
or foe? Gut, 69(10), 1867–1876. https://doi.org/10.1136/gutjnl-2020-321153 
Cherrington, C. A., Hinton, M., Pearson, G. R., & Chopra, I. (1991). Short-chain organic acids at 




The Journal of Applied Bacteriology, 70(2), 161–165. https://doi.org/10.1111/j.1365-
2672.1991.tb04442.x 
Chung, K.-T., & Bryant, M. P. (1997). Robert E. Hungate: Pioneer of Anaerobic Microbial 
Ecology. Anaerobe, 3(4), 213–217. https://doi.org/10.1006/anae.1997.0109 
Citorik, R. J., Mimee, M., & Lu, T. K. (2014). Sequence-specific antimicrobials using efficiently 
delivered RNA-guided nucleases. Nature Biotechnology, 32(11), 1141–1145. 
https://doi.org/10.1038/nbt.3011 
Clauset, A., Newman, M. E. J., & Moore, C. (2004). Finding community structure in very large 
networks. Physical Review E, 70(6), 066111. 
https://doi.org/10.1103/PhysRevE.70.066111 
Cogdill, A. P., Andrews, M. C., & Wargo, J. A. (2017). Hallmarks of response to immune 
checkpoint blockade. British Journal of Cancer, 117(1), 1–7. 
https://doi.org/10.1038/bjc.2017.136 
Commisso, C., Davidson, S. M., Soydaner-Azeloglu, R. G., Parker, S. J., Kamphorst, J. J., 
Hackett, S., Grabocka, E., Nofal, M., Drebin, J. A., Thompson, C. B., Rabinowitz, J. D., 
Metallo, C. M., Vander Heiden, M. G., & Bar-Sagi, D. (2013). Macropinocytosis of 
protein is an amino acid supply route in Ras-transformed cells. Nature, 497(7451), 633–
637. https://doi.org/10.1038/nature12138 
Conley, C., Bishop, B., & Andersen, B. (2016). Emotions and Emotion Regulation in Breast 
Cancer Survivorship. Healthcare, 4(3), 56. https://doi.org/10.3390/healthcare4030056 
Contreras, A., Doan, N., Chen, C., Rusitanonta, T., Flynn, M. J., & Slots, J. (2000). Importance 




Oral Microbiology and Immunology, 15(4), 269–272. https://doi.org/10.1034/j.1399-
302x.2000.150410.x 
Corbet, C., & Feron, O. (2017). Tumour acidosis: From the passenger to the driver’s seat. Nature 
Reviews Cancer, 17(10), 577–593. https://doi.org/10.1038/nrc.2017.77 
Cordasco, G., & Gargano, L. (2011). Community Detection via Semi-Synchronous Label 
Propagation Algorithms. ArXiv:1103.4550 [Physics]. https://doi.org/10.1504/..045103 
Corley, D. A., Jensen, C. D., Marks, A. R., Zhao, W. K., de Boer, J., Levin, T. R., Doubeni, C., 
Fireman, B. H., & Quesenberry, C. P. (2013). Variation of Adenoma Prevalence by Age, 
Sex, Race, and Colon Location in a Large Population: Implications for Screening and 
Quality Programs. Clinical Gastroenterology and Hepatology, 11(2), 172–180. 
https://doi.org/10.1016/j.cgh.2012.09.010 
Coussens, L. M., & Werb, Z. (2002). Inflammation and cancer. Nature, 420(6917), 860–867. 
PubMed. https://doi.org/10.1038/nature01322 
Cryan, J. F., & Dinan, T. G. (2012). Mind-altering microorganisms: The impact of the gut 
microbiota on brain and behaviour. Nature Reviews Neuroscience, 13(10), 701–712. 
https://doi.org/10.1038/nrn3346 
Cryan, J. F., & O’Mahony, S. M. (2011). The microbiome-gut-brain axis: From bowel to 
behavior. Neurogastroenterology and Motility : The Official Journal of the European 
Gastrointestinal Motility Society, 23(3), 187–192. https://doi.org/10.1111/j.1365-
2982.2010.01664.x 
Cui, M., Xiao, H., Li, Y., Zhou, L., Zhao, S., Luo, D., Zheng, Q., Dong, J., Zhao, Y., Zhang, X., 




against radiation‐induced toxicity. EMBO Molecular Medicine, 9(4), 448–461. 
https://doi.org/10.15252/emmm.201606932 
Dahm, C. C., Keogh, R. H., Spencer, E. A., Greenwood, D. C., Key, T. J., Fentiman, I. S., 
Shipley, M. J., Brunner, E. J., Cade, J. E., Burley, V. J., Mishra, G., Stephen, A. M., Kuh, 
D., White, I. R., Luben, R., Lentjes, M. A. H., Khaw, K. T., & Rodwell (Bingham), S. A. 
(2010). Dietary Fiber and Colorectal Cancer Risk: A Nested Case–Control Study Using 
Food Diaries. JNCI: Journal of the National Cancer Institute, 102(9), 614–626. 
https://doi.org/10.1093/jnci/djq092 
Dai, Z., Coker, O. O., Nakatsu, G., Wu, W. K. K., Zhao, L., Chen, Z., Chan, F. K. L., Kristiansen, 
K., Sung, J. J. Y., Wong, S. H., & Yu, J. (2018). Multi-cohort analysis of colorectal cancer 
metagenome identified altered bacteria across populations and universal bacterial 
markers. Microbiome, 6(1), 70. https://doi.org/10.1186/s40168-018-0451-2 
Darcy, J. L., Washburne, A. D., Robeson, M. S., Prest, T., Schmidt, S. K., & Lozupone, C. A. 
(2019). A phylogenetic model for the recruitment of species into microbial communities 
and application to studies of the human microbiome [Preprint]. Microbiology. 
http://biorxiv.org/lookup/doi/10.1101/685644 
Das, B., & Nair, G. B. (2019). Homeostasis and dysbiosis of the gut microbiome in health and 
disease. Journal of Biosciences, 44(5), 117. https://doi.org/10.1007/s12038-019-9926-y 
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., 
Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., Biddinger, S. B., Dutton, R. J., & 
Turnbaugh, P. J. (2014). Diet rapidly and reproducibly alters the human gut microbiome. 




de Visser, K. E., Eichten, A., & Coussens, L. M. (2006). Paradoxical roles of the immune system 
during cancer development. Nature Reviews. Cancer, 6(1), 24–37. 
https://doi.org/10.1038/nrc1782 
den Besten, G., van Eunen, K., Groen, A. K., Venema, K., Reijngoud, D.-J., & Bakker, B. M. 
(2013). The role of short-chain fatty acids in the interplay between diet, gut microbiota, 
and host energy metabolism. Journal of Lipid Research, 54(9), 2325–2340. 
https://doi.org/10.1194/jlr.R036012 
Derrien, M., van Passel, M. W. J., van de Bovenkamp, J. H. B., Schipper, R., de Vos, W., & 
Dekker, J. (2010). Mucin-bacterial interactions in the human oral cavity and digestive 
tract. Gut Microbes, 1(4), 254–268. https://doi.org/10.4161/gmic.1.4.12778 
Devaraj, S., Hemarajata, P., & Versalovic, J. (2013). The Human Gut Microbiome and Body 
Metabolism: Implications for Obesity and Diabetes. Clinical Chemistry, 
clinchem.2012.187617. https://doi.org/10.1373/clinchem.2012.187617 
Dhakan, D. B., Maji, A., Sharma, A. K., Saxena, R., Pulikkan, J., Grace, T., Gomez, A., Scaria, 
J., Amato, K. R., & Sharma, V. K. (2019). The unique composition of Indian gut 
microbiome, gene catalogue, and associated fecal metabolome deciphered using multi-
omics approaches. GigaScience, 8(3). https://doi.org/10.1093/gigascience/giz004 
Di Giacinto, C., Marinaro, M., Sanchez, M., Strober, W., & Boirivant, M. (2005). Probiotics 
ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent 
TGF-beta-bearing regulatory cells. Journal of Immunology (Baltimore, Md. : 1950), 




Dinan, T. G., Stanton, C., & Cryan, J. F. (2013). Psychobiotics: A novel class of psychotropic. 
Biological Psychiatry, 74(10), 720–726. https://doi.org/10.1016/j.biopsych.2013.05.001 
Dixit, S. N., Seyer, J. M., & Kang, A. H. (1977). Covalent Structure of Collagen: Amino-Acid 
Sequence of Chymotryptic Peptides from the Carboxyl-Terminal Region of alpha2-CB3 
of Chick-Skin Collagen. European Journal of Biochemistry, 81(3), 599–607. 
https://doi.org/10.1111/j.1432-1033.1977.tb11987.x 
Donaldson, G. P., Lee, S. M., & Mazmanian, S. K. (2016). Gut biogeography of the bacterial 
microbiota. Nature Reviews Microbiology, 14(1), 20–32. 
https://doi.org/10.1038/nrmicro3552 
Drewes, J. L. (2017). High-resolution bacterial 16S rRNA gene profile meta-analysis and biofilm 
status reveal common colorectal cancer consortia. Npj Biofilms and Microbiomes, 12. 
Dridi, B., Raoult, D., & Drancourt, M. (2011). Archaea as emerging organisms in complex 
human microbiomes. Anaerobe, 17(2), 56–63. 
https://doi.org/10.1016/j.anaerobe.2011.03.001 
D’Souza, G., Shitut, S., Preussger, D., Yousif, G., Waschina, S., & Kost, C. (2018). Ecology and 
evolution of metabolic cross-feeding interactions in bacteria. Natural Product Reports, 
35(5), 455–488. https://doi.org/10.1039/C8NP00009C 
Dvorak, H. F. (1986). Tumors: Wounds that do not heal. Similarities between tumor stroma 





Dzutsev, A., Goldszmid, R. S., Viaud, S., Zitvogel, L., & Trinchieri, G. (2015). The role of the 
microbiota in inflammation, carcinogenesis, and cancer therapy. European Journal of 
Immunology, 45(1), 17–31. https://doi.org/10.1002/eji.201444972 
Edgar, R. C. (2017). Accuracy of microbial community diversity estimated by closed- and open-
reference OTUs. PeerJ, 5, e3889. https://doi.org/10.7717/peerj.3889 
Edgar, R. C. (2018). Accuracy of taxonomy prediction for 16S rRNA and fungal ITS sequences. 
PeerJ, 6, e4652. https://doi.org/10.7717/peerj.4652 
Efron, B., & Tibshirani, R. (1986). Bootstrap Methods for Standard Errors, Confidence Intervals, 
and Other Measures of Statistical Accuracy. Statistical Science, 1(1), 54–75. 
https://doi.org/10.1214/ss/1177013815 
Eiler, A., Heinrich, F., & Bertilsson, S. (2012). Coherent dynamics and association networks 
among lake bacterioplankton taxa. The ISME Journal, 6(2), 330–342. 
https://doi.org/10.1038/ismej.2011.113 
EISEMAN, B., SILEN, W., BASCOM, G. S., & KAUVAR, A. J. (1958). Fecal enema as an 
adjunct in the treatment of pseudomembranous enterocolitis. Surgery, 44(5), 854–859. 
El-Gebali, S., Mistry, J., Bateman, A., Eddy, S. R., Luciani, A., Potter, S. C., Qureshi, M., 
Richardson, L. J., Salazar, G. A., Smart, A., Sonnhammer, E. L. L., Hirsh, L., Paladin, L., 
Piovesan, D., Tosatto, S. C. E., & Finn, R. D. (2019). The Pfam protein families database 





Encarnação, J. C., Abrantes, A. M., Pires, A. S., & Botelho, M. F. (2015). Revisit dietary fiber on 
colorectal cancer: Butyrate and its role on prevention and treatment. Cancer Metastasis 
Reviews, 34(3), 465–478. https://doi.org/10.1007/s10555-015-9578-9 
Escapa, I. F., Chen, T., Huang, Y., Gajare, P., Dewhirst, F. E., & Lemon, K. P. (2018). New 
Insights into Human Nostril Microbiome from the Expanded Human Oral Microbiome 
Database (eHOMD): A Resource for the Microbiome of the Human Aerodigestive Tract. 
MSystems, 3(6), e00187-18, /msystems/3/6/msys.00187-18.atom. 
https://doi.org/10.1128/mSystems.00187-18 
Falony, G., Joossens, M., Vieira-Silva, S., Wang, J., Darzi, Y., Faust, K., Kurilshikov, A., Bonder, 
M. J., Valles-Colomer, M., Vandeputte, D., Tito, R. Y., Chaffron, S., Rymenans, L., 
Verspecht, C., De Sutter, L., Lima-Mendez, G., D’hoe, K., Jonckheere, K., Homola, 
D., … Raes, J. (2016). Population-level analysis of gut microbiome variation. Science, 
352(6285), 560. https://doi.org/10.1126/science.aad3503 
Faust, K., & Raes, J. (2012). Microbial interactions: From networks to models. Nature Reviews 
Microbiology, 10(8), 538–550. https://doi.org/10.1038/nrmicro2832 
Favoriti, P., Carbone, G., Greco, M., Pirozzi, F., Pirozzi, R. E. M., & Corcione, F. (2016). 
Worldwide burden of colorectal cancer: A review. Updates in Surgery, 68(1), 7–11. 
https://doi.org/10.1007/s13304-016-0359-y 
Fearon, E. R., & Vogelstein, B. (1990). A genetic model for colorectal tumorigenesis. Cell, 61(5), 
759–767. https://doi.org/10.1016/0092-8674(90)90186-I 
Fedirko, V., Tramacere, I., Bagnardi, V., Rota, M., Scotti, L., Islami, F., Negri, E., Straif, K., 




colorectal cancer risk: An overall and dose–response meta-analysis of published studies. 
Annals of Oncology, 22(9), 1958–1972. https://doi.org/10.1093/annonc/mdq653 
Feng, Q., Liang, S., Jia, H., Stadlmayr, A., Tang, L., Lan, Z., Zhang, D., Xia, H., Xu, X., Jie, Z., 
Su, L., Li, X., Li, X., Li, J., Xiao, L., Huber-Schönauer, U., Niederseer, D., Xu, X., Al-
Aama, J. Y., … Wang, J. (2015). Gut microbiome development along the colorectal 
adenoma–carcinoma sequence. Nature Communications, 6(1), 6528. 
https://doi.org/10.1038/ncomms7528 
Fernandez, M. I., Pedron, T., Tournebize, R., Olivo-Marin, J. C., Sansonetti, P. J., & Phalipon, A. 
(2003). Anti-inflammatory role for intracellular dimeric immunoglobulin a by 
neutralization of lipopolysaccharide in epithelial cells. Immunity, 18(6), 739–749. 
https://doi.org/10.1016/s1074-7613(03)00122-5 
Fiers, W., Contreras, R., Duerinck, F., Haegeman, G., Iserentant, D., Merregaert, J., Min Jou, W., 
Molemans, F., Raeymaekers, A., Van den Berghe, A., Volckaert, G., & Ysebaert, M. 
(1976). Complete nucleotide sequence of bacteriophage MS2 RNA: primary and 
secondary structure of the replicase gene. Nature, 260(5551), 500–507. 
https://doi.org/10.1038/260500a0 
Finicle, B. T., Jayashankar, V., & Edinger, A. L. (2018). Nutrient scavenging in cancer. Nature 
Reviews Cancer, 18(10), 619–633. https://doi.org/10.1038/s41568-018-0048-x 
Fisher, C. K., & Mehta, P. (2014). Identifying Keystone Species in the Human Gut Microbiome 





Fleischmann, R. D., Adams, M. D., White, O., Clayton, R. A., Kirkness, E. F., Kerlavage, A. R., 
Bult, C. J., Tomb, J. F., Dougherty, B. A., & Merrick, J. M. (1995). Whole-genome 
random sequencing and assembly of Haemophilus influenzae Rd. Science (New York, 
N.Y.), 269(5223), 496–512. https://doi.org/10.1126/science.7542800 
Flemer, B., Lynch, D. B., Brown, J. M. R., Jeffery, I. B., Ryan, F. J., Claesson, M. J., O’Riordain, 
M., Shanahan, F., & O’Toole, P. W. (2017). Tumour-associated and non-tumour-
associated microbiota in colorectal cancer. Gut, 66(4), 633–643. 
https://doi.org/10.1136/gutjnl-2015-309595 
Flemer, B., Warren, R. D., Barrett, M. P., Cisek, K., Das, A., Jeffery, I. B., Hurley, E., 
O‘Riordain, M., Shanahan, F., & O‘Toole, P. W. (2018). The oral microbiota in colorectal 
cancer is distinctive and predictive. Gut, 67(8), 1454–1463. 
https://doi.org/10.1136/gutjnl-2017-314814 
Forsythe, P., Sudo, N., Dinan, T., Taylor, V. H., & Bienenstock, J. (2010). Mood and gut feelings. 
Brain, Behavior, and Immunity, 24(1), 9–16. https://doi.org/10.1016/j.bbi.2009.05.058 
Fortunato, S. (2010). Community detection in graphs. Physics Reports, 486(3–5), 75–174. 
https://doi.org/10.1016/j.physrep.2009.11.002 
Foster, K. R., & Bell, T. (2012). Competition, Not Cooperation, Dominates Interactions among 
Culturable Microbial Species. Current Biology, 22(19), 1845–1850. 
https://doi.org/10.1016/j.cub.2012.08.005 
Fox, G. E., Magrum, L. J., Balch, W. E., Wolfe, R. S., & Woese, C. R. (1977). Classification of 




National Academy of Sciences, 74(10), 4537–4541. 
https://doi.org/10.1073/pnas.74.10.4537 
Francescone, R., Hou, V., & Grivennikov, S. I. (2014). Microbiome, inflammation, and cancer. 
Cancer Journal (Sudbury, Mass.), 20(3), 181–189. 
https://doi.org/10.1097/PPO.0000000000000048 
Frankel, A. E., Coughlin, L. A., Kim, J., Froehlich, T. W., Xie, Y., Frenkel, E. P., & Koh, A. Y. 
(2017). Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify 
Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint 
Therapy Efficacy in Melanoma Patients. Neoplasia, 19(10), 848–855. 
https://doi.org/10.1016/j.neo.2017.08.004 
Franzosa, E. A., Sirota-Madi, A., Avila-Pacheco, J., Fornelos, N., Haiser, H. J., Reinker, S., 
Vatanen, T., Hall, A. B., Mallick, H., McIver, L. J., Sauk, J. S., Wilson, R. G., Stevens, B. 
W., Scott, J. M., Pierce, K., Deik, A. A., Bullock, K., Imhann, F., Porter, J. A., … Xavier, 
R. J. (2019). Gut microbiome structure and metabolic activity in inflammatory bowel 
disease. Nature Microbiology, 4(2), 293–305. https://doi.org/10.1038/s41564-018-0306-4 
Friedman, J., & Alm, E. J. (2012). Inferring Correlation Networks from Genomic Survey Data. 
PLOS Computational Biology, 8(9), e1002687. 
https://doi.org/10.1371/journal.pcbi.1002687 
Friedman, J., Hastie, T., & Tibshirani, R. (2008). Sparse inverse covariance estimation with the 




Fung, T. C., Artis, D., & Sonnenberg, G. F. (2014). Anatomical localization of commensal 
bacteria in immune cell homeostasis and disease. Immunological Reviews, 260(1), 35–49. 
https://doi.org/10.1111/imr.12186 
Gallo, R. L., & Hooper, L. V. (2012). Epithelial antimicrobial defence of the skin and intestine. 
Nature Reviews Immunology, 12(7), 503–516. https://doi.org/10.1038/nri3228 
Garsin, D. A. (2010). Ethanolamine utilization in bacterial pathogens: Roles and regulation. 
Nature Reviews Microbiology, 8(4), 290–295. https://doi.org/10.1038/nrmicro2334 
Genome Reference Consortium. (2017). The GRCh38.p12 Human Genome. 
https://www.ncbi.nlm.nih.gov/assembly/GCF_000001405.38/ 
Gevers, D., Kugathasan, S., Denson, L. A., Vázquez-Baeza, Y., Van Treuren, W., Ren, B., 
Schwager, E., Knights, D., Song, S. J., Yassour, M., Morgan, X. C., Kostic, A. D., Luo, 
C., González, A., McDonald, D., Haberman, Y., Walters, T., Baker, S., Rosh, J., … 
Xavier, R. J. (2014). The Treatment-Naive Microbiome in New-Onset Crohn’s Disease. 
Cell Host & Microbe, 15(3), 382–392. https://doi.org/10.1016/j.chom.2014.02.005 
Gilbert, W., & Maxam, A. (1973). The Nucleotide Sequence of the <em>lac</em> Operator. 
Proceedings of the National Academy of Sciences, 70(12), 3581. 
https://doi.org/10.1073/pnas.70.12.3581 
Gloor, G. B., Macklaim, J. M., Pawlowsky-Glahn, V., & Egozcue, J. J. (2017). Microbiome 
Datasets Are Compositional: And This Is Not Optional. Frontiers in Microbiology, 8, 
2224. https://doi.org/10.3389/fmicb.2017.02224 
Godl, K., Johansson, M. E. V., Lidell, M. E., Mörgelin, M., Karlsson, H., Olson, F. J., Gum, J. R., 




Trimers That Are Held Together within a Trypsin-resistant Core Fragment. Journal of 
Biological Chemistry, 277(49), 47248–47256. https://doi.org/10.1074/jbc.M208483200 
Gonzalez, H., Hagerling, C., & Werb, Z. (2018). Roles of the immune system in cancer: From 
tumor initiation to metastatic progression. 18. https://doi.org/10.1101/gad.314617.118 
Goodrich, J. K., Waters, J. L., Poole, A. C., Sutter, J. L., Koren, O., Blekhman, R., Beaumont, 
M., Van Treuren, W., Knight, R., Bell, J. T., Spector, T. D., Clark, A. G., & Ley, R. E. 
(2014). Human Genetics Shape the Gut Microbiome. Cell, 159(4), 789–799. 
https://doi.org/10.1016/j.cell.2014.09.053 
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., 
Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., Cogdill, A. P., Zhao, L., Hudgens, C. 
W., Hutchinson, D. S., Manzo, T., Petaccia de Macedo, M., Cotechini, T., Kumar, T., 
Chen, W. S., … Wargo, J. A. (2018). Gut microbiome modulates response to anti–PD-1 
immunotherapy in melanoma patients. Science, 359(6371), 97–103. 
https://doi.org/10.1126/science.aan4236 
Gould, A. L., Zhang, V., Lamberti, L., Jones, E. W., Obadia, B., Korasidis, N., Gavryushkin, A., 
Carlson, J. M., Beerenwinkel, N., & Ludington, W. B. (2018). Microbiome interactions 
shape host fitness. Proceedings of the National Academy of Sciences, 115(51), E11951–
E11960. https://doi.org/10.1073/pnas.1809349115 
Guimerà, R., Sales-Pardo, M., & Amaral, L. A. N. (2004). Modularity from fluctuations in 





Gur, C., Ibrahim, Y., Isaacson, B., Yamin, R., Abed, J., Gamliel, M., Enk, J., Bar-On, Y., 
Stanietsky-Kaynan, N., Coppenhagen-Glazer, S., Shussman, N., Almogy, G., Cuapio, A., 
Hofer, E., Mevorach, D., Tabib, A., Ortenberg, R., Markel, G., Miklić, K., … 
Mandelboim, O. (2015). Binding of the Fap2 protein of Fusobacterium nucleatum to 
human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity, 
42(2), 344–355. https://doi.org/10.1016/j.immuni.2015.01.010 
Haft, D. H. (2001). TIGRFAMs: A protein family resource for the functional identification of 
proteins. Nucleic Acids Research, 29(1), 41–43. https://doi.org/10.1093/nar/29.1.41 
Hagberg, A. A., Schult, D. A., & Swart, P. J. (2008). Exploring Network Structure, Dynamics, 
and Function using NetworkX. 6. 
Hakansson, A., & Molin, G. (2011). Gut microbiota and inflammation. Nutrients, 3(6), 637–682. 
PubMed. https://doi.org/10.3390/nu3060637 
Hall, C. V., Lord, A., Betzel, R., Zakrzewski, M., Simms, L. A., Zalesky, A., Radford-Smith, G., 
& Cocchi, L. (2019). Co-existence of Network Architectures Supporting the Human Gut 
Microbiome. IScience, 22, 380–391. https://doi.org/10.1016/j.isci.2019.11.032 
Hamilton, W. D. (1964). The genetical evolution of social behaviour. I. Journal of Theoretical 
Biology, 7(1), 1–16. https://doi.org/10.1016/0022-5193(64)90038-4 
Hansson, G. C. (2012). Role of mucus layers in gut infection and inflammation. Current Opinion 
in Microbiology, 15(1), 57–62. https://doi.org/10.1016/j.mib.2011.11.002 





Harris, A. L. (2002). Hypoxia—A key regulatory factor in tumour growth. Nature Reviews 
Cancer, 2(1), 38–47. https://doi.org/10.1038/nrc704 
Haubrich, W. S. (2002). Escherich of Escherichia coli. Gastroenterology, 122(1), 54. 
https://doi.org/10.1016/S0016-5085(02)80065-8 
Heazlewood, C. K., Cook, M. C., Eri, R., Price, G. R., Tauro, S. B., Taupin, D., Thornton, D. J., 
Png, C. W., Crockford, T. L., Cornall, R. J., Adams, R., Kato, M., Nelms, K. A., Hong, N. 
A., Florin, T. H. J., Goodnow, C. C., & McGuckin, M. A. (2008). Aberrant Mucin 
Assembly in Mice Causes Endoplasmic Reticulum Stress and Spontaneous Inflammation 
Resembling Ulcerative Colitis. PLoS Medicine, 5(3), 21. 
Herrmann, A., Davies, J. R., Lindell, G., Mårtensson, S., Packer, N. H., Swallow, D. M., & 
Carlstedt, I. (1999). Studies on the “Insoluble” Glycoprotein Complex from Human 
Colon. Journal of Biological Chemistry, 274(22), 15828–15836. 
https://doi.org/10.1074/jbc.274.22.15828 
Hibberd, A. A., Lyra, A., Ouwehand, A. C., Rolny, P., Lindegren, H., Cedgård, L., & Wettergren, 
Y. (2017). Intestinal microbiota is altered in patients with colon cancer and modified by 
probiotic intervention. BMJ Open Gastroenterology, 4(1), e000145. 
https://doi.org/10.1136/bmjgast-2017-000145 
Hibbing, M. E., Fuqua, C., Parsek, M. R., & Peterson, S. B. (2010). Bacterial competition: 





Holley, R. W., Apgar, J., Everett, G. A., Madison, J. T., Marquisee, M., Merrill, S. H., Penswick, 
J. R., & Zamir, A. (1965). Structure of a Ribonucleic Acid. Science, 147(3664), 1462. 
https://doi.org/10.1126/science.147.3664.1462 
Honda, K., & Littman, D. R. (2016). The microbiota in adaptive immune homeostasis and 
disease. Nature, 535(7610), 75–84. https://doi.org/10.1038/nature18848 
Hopkins, M. J., Englyst, H. N., Macfarlane, S., Furrie, E., Macfarlane, G. T., & McBain, A. J. 
(2003). Degradation of Cross-Linked and Non-Cross-Linked Arabinoxylans by the 
Intestinal Microbiota in Children. Applied and Environmental Microbiology, 69(11), 
6354–6360. https://doi.org/10.1128/AEM.69.11.6354-6360.2003 
Horiuchi, A., Kokubu, E., Warita, T., & Ishihara, K. (2020). Synergistic biofilm formation by 
Parvimonas micra and Fusobacterium nucleatum. Anaerobe, 62, 102100. 
https://doi.org/10.1016/j.anaerobe.2019.102100 
Human Microbiome Project Consortium. (2012). Structure, function and diversity of the healthy 
human microbiome. Nature, 486(7402), 207–214. https://doi.org/10.1038/nature11234 
Hyatt, D., Chen, G.-L., LoCascio, P. F., Land, M. L., Larimer, F. W., & Hauser, L. J. (2010). 
Prodigal: Prokaryotic gene recognition and translation initiation site identification. BMC 
Bioinformatics, 11(1), 119. https://doi.org/10.1186/1471-2105-11-119 
Iida, N., Dzutsev, A., Stewart, C. A., Smith, L., Bouladoux, N., Weingarten, R. A., Molina, D. A., 
Salcedo, R., Back, T., Cramer, S., Dai, R.-M., Kiu, H., Cardone, M., Naik, S., Patri, A. 
K., Wang, E., Marincola, F. M., Frank, K. M., Belkaid, Y., … Goldszmid, R. S. (2013). 




microenvironment. Science (New York, N.Y.), 342(6161), 967–970. 
https://doi.org/10.1126/science.1240527 
Jackson, M. A., Bonder, M. J., Kuncheva, Z., Zierer, J., Fu, J., Kurilshikov, A., Wijmenga, C., 
Zhernakova, A., Bell, J. T., Spector, T. D., & Steves, C. J. (2018). Detection of stable 
community structures within gut microbiota co-occurrence networks from different 
human populations. PeerJ, 6. https://doi.org/10.7717/peerj.4303 
Jalava, J., & Eerola, E. (1999). Phylogenetic analysis of Fusobacterium alocis and Fusobacterium 
sulci based on 16S  rRNA gene sequences: Proposal of Filifactor alocis (Cato, Moore and 
Moore) comb.  Nov. And Eubacterium sulci (Cato, Moore and Moore) comb. Nov. 
International Journal of Systematic Bacteriology, 49 Pt 4, 1375–1379. 
https://doi.org/10.1099/00207713-49-4-1375 
Janda, J. M., & Abbott, S. L. (2007). 16S rRNA Gene Sequencing for Bacterial Identification in 
the Diagnostic Laboratory: Pluses, Perils, and Pitfalls. Journal of Clinical Microbiology, 
45(9), 2761–2764. https://doi.org/10.1128/JCM.01228-07 
Jasperson, K. W., Tuohy, T. M., Neklason, D. W., & Burt, R. W. (2010). Hereditary and Familial 
Colon Cancer. Gastroenterology, 138(6), 2044–2058. 
https://doi.org/10.1053/j.gastro.2010.01.054 
Johansson, M. E. V., Phillipson, M., Petersson, J., Velcich, A., Holm, L., & Hansson, G. C. 
(2010). The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of 
bacteria. MEDICAL SCIENCES, 6. https://doi.org/10.4161/gmic.1.1.10470. 
Johnson, A. J., Vangay, P., Al-Ghalith, G. A., Hillmann, B. M., Ward, T. L., Shields-Cutler, R. R., 




D. (2019). Daily Sampling Reveals Personalized Diet-Microbiome Associations in 
Humans. Cell Host & Microbe, 25(6), 789-802.e5. 
https://doi.org/10.1016/j.chom.2019.05.005 
Johnson, K. V.-A., & Burnet, P. W. J. (2016). Microbiome: Should we diversify from diversity? 
Gut Microbes, 7(6), 455–458. https://doi.org/10.1080/19490976.2016.1241933 
Jones, M. B., Highlander, S. K., Anderson, E. L., Li, W., Dayrit, M., Klitgord, N., Fabani, M. M., 
Seguritan, V., Green, J., Pride, D. T., Yooseph, S., Biggs, W., Nelson, K. E., & Venter, J. 
C. (2015). Library preparation methodology can influence genomic and functional 
predictions in human microbiome research. Proceedings of the National Academy of 
Sciences, 112(45), 14024–14029. https://doi.org/10.1073/pnas.1519288112 
Jones, P., Binns, D., Chang, H.-Y., Fraser, M., Li, W., McAnulla, C., McWilliam, H., Maslen, J., 
Mitchell, A., Nuka, G., Pesseat, S., Quinn, A. F., Sangrador-Vegas, A., Scheremetjew, M., 
Yong, S.-Y., Lopez, R., & Hunter, S. (2014). InterProScan 5: Genome-scale protein 
function classification. Bioinformatics, 30(9), 1236–1240. 
https://doi.org/10.1093/bioinformatics/btu031 
Jones, S., Chen, W. -d., Parmigiani, G., Diehl, F., Beerenwinkel, N., Antal, T., Traulsen, A., 
Nowak, M. A., Siegel, C., Velculescu, V. E., Kinzler, K. W., Vogelstein, B., Willis, J., & 
Markowitz, S. D. (2008). Comparative lesion sequencing provides insights into tumor 





Jost, T., Lacroix, C., Braegger, C. P., Rochat, F., & Chassard, C. (2014). Vertical mother–neonate 
transfer of maternal gut bacteria via breastfeeding. Environmental Microbiology, 16(9), 
2891–2904. https://doi.org/10.1111/1462-2920.12238 
Juge, N. (2012). Microbial adhesins to gastrointestinal mucus. Trends in Microbiology, 20(1), 
30–39. https://doi.org/10.1016/j.tim.2011.10.001 
Kamada, N., Chen, G. Y., Inohara, N., & Núñez, G. (2013). Control of pathogens and 
pathobionts by the gut microbiota. Nature Immunology, 14(7), 685–690. 
https://doi.org/10.1038/ni.2608 
Kamphorst, J. J., Nofal, M., Commisso, C., Hackett, S. R., Grabocka, E., Heiden, M. G. V., 
Miller, G., Drebin, J. A., Bar-Sagi, D., Thompson, C. B., & Rabinowitz, J. D. (2016). 
Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge 
extracellular protein. 20. 
Kara, E. L., Hanson, P. C., Hu, Y. H., Winslow, L., & McMahon, K. D. (2013). A decade of 
seasonal dynamics and co-occurrences within freshwater bacterioplankton communities 
from eutrophic Lake Mendota, WI, USA. The ISME Journal, 7(3), 680–684. 
https://doi.org/10.1038/ismej.2012.118 
Karin, M. (2006). Nuclear factor-kappaB in cancer development and progression. Nature, 
441(7092), 431–436. https://doi.org/10.1038/nature04870 
Karlsson, F. H., Fåk, F., Nookaew, I., Tremaroli, V., Fagerberg, B., Petranovic, D., Bäckhed, F., 
& Nielsen, J. (2012). Symptomatic atherosclerosis is associated with an altered gut 




Karlsson, F. H., Tremaroli, V., Nookaew, I., Bergström, G., Behre, C. J., Fagerberg, B., Nielsen, 
J., & Bäckhed, F. (2013). Gut metagenome in European women with normal, impaired 
and diabetic glucose control. Nature, 498(7452), 99–103. 
https://doi.org/10.1038/nature12198 
Kho, Z. Y., & Lal, S. K. (2018). The Human Gut Microbiome – A Potential Controller of 
Wellness and Disease. Frontiers in Microbiology, 9, 1835. 
https://doi.org/10.3389/fmicb.2018.01835 
Kim, Y. S., Unno, T., Kim, B.-Y., & Park, M.-S. (2019). Sex Differences in Gut Microbiota. The 
World Journal of Men’s Health, 37. https://doi.org/10.5534/wjmh.190009 
Koh, A., De Vadder, F., Kovatcheva-Datchary, P., & Bäckhed, F. (2016). From Dietary Fiber to 
Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites. Cell, 165(6), 
1332–1345. https://doi.org/10.1016/j.cell.2016.05.041 
Koren, O., Spor, A., Felin, J., Fak, F., Stombaugh, J., Tremaroli, V., Behre, C. J., Knight, R., 
Fagerberg, B., Ley, R. E., & Backhed, F. (2011). Human oral, gut, and plaque microbiota 
in patients with atherosclerosis. Proceedings of the National Academy of Sciences, 
108(Supplement_1), 4592–4598. https://doi.org/10.1073/pnas.1011383107 
Kostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud, M., Clancy, T. 
E., Chung, D. C., Lochhead, P., Hold, G. L., El-Omar, E. M., Brenner, D., Fuchs, C. S., 
Meyerson, M., & Garrett, W. S. (2013). Fusobacterium nucleatum Potentiates Intestinal 
Tumorigenesis and Modulates the Tumor-Immune Microenvironment. Cell Host & 




Kostic, A. D., Gevers, D., Pedamallu, C. S., Michaud, M., Duke, F., Earl, A. M., Ojesina, A. I., 
Jung, J., Bass, A. J., Tabernero, J., Baselga, J., Liu, C., Shivdasani, R. A., Ogino, S., 
Birren, B. W., Huttenhower, C., Garrett, W. S., & Meyerson, M. (2012). Genomic 
analysis identifies association of Fusobacterium with colorectal carcinoma. Genome 
Research, 22(2), 292–298. https://doi.org/10.1101/gr.126573.111 
Kostic, A. D., Xavier, R. J., & Gevers, D. (2014). The Microbiome in Inflammatory Bowel 
Disease: Current Status and the Future Ahead. Gastroenterology, 146(6), 1489–1499. 
https://doi.org/10.1053/j.gastro.2014.02.009 
Kurtz, Z. D., Müller, C. L., Miraldi, E. R., Littman, D. R., Blaser, M. J., & Bonneau, R. A. 
(2015). Sparse and Compositionally Robust Inference of Microbial Ecological Networks. 
PLOS Computational Biology, 11(5), e1004226. 
https://doi.org/10.1371/journal.pcbi.1004226 
Lahti, L., Salojärvi, J., Salonen, A., Scheffer, M., & de Vos, W. M. (2014). Tipping elements in 
the human intestinal ecosystem. Nature Communications, 5(1), 4344. 
https://doi.org/10.1038/ncomms5344 
Lane, D. J., Pace, B., Olsen, G. J., Stahl, D. A., Sogin, M. L., & Pace, N. R. (1985). Rapid 
determination of 16S ribosomal RNA sequences for phylogenetic analyses. Proceedings 
of the National Academy of Sciences of the United States of America, 82(20), 6955–6959. 
PubMed. https://doi.org/10.1073/pnas.82.20.6955 
Lane, N. (2015). The unseen world: Reflections on Leeuwenhoek (1677) ‘Concerning little 
animals.’ Philosophical Transactions of the Royal Society B: Biological Sciences, 




Langmead, B., & Salzberg, S. L. (2012). Fast gapped-read alignment with Bowtie 2. Nature 
Methods, 9(4), 357–359. https://doi.org/10.1038/nmeth.1923 
Laqueur, G. L., McDaniel, E. G., & Matsumoto, H. (1967). Tumor induction in germfree rats 
with methylazoxymethanol (MAM) and synthetic MAM acetate. Journal of the National 
Cancer Institute, 39(2), 355–371. 
Laudadio, I., Fulci, V., Palone, F., Stronati, L., Cucchiara, S., & Carissimi, C. (2018). 
Quantitative Assessment of Shotgun Metagenomics and 16S rDNA Amplicon Sequencing 
in the Study of Human Gut Microbiome. OMICS: A Journal of Integrative Biology, 22, 
248–254. https://doi.org/10.1089/omi.2018.0013 
Lauritano, D. (2017). FOCUS ON PERIODONTAL DISEASE AND COLORECTAL 
CARCINOMA. Oral & Implantology, 10(3), 229. 
https://doi.org/10.11138/orl/2017.10.3.229 
Layeghifard, M., Hwang, D. M., & Guttman, D. S. (2017). Disentangling Interactions in the 
Microbiome: A Network Perspective. Trends in Microbiology, 25(3), 217–228. 
https://doi.org/10.1016/j.tim.2016.11.008 
Lee, D., Jung, K. U., Kim, H. O., Kim, H., & Chun, H.-K. (2018). Association between oral 
health and colorectal adenoma in a screening population. Medicine, 97(37), e12244. 
https://doi.org/10.1097/MD.0000000000012244 
Lee, S.-H., Yoon, S.-H., Jung, Y., Kim, N., Min, U., Chun, J., & Choi, I. (2020). Emotional well-





Lee, Y. K., & Mazmanian, S. K. (2010). Has the microbiota played a critical role in the evolution 
of the adaptive immune system? Science (New York, N.Y.), 330(6012), 1768–1773. 
https://doi.org/10.1126/science.1195568 
Leeuwenhoek, A. V. (1677). Observations, communicated to the publisher by Mr. Antony van 
Leewenhoeck, in a dutch letter of the 9th Octob. 1676. Here English’d: Concerning little 
animals by him observed in rain-well-sea- and snow water; as also in water wherein 
pepper had lain infused. Philosophical Transactions of the Royal Society of London, 
12(133), 821–831. https://doi.org/10.1098/rstl.1677.0003 
Levine, J. S., & Ahnen, D. J. (2006). Clinical practice. Adenomatous polyps of the colon. The 
New England Journal of Medicine, 355(24), 2551–2557. 
https://doi.org/10.1056/NEJMcp063038 
Li, H., Limenitakis, J. P., Fuhrer, T., Geuking, M. B., Lawson, M. A., Wyss, M., Brugiroux, S., 
Keller, I., Macpherson, J. A., Rupp, S., Stolp, B., Stein, J. V., Stecher, B., Sauer, U., 
McCoy, K. D., & Macpherson, A. J. (2015). The outer mucus layer hosts a distinct 
intestinal microbial niche. Nature Communications, 6(1), 8292. 
https://doi.org/10.1038/ncomms9292 
Li, S., Konstantinov, S. R., Smits, R., & Peppelenbosch, M. P. (2017). Bacterial Biofilms in 
Colorectal Cancer Initiation and Progression. Trends in Molecular Medicine, 23(1), 18–
30. https://doi.org/10.1016/j.molmed.2016.11.004 
Liao, H., Li, C., Ai, Y., & Kou, Y. (2020). The gut microbiome is more stable in males than in 





Liao, Y., Smyth, G. K., & Shi, W. (2014). featureCounts: An efficient general purpose program 
for assigning sequence reads to genomic features. Bioinformatics, 30(7), 923–930. 
https://doi.org/10.1093/bioinformatics/btt656 
Lidell, M. E., Johansson, M. E. V., Mörgelin, M., Asker, N., Gum, J. R., Kim, Y. S., & Hansson, 
G. C. (2003). The recombinant C-terminus of the human MUC2 mucin forms dimers in 
Chinese-hamster ovary cells and heterodimers with full-length MUC2 in LS 174T cells. 
Biochemical Journal, 372(2), 335–345. https://doi.org/10.1042/bj20030003 
Liu, H., Roeder, K., & Wasserman, L. (2010). Stability Approach to Regularization Selection 
(StARS) for High Dimensional Graphical Models. ArXiv:1006.3316 [Stat]. 
http://arxiv.org/abs/1006.3316 
Lloyd-Price, J., Abu-Ali, G., & Huttenhower, C. (2016). The healthy human microbiome. 
Genome Medicine, 8(1), 51. https://doi.org/10.1186/s13073-016-0307-y 
Loomba, R., Seguritan, V., Li, W., Long, T., Klitgord, N., Bhatt, A., Dulai, P. S., Caussy, C., 
Bettencourt, R., Highlander, S. K., Jones, M. B., Sirlin, C. B., Schnabl, B., Brinkac, L., 
Schork, N., Chen, C.-H., Brenner, D. A., Biggs, W., Yooseph, S., … Nelson, K. E. (2017). 
Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced 
Fibrosis in Human Nonalcoholic Fatty Liver Disease. Cell Metabolism, 25(5), 1054-
1062.e5. https://doi.org/10.1016/j.cmet.2017.04.001 
Lowery, J. T., Ahnen, D. J., Schroy, P. C., Hampel, H., Baxter, N., Boland, C. R., Burt, R. W., 
Butterly, L., Doerr, M., Doroshenk, M., Feero, W. G., Henrikson, N., Ladabaum, U., 
Lieberman, D., McFarland, E. G., Peterson, S. K., Raymond, M., Samadder, N. J., 




colorectal cancer risk and its clinical implications: A state-of-the-science review: Family 
History and Colorectal Cancer. Cancer, 122(17), 2633–2645. 
https://doi.org/10.1002/cncr.30080 
Lozupone, C. A., Stombaugh, J. I., Gordon, J. I., Jansson, J. K., & Knight, R. (2012). Diversity, 
stability and resilience of the human gut microbiota. Nature, 489(7415), 220–230. 
https://doi.org/10.1038/nature11550 
Lupatini, M., Suleiman, A. K. A., Jacques, R. J. S., Antoniolli, Z. I., de Siqueira Ferreira, A., 
Kuramae, E. E., & Roesch, L. F. W. (2014). Network topology reveals high connectance 
levels and few key microbial genera within soils. Frontiers in Environmental Science, 2. 
https://doi.org/10.3389/fenvs.2014.00010 
Lynd, L. R., Weimer, P. J., van Zyl, W. H., & Pretorius, I. S. (2002). Microbial Cellulose 
Utilization: Fundamentals and Biotechnology. MICROBIOL. MOL. BIOL. REV., 66, 72. 
Mann, H. B., & Whitney, D. R. (1947). On a Test of Whether one of Two Random Variables is 
Stochastically Larger than the Other. Ann. Math. Statist., 18(1), 50–60. 
https://doi.org/10.1214/aoms/1177730491 
Marcobal, A., Barboza, M., Froehlich, J. W., Block, D. E., German, J. B., Lebrilla, C. B., & 
Mills, D. A. (2010). Consumption of human milk oligosaccharides by gut-related 
microbes. Journal of Agricultural and Food Chemistry, 58(9), 5334–5340. 
https://doi.org/10.1021/jf9044205 
Marcobal, A., & Sonnenburg, J. L. (2012). Human milk oligosaccharide consumption by 




the European Society of Clinical Microbiology and Infectious Diseases, 18 Suppl 4(0 4), 
12–15. https://doi.org/10.1111/j.1469-0691.2012.03863.x 
Mark Welch, J. L., Hasegawa, Y., McNulty, N. P., Gordon, J. I., & Borisy, G. G. (2017). Spatial 
organization of a model 15-member human gut microbiota established in gnotobiotic 
mice. Proceedings of the National Academy of Sciences, 114(43), E9105–E9114. 
https://doi.org/10.1073/pnas.1711596114 
Markle, J. G. M., Frank, D. N., Mortin-Toth, S., Robertson, C. E., Feazel, L. M., Rolle-
Kampczyk, U., von Bergen, M., McCoy, K. D., Macpherson, A. J., & Danska, J. S. 
(2013). Sex Differences in the Gut Microbiome Drive Hormone-Dependent Regulation of 
Autoimmunity. Science, 339(6123), 1084–1088. https://doi.org/10.1126/science.1233521 
Martín, R., Langa, S., Reviriego, C., Jimínez, E., Marín, M. L., Xaus, J., Fernández, L., & 
Rodríguez, J. M. (2003). Human milk is a source of lactic acid bacteria for the infant gut. 
The Journal of Pediatrics, 143(6), 754–758. https://doi.org/10.1016/j.jpeds.2003.09.028 
Matson, V., Fessler, J., Bao, R., Chongsuwat, T., Zha, Y., Alegre, M.-L., Luke, J. J., & Gajewski, 
T. F. (2018). The commensal microbiome is associated with anti–PD-1 efficacy in 
metastatic melanoma patients. Science, 359(6371), 104–108. 
https://doi.org/10.1126/science.aao3290 
Maxam, A. M., & Gilbert, W. (1977). A new method for sequencing DNA. Proceedings of the 
National Academy of Sciences, 74(2), 560. https://doi.org/10.1073/pnas.74.2.560 
Mayer, E. A., Padua, D., & Tillisch, K. (2014). Altered brain-gut axis in autism: Comorbidity or 
causative mechanisms? BioEssays : News and Reviews in Molecular, Cellular and 




Mazmanian, S. K., Liu, C. H., Tzianabos, A. O., & Kasper, D. L. (2005). An immunomodulatory 
molecule of symbiotic bacteria directs maturation of the host immune system. Cell, 
122(1), 107–118. https://doi.org/10.1016/j.cell.2005.05.007 
McDermott, J., & Jimeno, A. (2015). Pembrolizumab: PD-1 inhibition as a therapeutic strategy 
in cancer. Drugs of Today (Barcelona, Spain : 1998), 51(1), 7–20. 
https://doi.org/10.1358/dot.2015.51.1.2250387 
Menze, B. H., Kelm, B. M., Masuch, R., Himmelreich, U., Bachert, P., Petrich, W., & 
Hamprecht, F. A. (2009). A comparison of random forest and its Gini importance with 
standard chemometric methods for the feature selection and classification of spectral 
data. BMC Bioinformatics, 10(1), 213. https://doi.org/10.1186/1471-2105-10-213 
Messing, J., Crea, R., & Seeburg, P. H. (1981). A system for shotgun DNA sequencing. Nucleic 
Acids Research, 9(2), 309–321. https://doi.org/10.1093/nar/9.2.309 
MetaHIT consortium, Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., 
Almeida, M., Arumugam, M., Batto, J.-M., Kennedy, S., Leonard, P., Li, J., Burgdorf, K., 
Grarup, N., Jørgensen, T., Brandslund, I., Nielsen, H. B., Juncker, A. S., … Pedersen, O. 
(2013). Richness of human gut microbiome correlates with metabolic markers. Nature, 
500(7464), 541–546. https://doi.org/10.1038/nature12506 
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., 
Nielsen, T., Pons, N., Levenez, F., Yamada, T., Mende, D. R., Li, J., Xu, J., Li, S., Li, D., 
Cao, J., Wang, B., Liang, H., … Wang, J. (2010). A human gut microbial gene catalogue 





Michaud, D. S., Fu, Z., Shi, J., & Chung, M. (2017). Periodontal Disease, Tooth Loss, and 
Cancer Risk. Epidemiologic Reviews, 39(1), 49–58. 
https://doi.org/10.1093/epirev/mxx006 
Mima, K., Cao, Y., Chan, A. T., Qian, Z. R., Nowak, J. A., Masugi, Y., Shi, Y., Song, M., da 
Silva, A., Gu, M., Li, W., Hamada, T., Kosumi, K., Hanyuda, A., Liu, L., Kostic, A. D., 
Giannakis, M., Bullman, S., Brennan, C. A., … Ogino, S. (2016). Fusobacterium 
nucleatum in Colorectal Carcinoma Tissue According to Tumor Location: Clinical and 
Translational Gastroenterology, 7(11), e200. https://doi.org/10.1038/ctg.2016.53 
Moeller, A. H., Caro-Quintero, A., Mjungu, D., Georgiev, A. V., Lonsdorf, E. V., Muller, M. N., 
Pusey, A. E., Peeters, M., Hahn, B. H., & Ochman, H. (2016). Cospeciation of gut 
microbiota with hominids. Science, 353(6297), 380–382. 
https://doi.org/10.1126/science.aaf3951 
Momen-Heravi, F., Babic, A., Tworoger, S. S., Zhang, L., Wu, K., Smith-Warner, S. A., Ogino, 
S., Chan, A. T., Meyerhardt, J., Giovannucci, E., Fuchs, C., Cho, E., Michaud, D. S., 
Stampfer, M. J., Yu, Y.-H., Kim, D., & Zhang, X. (2017). Periodontal disease, tooth loss 
and colorectal cancer risk: Results from the Nurses’ Health Study: Periodontal disease, 
tooth loss and colorectal cancer risk. International Journal of Cancer, 140(3), 646–652. 
https://doi.org/10.1002/ijc.30486 
Mowat, A. M., & Agace, W. W. (2014). Regional specialization within the intestinal immune 
system. Nature Reviews Immunology, 14(10), 667–685. https://doi.org/10.1038/nri3738 
Mukherjee, S., Partch, C. L., Lehotzky, R. E., Whitham, C. V., Chu, H., Bevins, C. L., Gardner, 




flexible N-terminal prosegment. The Journal of Biological Chemistry, 284(8), 4881–
4888. https://doi.org/10.1074/jbc.M808077200 
Musso, G., Gambino, R., & Cassader, M. (2010). Obesity, Diabetes, and Gut Microbiota: The 
hygiene hypothesis expanded? Diabetes Care, 33(10), 2277–2284. 
https://doi.org/10.2337/dc10-0556 
Nakatsu, G., Li, X., Zhou, H., Sheng, J., Wong, S. H., Wu, W. K. K., Ng, S. C., Tsoi, H., Dong, 
Y., Zhang, N., He, Y., Kang, Q., Cao, L., Wang, K., Zhang, J., Liang, Q., Yu, J., & Sung, 
J. J. Y. (2015). Gut mucosal microbiome across stages of colorectal carcinogenesis. 
Nature Communications, 6(1), 8727. https://doi.org/10.1038/ncomms9727 
Neilands, J., Davies, J. R., Bikker, F. J., & Svensäter, G. (2019). Parvimonas micra stimulates 
expression of gingipains from Porphyromonas gingivalis in multi-species communities. 
Anaerobe, 55, 54–60. https://doi.org/10.1016/j.anaerobe.2018.10.007 
Neis, E., Dejong, C., & Rensen, S. (2015). The Role of Microbial Amino Acid Metabolism in 
Host Metabolism. Nutrients, 7(4), 2930–2946. https://doi.org/10.3390/nu7042930 
Nemergut, D. R., Schmidt, S. K., Fukami, T., O’Neill, S. P., Bilinski, T. M., Stanish, L. F., 
Knelman, J. E., Darcy, J. L., Lynch, R. C., Wickey, P., & Ferrenberg, S. (2013). Patterns 
and Processes of Microbial Community Assembly. Microbiology and Molecular Biology 
Reviews, 77(3), 342–356. https://doi.org/10.1128/MMBR.00051-12 
Nesić, D., Hsu, Y., & Stebbins, C. E. (2004). Assembly and function of a bacterial genotoxin. 
Nature, 429(6990), 429–433. https://doi.org/10.1038/nature02532 





Newman, M. E. J. (2010). Networks: An Introduction (pp. 168–234). Oxford University Press, 
Inc. 
Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., & Pettersson, S. 
(2012). Host-Gut Microbiota Metabolic Interactions. Science, 336(6086), 1262–1267. 
https://doi.org/10.1126/science.1223813 
O’Keefe, S. J. D., Li, J. V., Lahti, L., Ou, J., Carbonero, F., Mohammed, K., Posma, J. M., 
Kinross, J., Wahl, E., Ruder, E., Vipperla, K., Naidoo, V., Mtshali, L., Tims, S., Puylaert, 
P. G. B., DeLany, J., Krasinskas, A., Benefiel, A. C., Kaseb, H. O., … Zoetendal, E. G. 
(2015). Fat, fibre and cancer risk in African Americans and rural Africans. Nature 
Communications, 6, 6342. https://doi.org/10.1038/ncomms7342 
O’Leary, N. A., Wright, M. W., Brister, J. R., Ciufo, S., Haddad, D., McVeigh, R., Rajput, B., 
Robbertse, B., Smith-White, B., Ako-Adjei, D., Astashyn, A., Badretdin, A., Bao, Y., 
Blinkova, O., Brover, V., Chetvernin, V., Choi, J., Cox, E., Ermolaeva, O., … Pruitt, K. 
D. (2016). Reference sequence (RefSeq) database at NCBI: Current status, taxonomic 
expansion, and functional annotation. Nucleic Acids Research, 44(D1), D733–D745. 
https://doi.org/10.1093/nar/gkv1189 
Oswal, P., Katti, S., Joshi, V., & Shaikh, H. (2020). Identification of Dialister pneumosintes in 
healthy and chronic periodontitis patients with Type 2 diabetes mellitus and its 
correlation with the red complex bacteria. Journal of Interdisciplinary Dentistry, 10(1), 
17. https://doi.org/10.4103/jid.jid_4_19 





Pacheco, A. R., Moel, M., & Segrè, D. (2019). Costless metabolic secretions as drivers of 
interspecies interactions in microbial ecosystems. Nature Communications, 10(1), 103. 
https://doi.org/10.1038/s41467-018-07946-9 
Pannaraj, P. S., Li, F., Cerini, C., Bender, J. M., Yang, S., Rollie, A., Adisetiyo, H., Zabih, S., 
Lincez, P. J., Bittinger, K., Bailey, A., Bushman, F. D., Sleasman, J. W., & Aldrovandi, G. 
M. (2017). Association Between Breast Milk Bacterial Communities and Establishment 
and Development of the Infant Gut Microbiome. JAMA Pediatrics, 171(7), 647. 
https://doi.org/10.1001/jamapediatrics.2017.0378 
Parks, D. H., Imelfort, M., Skennerton, C. T., Hugenholtz, P., & Tyson, G. W. (2015). CheckM: 
Assessing the quality of microbial genomes recovered from isolates, single cells, and 
metagenomes. Genome Research, 25(7), 1043–1055. 
https://doi.org/10.1101/gr.186072.114 
Patel, S. G., & Ahnen, D. J. (2012). Familial Colon Cancer Syndromes: An Update of a Rapidly 
Evolving Field. Current Gastroenterology Reports, 14(5), 428–438. 
https://doi.org/10.1007/s11894-012-0280-6 
Pedregosa, F., Varoquaux, G., Gramfort, A., Michel, V., Thirion, B., Grisel, O., Blondel, M., 
Prettenhofer, P., Weiss, R., Dubourg, V., Vanderplas, J., Passos, A., & Cournapeau, D. 
(2011). Scikit-learn: Machine Learning in Python. MACHINE LEARNING IN PYTHON, 
6. 
Peluso, G., Incollingo, P., Calogero, A., Tammaro, V., Rupealta, N., Chiacchio, G., Sandoval 
Sotelo, M. L., Minieri, G., Pisani, A., Riccio, E., Sabbatini, M., Bracale, U. M., Dodaro, 




Cancer: A Literature Review. BioMed Research International, 2017, 2605628–2605628. 
PubMed. https://doi.org/10.1155/2017/2605628 
Pessione, E. (2012). Lactic acid bacteria contribution to gut microbiota complexity: Lights and 
shadows. Frontiers in Cellular and Infection Microbiology, 2. 
https://doi.org/10.3389/fcimb.2012.00086 
Petersen, C., & Round, J. L. (2014). Defining dysbiosis and its influence on host immunity and 
disease: How changes in microbiota structure influence health. Cellular Microbiology, 
16(7), 1024–1033. https://doi.org/10.1111/cmi.12308 
Phang, J. M., Liu, W., Hancock, C. N., & Fischer, J. W. (2015). Proline metabolism and cancer: 
Emerging links to glutamine and collagen. Current Opinion in Clinical Nutrition and 
Metabolic Care, 18(1), 71–77. https://doi.org/10.1097/MCO.0000000000000121 
Podolsky, D. K., & Isselbacher, K. J. (1983). Composition of human colonic mucin. Selective 
alteration in inflammatory bowel disease. Journal of Clinical Investigation, 72(1), 142–
153. https://doi.org/10.1172/JCI110952 
Prettejohn, B. J., Berryman, M. J., & McDonnell, M. D. (2011). Methods for Generating 
Complex Networks with Selected Structural Properties for Simulations: A Review and 
Tutorial for Neuroscientists. Frontiers in Computational Neuroscience, 5. 
https://doi.org/10.3389/fncom.2011.00011 
R Core Team. (2020). R: A Language and Environment for Statistical Computing (3.6.3) 
[Computer software]. R Foundation for Statistical Computing. https://www.R-project.org 
Ranjan, R., Rani, A., Metwally, A., McGee, H. S., & Perkins, D. L. (2016). Analysis of the 




Biochemical and Biophysical Research Communications, 469(4), 967–977. 
https://doi.org/10.1016/j.bbrc.2015.12.083 
Rasmussen, C. L., Palarea-Albaladejo, J., Johansson, M. S., Crowley, P., Stevens, M. L., Gupta, 
N., Karstad, K., & Holtermann, A. (2020). Zero problems with compositional data of 
physical behaviors: A comparison of three zero replacement methods. International 
Journal of Behavioral Nutrition and Physical Activity, 17(1), 126. 
https://doi.org/10.1186/s12966-020-01029-z 
Risio, M. (2010). The natural history of adenomas. Best Practice & Research. Clinical 
Gastroenterology, 24(3), 271–280. https://doi.org/10.1016/j.bpg.2010.04.005 
Rodier, F., Coppé, J.-P., Patil, C. K., Hoeijmakers, W. A. M., Muñoz, D. P., Raza, S. R., Freund, 
A., Campeau, E., Davalos, A. R., & Campisi, J. (2009). Persistent DNA damage 
signalling triggers senescence-associated inflammatory cytokine secretion. Nature Cell 
Biology, 11(8), 973–979. https://doi.org/10.1038/ncb1909 
Round, J. L., & Mazmanian, S. K. (2009). The gut microbiota shapes intestinal immune 
responses during health and disease. Nature Reviews Immunology, 9(5), 313–323. 
https://doi.org/10.1038/nri2515 
Rousee, J. M., Bermond, D., Piemont, Y., Tournoud, C., Heller, R., Kehrli, P., Harlay, M. L., 
Monteil, H., & Jaulhac, B. (2002). Dialister pneumosintes Associated with Human Brain 
Abscesses. Journal of Clinical Microbiology, 40(10), 3871–3873. 
https://doi.org/10.1128/JCM.40.10.3871-3873.2002 
Rubinstein, M. R., Baik, J. E., Lagana, S. M., Han, R. P., Raab, W. J., Sahoo, D., Dalerba, P., 




by inducing Wnt/β‐catenin modulator Annexin A1. EMBO Reports, 20(4). 
https://doi.org/10.15252/embr.201847638 
Sanger, F., Air, G. M., Barrell, B. G., Brown, N. L., Coulson, A. R., Fiddes, J. C., Hutchison, C. 
A., Slocombe, P. M., & Smith, M. (1977). Nucleotide sequence of bacteriophage φX174 
DNA. Nature, 265(5596), 687–695. https://doi.org/10.1038/265687a0 
Sanger, F., Brownlee, G. G., & Barrell, B. G. (1965). A two-dimensional fractionation procedure 
for radioactive nucleotides. Journal of Molecular Biology, 13(2), 373-IN4. 
https://doi.org/10.1016/S0022-2836(65)80104-8 
Sanger, F., Coulson, A. R., Hong, G. F., Hill, D. F., & Petersen, G. B. (1982). Nucleotide 
sequence of bacteriophage λ DNA. Journal of Molecular Biology, 162(4), 729–773. 
https://doi.org/10.1016/0022-2836(82)90546-0 
Sanger, F., & Thompson, E. O. P. (1953). The amino-acid sequence in the glycyl chain of insulin. 
II. The investigation of peptides from enzymic hydrolysates. The Biochemical Journal, 
53(3), 366–374. PubMed. https://doi.org/10.1042/bj0530366 
Saunders, A. M., Albertsen, M., Vollertsen, J., & Nielsen, P. H. (2016). The activated sludge 
ecosystem contains a core community of abundant organisms. The ISME Journal, 10(1), 
11–20. https://doi.org/10.1038/ismej.2015.117 
Savage, D. C. (2001). Microbial Biota of the Human Intestine: 17. 
Schamberger, G. P., & Diez-Gonzalez, F. (2002). Selection of recently isolated colicinogenic 
Escherichia coli strains inhibitory to Escherichia coli O157:H7. Journal of Food 




Schlafer, S., Riep, B., Griffen, A. L., Petrich, A., Hübner, J., Berning, M., Friedmann, A., Göbel, 
U. B., & Moter, A. (2010). Filifactor alocis—Involvement in periodontal biofilms. BMC 
Microbiology, 10(1), 66. https://doi.org/10.1186/1471-2180-10-66 
Schroeder, B. O. (2019). Fight them or feed them: How the intestinal mucus layer manages the 
gut microbiota. Gastroenterology Report, 7(1), 3–12. 
https://doi.org/10.1093/gastro/goy052 
Scott, A. J., Alexander, J. L., Merrifield, C. A., Cunningham, D., Jobin, C., Brown, R., Alverdy, 
J., O’Keefe, S. J., Gaskins, H. R., Teare, J., Yu, J., Hughes, D. J., Verstraelen, H., Burton, 
J., O’Toole, P. W., Rosenberg, D. W., Marchesi, J. R., & Kinross, J. M. (2019). 
International Cancer Microbiome Consortium consensus statement on the role of the 
human microbiome in carcinogenesis. Gut, 68(9), 1624–1632. 
https://doi.org/10.1136/gutjnl-2019-318556 
Sears, C. L., & Pardoll, D. M. (2011). Perspective: Alpha-Bugs, Their Microbial Partners, and 
the Link to Colon Cancer. The Journal of Infectious Diseases, 203(3), 306–311. 
https://doi.org/10.1093/jinfdis/jiq061 
Sebald, M., & Hauser, D. (1995). Pasteur, oxygen and the anaerobes revisited. Anaerobe, 1(1), 
11–16. https://doi.org/10.1016/s1075-9964(95)80353-x 
Sender, R., Fuchs, S., & Milo, R. (2016). Revised Estimates for the Number of Human and 
Bacteria Cells in the Body. PLOS Biology, 14(8), e1002533. 
https://doi.org/10.1371/journal.pbio.1002533 




Shetty, S. A., Hugenholtz, F., Lahti, L., Smidt, H., & de Vos, W. M. (2017). Intestinal 
microbiome landscaping: Insight in community assemblage and implications for 
microbial modulation strategies. FEMS Microbiology Reviews, 41(2), 182–199. 
https://doi.org/10.1093/femsre/fuw045 
Shibolet, O., & Podolsky, D. K. (2007). TLRs in the Gut.IV. Negative regulation of Toll-like 
receptors and intestinal homeostasis: Addition by subtraction. American Journal of 
Physiology-Gastrointestinal and Liver Physiology, 292(6), G1469–G1473. 
https://doi.org/10.1152/ajpgi.00531.2006 
Shin, R., Suzuki, M., & Morishita, Y. (2002). Influence of intestinal anaerobes and organic acids 
on the growth of enterohaemorrhagic Escherichia coli O157:H7. Journal of Medical 
Microbiology, 51(3), 201–206. https://doi.org/10.1099/0022-1317-51-3-201 
Shreiner, A. B., Kao, J. Y., & Young, V. B. (2015). The gut microbiome in health and in disease: 
Current Opinion in Gastroenterology, 31(1), 69–75. 
https://doi.org/10.1097/MOG.0000000000000139 
Shulman, S. T., Friedmann, H. C., & Sims, R. H. (2007). Theodor Escherich: The first pediatric 
infectious diseases physician? Clinical Infectious Diseases : An Official Publication of 
the Infectious Diseases Society of America, 45(8), 1025–1029. 
https://doi.org/10.1086/521946 
Siegel, R. L., Miller, K. D., Goding Sauer, A., Fedewa, S. A., Butterly, L. F., Anderson, J. C., 
Cercek, A., Smith, R. A., & Jemal, A. (2020). Colorectal cancer statistics, 2020. CA: A 




Smith, K., McCoy, K. D., & Macpherson, A. J. (2007). Use of axenic animals in studying the 
adaptation of mammals to their commensal intestinal microbiota. Seminars in 
Immunology, 19(2), 59–69. https://doi.org/10.1016/j.smim.2006.10.002 
Sobhani, I., Tap, J., Roudot-Thoraval, F., Roperch, J. P., Letulle, S., Langella, P., Corthier, G., 
Van Nhieu, J. T., & Furet, J. P. (2011). Microbial Dysbiosis in Colorectal Cancer (CRC) 
Patients. PLoS ONE, 6(1), e16393. https://doi.org/10.1371/journal.pone.0016393 
Socransky, S. S., & Haffajee, A. D. (2002). Dental biofilms: Difficult therapeutic targets: Dental 
biofilms: difficult therapeutic targets. Periodontology 2000, 28(1), 12–55. 
https://doi.org/10.1034/j.1600-0757.2002.280102.x 
Spiljar, M., Merkler, D., & Trajkovski, M. (2017). The Immune System Bridges the Gut 
Microbiota with Systemic Energy Homeostasis: Focus on TLRs, Mucosal Barrier, and 
SCFAs. Frontiers in Immunology, 8, 1353. https://doi.org/10.3389/fimmu.2017.01353 
Stachowicz, J. J. (2001). Mutualism, Facilitation, and the Structure of Ecological Communities. 
BioScience, 51(3), 235. https://doi.org/10.1641/0006-
3568(2001)051[0235:MFATSO]2.0.CO;2 
Staden, R. (1979). A strategy of DNA sequencing employing computer programs. Nucleic Acids 
Research, 6(7), 2601–2610. https://doi.org/10.1093/nar/6.7.2601 
Stadtfeld, C., Takács, K., & Vörös, A. (2020). The Emergence and Stability of Groups in Social 
Networks. Soc. Networks, 60, 129–145. 
Staley, J. T., & Konopka, A. (1985). Measurement of in Situ Activities of Nonphotosynthetic 
Microorganisms in Aquatic and Terrestrial Habitats. Annual Review of Microbiology, 




Steele, J. A., Countway, P. D., Xia, L., Vigil, P. D., Beman, J. M., Kim, D. Y., Chow, C.-E. T., 
Sachdeva, R., Jones, A. C., Schwalbach, M. S., Rose, J. M., Hewson, I., Patel, A., Sun, F., 
Caron, D. A., & Fuhrman, J. A. (2011). Marine bacterial, archaeal and protistan 
association networks reveal ecological linkages. The ISME Journal, 5(9), 1414–1425. 
https://doi.org/10.1038/ismej.2011.24 
Street, W. (2020). Colorectal Cancer Facts & Figures 2020-2022. 48. 
Strobl, C., Boulesteix, A.-L., Zeileis, A., & Hothorn, T. (2007). Bias in random forest variable 
importance measures: Illustrations, sources and a solution. BMC Bioinformatics, 8(1), 25. 
https://doi.org/10.1186/1471-2105-8-25 
Stryker, S. J., Wolff, B. G., Culp, C. E., Libbe, S. D., Ilstrup, D. M., & MacCarty, R. L. (1987). 
Natural history of untreated colonic polyps. Gastroenterology, 93(5), 1009–1013. 
https://doi.org/10.1016/0016-5085(87)90563-4 
Swidsinski, A., Khilkin, M., Kerjaschki, D., Schreiber, S., Ortner, M., Weber, J., & Lochs, H. 
(1998). Association between intraepithelial Escherichia coli and colorectal cancer. 
Gastroenterology, 115(2), 281–286. https://doi.org/10.1016/S0016-5085(98)70194-5 
Szentkuti, L., Riedesel, H., Enss, M. L., Gaertner, K., & Von Engelhardt, W. (1990). Pre-
epithelial mucus layer in the colon of conventional and germ-free rats. The Histochemical 
Journal, 22(9), 491–497. https://doi.org/10.1007/BF01007234 
Takahashi, N. (2005). Microbial ecosystem in the oral cavity: Metabolic diversity in an 
ecological niche and its relationship with oral diseases. Interface Oral Health Science, 




Talham, G. L., Jiang, H. Q., Bos, N. A., & Cebra, J. J. (1999). Segmented filamentous bacteria 
are potent stimuli of a physiologically normal state of the murine gut mucosal immune 
system. Infection and Immunity, 67(4), 1992–2000. 
Thaiss, C. A., Zmora, N., Levy, M., & Elinav, E. (2016). The microbiome and innate immunity. 
Nature, 535(7610), 65–74. https://doi.org/10.1038/nature18847 
Thanikachalam, K., & Khan, G. (2019). Colorectal Cancer and Nutrition. Nutrients, 11(1), 164. 
https://doi.org/10.3390/nu11010164 
Thomas, A. M., Manghi, P., Asnicar, F., Pasolli, E., Armanini, F., Zolfo, M., Beghini, F., Manara, 
S., Karcher, N., Pozzi, C., Gandini, S., Serrano, D., Tarallo, S., Francavilla, A., Gallo, G., 
Trompetto, M., Ferrero, G., Mizutani, S., Shiroma, H., … Segata, N. (2019). 
Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial 
diagnostic signatures and a link with choline degradation. Nature Medicine, 25(4), 667–
678. https://doi.org/10.1038/s41591-019-0405-7 
Tjalsma, H., Boleij, A., Marchesi, J. R., & Dutilh, B. E. (2012). A bacterial driver–passenger 
model for colorectal cancer: Beyond the usual suspects. Nature Reviews Microbiology, 
10(8), 575–582. https://doi.org/10.1038/nrmicro2819 
Trosvik, P., & de Muinck, E. J. (2015). Ecology of bacteria in the human gastrointestinal tract—
Identification of keystone and foundation taxa. Microbiome, 3(1), 44. 
https://doi.org/10.1186/s40168-015-0107-4 
Tsoy, O., Ravcheev, D., & Mushegian, A. (2009). Comparative Genomics of Ethanolamine 





Tsvetovat, M., & Kouznetsov, A. (2011). Social network analysis for startups. O’Reilly Media 
Inc. 
Turnbaugh, P. J., Ley, R. E., Hamady, M., Fraser-Liggett, C. M., Knight, R., & Gordon, J. I. 
(2007). The Human Microbiome Project. Nature, 449(7164), 804–810. 
https://doi.org/10.1038/nature06244 
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. 
(2006). An obesity-associated gut microbiome with increased capacity for energy harvest. 
Nature, 444(7122), 1027–1031. https://doi.org/10.1038/nature05414 
Turroni, F., Özcan, E., Milani, C., Mancabelli, L., Viappiani, A., van Sinderen, D., Sela, D. A., & 
Ventura, M. (2015). Glycan cross-feeding activities between bifidobacteria under in vitro 
conditions. Frontiers in Microbiology, 6. https://doi.org/10.3389/fmicb.2015.01030 
Ulger Toprak, N., Yagci, A., Gulluoglu, B. M., Akin, M. L., Demirkalem, P., Celenk, T., & 
Soyletir, G. (2006). A possible role of Bacteroides fragilis enterotoxin in the aetiology of 
colorectal cancer. Clinical Microbiology and Infection, 12(8), 782–786. 
https://doi.org/10.1111/j.1469-0691.2006.01494.x 
van Passel, M. W. J., Kant, R., Zoetendal, E. G., Plugge, C. M., Derrien, M., Malfatti, S. A., 
Chain, P. S. G., Woyke, T., Palva, A., de Vos, W. M., & Smidt, H. (2011). The Genome of 
Akkermansia muciniphila, a Dedicated Intestinal Mucin Degrader, and Its Use in 
Exploring Intestinal Metagenomes. PLoS ONE, 6(3), e16876. 
https://doi.org/10.1371/journal.pone.0016876 
Venter, J. C., Remington, K., Heidelberg, J. F., Halpern, A. L., Rusch, D., Eisen, J. A., Wu, D., 




Nealson, K., White, O., Peterson, J., Hoffman, J., Parsons, R., … Smith, H. O. (2004). 
Environmental Genome Shotgun Sequencing of the Sargasso Sea. Science, 304(5667), 
66. https://doi.org/10.1126/science.1093857 
Verster, A. J., & Borenstein, E. (2018). Competitive lottery-based assembly of selected clades in 
the human gut microbiome. Microbiome, 6(1), 186. https://doi.org/10.1186/s40168-018-
0571-8 
Vetizou, M., Pitt, J. M., Daillere, R., Lepage, P., Waldschmitt, N., Flament, C., Rusakiewicz, S., 
Routy, B., Roberti, M. P., Duong, C. P. M., Poirier-Colame, V., Roux, A., Becharef, S., 
Formenti, S., Golden, E., Cording, S., Eberl, G., Schlitzer, A., Ginhoux, F., … Zitvogel, 
L. (2015). Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. 
Science, 350(6264), 1079–1084. https://doi.org/10.1126/science.aad1329 
Větrovský, T., & Baldrian, P. (2013). The Variability of the 16S rRNA Gene in Bacterial 
Genomes and Its Consequences for Bacterial Community Analyses. PLoS ONE, 8(2), 
e57923. https://doi.org/10.1371/journal.pone.0057923 
Villmones, H. C., Haug, E. S., Ulvestad, E., Grude, N., Stenstad, T., Halland, A., & Kommedal, 
Ø. (2018). Species Level Description of the Human Ileal Bacterial Microbiota. Scientific 
Reports, 8(1), 4736. https://doi.org/10.1038/s41598-018-23198-5 
Visconti, A., Le Roy, C. I., Rosa, F., Rossi, N., Martin, T. C., Mohney, R. P., Li, W., de Rinaldis, 
E., Bell, J. T., Venter, J. C., Nelson, K. E., Spector, T. D., & Falchi, M. (2019). Interplay 
between the human gut microbiome and host metabolism. Nature Communications, 




Waldecker, M., Kautenburger, T., Daumann, H., Busch, C., & Schrenk, D. (2008). Inhibition of 
histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites 
formed in the colon. The Journal of Nutritional Biochemistry, 19(9), 587–593. 
https://doi.org/10.1016/j.jnutbio.2007.08.002 
Wang, J., Li, D., Cang, H., & Guo, B. (2019). Crosstalk between cancer and immune cells: Role 
of tumor‐associated macrophages in the tumor microenvironment. Cancer Medicine, 
8(10), 4709–4721. https://doi.org/10.1002/cam4.2327 
Wang, T., Cai, G., Qiu, Y., Fei, N., Zhang, M., Pang, X., Jia, W., Cai, S., & Zhao, L. (2012). 
Structural segregation of gut microbiota between colorectal cancer patients and healthy 
volunteers. The ISME Journal, 6(2), 320–329. https://doi.org/10.1038/ismej.2011.109 
Wang, Y.-H., Yao, N., Wei, K.-K., Jiang, L., Hanif, S., Wang, Z.-X., & Pei, C.-X. (2016). The 
efficacy and safety of probiotics for prevention of chemoradiotherapy-induced diarrhea in 
people with abdominal and pelvic cancer: A systematic review and  meta-analysis. 
European Journal of Clinical Nutrition, 70(11), 1246–1253. 
https://doi.org/10.1038/ejcn.2016.102 
Warburg, O., Wind, F., & Negelein, E. (1927). THE METABOLISM OF TUMORS IN THE 
BODY. The Journal of General Physiology, 8(6), 519–530. 
https://doi.org/10.1085/jgp.8.6.519 
Warren, R. L., Freeman, D. J., Pleasance, S., Watson, P., Moore, R. A., Cochrane, K., Allen-
Vercoe, E., & Holt, R. A. (2013). Co-occurrence of anaerobic bacteria in colorectal 




Watson, A. J. M., & Collins, P. D. (2011). Colon Cancer: A Civilization Disorder. Digestive 
Diseases, 29(2), 222–228. https://doi.org/10.1159/000323926 
Weidinger, A., & Kozlov, A. V. (2015). Biological Activities of Reactive Oxygen and Nitrogen 
Species: Oxidative Stress versus Signal Transduction. Biomolecules, 5(2), 472–484. 
PubMed. https://doi.org/10.3390/biom5020472 
Winawer, S. J., & Zauber, A. G. (2002). The advanced adenoma as the primary target of 
screening. Gastrointestinal Endoscopy Clinics of North America, 12(1), 1–9, v. 
https://doi.org/10.1016/s1052-5157(03)00053-9 
Woese, C. R., & Fox, G. E. (1977). Phylogenetic structure of the prokaryotic domain: The 
primary kingdoms. Proceedings of the National Academy of Sciences, 74(11), 5088–
5090. https://doi.org/10.1073/pnas.74.11.5088 
Wu, R., & Kaiser, A. D. (1968). Structure and base sequence in the cohesive ends of 
bacteriophage lambda DNA. Journal of Molecular Biology, 35(3), 523–537. 
https://doi.org/10.1016/s0022-2836(68)80012-9 
Xia, L. C., Cram, J. A., Chen, T., Fuhrman, J. A., & Sun, F. (2011). Accurate Genome Relative 
Abundance Estimation Based on Shotgun Metagenomic Reads. PLoS ONE, 6(12), 
e27992. https://doi.org/10.1371/journal.pone.0027992 
Xu, M., Yamada, M., Li, M., Liu, H., Chen, S. G., & Han, Y. W. (2007). FadA from 
Fusobacterium nucleatum Utilizes both Secreted and Nonsecreted Forms for Functional 
Oligomerization for Attachment and Invasion of Host Cells. Journal of Biological 




Yachida, S., Mizutani, S., Shiroma, H., Shiba, S., Nakajima, T., Sakamoto, T., Watanabe, H., 
Masuda, K., Nishimoto, Y., Kubo, M., Hosoda, F., Rokutan, H., Matsumoto, M., 
Takamaru, H., Yamada, M., Matsuda, T., Iwasaki, M., Yamaji, T., Yachida, T., … Yamada, 
T. (2019). Metagenomic and metabolomic analyses reveal distinct stage-specific 
phenotypes of the gut microbiota in colorectal cancer. Nature Medicine, 25(6), 968–976. 
https://doi.org/10.1038/s41591-019-0458-7 
Yang, Y., Weng, W., Peng, J., Hong, L., Yang, L., Toiyama, Y., Gao, R., Liu, M., Yin, M., Pan, C., 
Li, H., Guo, B., Zhu, Q., Wei, Q., Moyer, M.-P., Wang, P., Cai, S., Goel, A., Qin, H., & 
Ma, Y. (2017). Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer 
Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to 
Nuclear Factor−κB, and Up-regulating Expression of MicroRNA-21. Gastroenterology, 
152(4), 851-866.e24. https://doi.org/10.1053/j.gastro.2016.11.018 
Yilmaz, P., Parfrey, L. W., Yarza, P., Gerken, J., Pruesse, E., Quast, C., Schweer, T., Peplies, J., 
Ludwig, W., & Glöckner, F. O. (2014). The SILVA and “All-species Living Tree Project 
(LTP)” taxonomic frameworks. Nucleic Acids Research, 42(D1), D643–D648. 
https://doi.org/10.1093/nar/gkt1209 
Yu, J., Feng, Q., Wong, S. H., Zhang, D., Liang, Q. yi, Qin, Y., Tang, L., Zhao, H., Stenvang, J., 
Li, Y., Wang, X., Xu, X., Chen, N., Wu, W. K. K., Al-Aama, J., Nielsen, H. J., Kiilerich, 
P., Jensen, B. A. H., Yau, T. O., … Wang, J. (2017). Metagenomic analysis of faecal 
microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. 




Yu, T., Guo, F., Yu, Y., Sun, T., Ma, D., Han, J., Qian, Y., Kryczek, I., Sun, D., Nagarsheth, N., 
Chen, Y., Chen, H., Hong, J., Zou, W., & Fang, J.-Y. (2017). Fusobacterium nucleatum 
Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy. Cell, 170(3), 
548-563.e16. https://doi.org/10.1016/j.cell.2017.07.008 
Zackular, J. P., Rogers, M. A. M., Ruffin, M. T., & Schloss, P. D. (2014). The Human Gut 
Microbiome as a Screening Tool for Colorectal Cancer. Cancer Prevention Research, 
7(11), 1112–1121. https://doi.org/10.1158/1940-6207.CAPR-14-0129 
Zamarron, B. F., & Chen, W. (2011). Dual Roles of Immune Cells and Their Factors in Cancer 
Development and Progression. International Journal of Biological Sciences, 7(5), 651–
658. https://doi.org/10.7150/ijbs.7.651 
Zarrinpar, A., Chaix, A., Yooseph, S., & Panda, S. (2014). Diet and Feeding Pattern Affect the 
Diurnal Dynamics of the Gut Microbiome. Cell Metabolism, 20(6), 1006–1017. 
https://doi.org/10.1016/j.cmet.2014.11.008 
Zeller, G., Tap, J., Voigt, A. Y., Sunagawa, S., Kultima, J. R., Costea, P. I., Amiot, A., Böhm, J., 
Brunetti, F., Habermann, N., Hercog, R., Koch, M., Luciani, A., Mende, D. R., Schneider, 
M. A., Schrotz‐King, P., Tournigand, C., Tran Van Nhieu, J., Yamada, T., … Bork, P. 
(2014). Potential of fecal microbiota for early‐stage detection of colorectal cancer. 
Molecular Systems Biology, 10(11), 766. https://doi.org/10.15252/msb.20145645 
Zhao, T., Liu, H., Roeder, K., & Wasserman, L. (2016). The huge Package for High-dimensional 
Undirected Graph Estimation in R. 6. 
Zheng, D.-W., Dong, X., Pan, P., Chen, K.-W., Fan, J.-X., Cheng, S.-X., & Zhang, X.-Z. (2019). 




augments their responses to chemotherapy. Nature Biomedical Engineering, 3(9), 717–
728. https://doi.org/10.1038/s41551-019-0423-2 
Zheng, X., Turkowski, K., Mora, J., Brüne, B., Seeger, W., Weigert, A., & Savai, R. (2017). 
Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel 
strategy for cancer therapy. Oncotarget, 8(29), 48436–48452. PubMed. 
https://doi.org/10.18632/oncotarget.17061 
Zhou, J., Deng, Y., Luo, F., He, Z., & Yang, Y. (2011). Phylogenetic Molecular Ecological 
Network of Soil Microbial Communities in Response to Elevated CO2. MBio, 2(4), 
e00122-11. https://doi.org/10.1128/mBio.00122-11 
 
